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The enzymes of the ribonuclease (RNase) family catalyze the hydrolysis of ribonucleic acid 
(RNA). There is a wide interest in therapeutic interventions of human RNases (hRNases) due to 
their critical role in host defense, cancer cell proliferation and neurodegenerative diseases. 
Development of structure-based therapeutics targeting individual members of a closely related 
enzyme family is difficult. The structural conservation among hRNases cannot explain a million-
fold difference in the catalytic efficiency of these enzymes. We hypothesize, this ambiguity in the 
structure activity relationship of hRNases can be explained by their dynamical behavior. The rate 
of substrate turnover in RNases correlates strongly with the rates of conformational dynamics. 
Moreover, catalytic efficiency is also linked to the ability of an enzyme to sample conformational 
sub-states that promote specific interaction between reactants at various stages of catalysis. 
Detailed characterization of the structure-function-dynamics relationship in hRNases can help in 
determining similarities and differences in the motions associated to catalysis thereby enhancing 
the possible druggability of this enzyme family.  
 
This study investigates the role of functionally relevant conformational sub-states and dynamics 
in each step of the RNase members catalytic cycle; apo, substrate-bound, the chemical step, and 
product release. Computer simulations and nuclear magnetic resonance (NMR) relaxation 
dispersion experiments indicated an increased dynamics in distal loop regions of RNases in their 
apo state. Similar dynamical patterns were observed within the members of an individual sub-
family, while dynamics were different across sub-families. Nucleotide binding properties probed 
using computer simulations indicated diverse binding preferences in hRNases. Additionally, 
structural and dynamical properties of hRNases varied significantly with subtle change in 
temperature. Quasi anharmonic analysis revealed sampling of separate conformational sub-
states in product release step of RNases. Further, NMR chemical shift titrations along with the 
chemical shift projection analysis revealed distinct conformational rearrangements in hRNases 
upon binding of ligands that mimic cleaved products. Steady-state kinetics experiments showed 
million-fold difference in the catalytic efficiency of hRNases. Finally, hybrid quantum 
mechanical/molecular mechanics calculations identified conformational sub-states associated 
with the chemical step in bovine RNase A. Broadly, these results strongly support our hypothesis 
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1.1 Enzymes and ribonuclease A superfamily  
Enzymes are biological macromolecules that catalyze cellular reactions essential to sustain life. 
Enzyme have the ability to enhance the rate of a chemical reaction by more than 1020 folds, 
making them the most efficient catalysts occurring naturally.1 The molecules upon which enzymes 
act are called as substrates; with each enzyme recognizing and acting upon a defined list of 
substrates. Upon completion of an enzymatic reaction, substrate(s) are converted into product(s). 
Enzymatic reactions occur in a cycle of multistep process, called as the catalytic cycle, which 
includes substrate(s) binding, chemical step and product(s) release. All these steps can occur 
within a few milliseconds or even less. During an enzymatic reaction the smallest fraction of time 
is spent in the most important part of the catalytic cycle, called the transition state (TS).2 TS is the 
highest energy transitory structure in a reaction which is no longer a substrate but not a product 
as yet. The energy required to reach the TS is the minimum energy required to convert a reactant 
into product, in this case also called as the activation energy. Compared to reaction in water or 
gas-phase, enzymes decrease activation energy by shaping their active site such that it binds to 
the transition state even better than the substrate.3 Most enzymes are tailored to bind a specific 
substrate(s) and perform a specific function (reaction). Enzymes' specificity comes from their 
unique three-dimensional (3D) structures. Enzymes are proteins, and their structure comprises of 
unbranched chain of amino acids that adopts a specific three-dimensional fold. Enzymes that 
share a common fold and catalyze same/similar reaction belong to a same protein family. A 
number of protein families together form a super family. In other words, protein super family refer 
to a group of structurally or functionally related proteins that may or may not have a common 
evolutionary origin.  
 
Ribonuclease A superfamily is a group of enzymes that catalyze the hydrolysis/degradation of 
ribonucleic acid (RNA) molecules into smaller components. Ribonucleases A enzymes specific to 
vertebrates are found in high quantity in the pancreas of certain mammals and some reptiles, and 
therefore are also called as pancreatic-type ribonuclease superfamily, hence forth called as 
RNase family.4-6  RNases have a marked preference for cleavage of RNA at the P-O5’ bond on 
the 3’ side of the pyrimidine residue and do not require any metal ion or cofactor (Figure 1.1).7 
The sequence identity among the RNase family members is sometime as low as ~20%.8 However, 
two histidine and one lysine residues essential for the RNase function are conserved (Figure 
1.2).8, 9 Structural information for several RNase homologs has been obtained by X-ray 





(~13-15 kilodaltons, kDa). In addition, they generally also have a short signal peptide of ~25 amino 
acids. Signal peptides are short segments usually at the N-terminal end of a newly synthesized 
protein, with a function to prompt the cell to translocate the synthesized protein usually to cell 
membranes. Even with a low primary sequence identity RNases adopt a common ⍺+𝛽𝛽 kidney 
shaped fold (Figure 1.3 A). The protein secondary structure elements (⍺ helix and 𝛽𝛽 sheets) are 
conserved, and variations can be observed only in loop regions (Figure 1.3 B). RNases have 6 to 
8 cysteine residues in their primary sequence that form three to four disulfide bonds in their three-
dimensional structure (Figure 1.3 A). Two antiparallel 𝛽𝛽 -sheets define the V1 and V2 domains 
linked by a hinge region in their kidney shaped structure. They have a well-defined binding cleft 








Figure 1.1: Schematic representation of Ribonuclease A function. RNA substrate is shown 
on left. The phosphodiester bond cleaved during RNase reaction is marked with an arrow. The 







Figure 1.2: Multiple sequence alignment of RNases. Sequence for human RNases and bovine 
RNase A is included. Fully conserved residues are highlighted in red boxes. Catalytic residues 
are marked with blue stars. Gaps in the alignment are represented using dotted lines. Consensus 
sequence number is shown at the top and bovine RNase A sequence numbering is shown at the 








Figure 1.3: Structure and structural alignment of RNases family members. (A) Ribbon 
diagram of the crystal structure of bovine RNase A (PDB ID 7RSA); cysteine residues are 
represented as purple sticks and the disulfide bonds are shown in yellow. V1 and V2 domain is 
represented in dashed line. (B) Structural alignment of representative RNases. Structures include 
1QMT (violet), 2K11(orange); 1ANG (cyan) and 1RNF (green). Catalytic residues are displayed 






1.2 Human RNases and their role in health 
RNase superfamily has remarkably high rates of gene duplication and gene loss, resulting in 
variable numbers of genes in different species.12 In humans, there are thirteen RNase type genes 
located on chromosome 14 within cluster 14q11.2 (Figure 1.4).13 Eight of these human RNases 
(hRNases 1-8) have the RNases function (i.e. can hydrolyze RNA molecule) and are referred to 
as canonical RNases. The other five open reading frames (ORFs), i.e. RNase 9-13 encode 
proteins that lacks the catalytic residues (two histidine and one lysine) essential for RNase 
function.5 The canonical hRNases are secretory protein, i.e. they are released from the cells 
where they were produced and translocated to target cells when they perform their designated 
function. These proteins are secreted by various innate immune cells, from blood cells to epithelial 
cells.14 They exhibit diverse expression pattern and are widely distributed in various organs, 
tissues and body fluids. The levels RNases in our body fluids correlate with infection and 
inflammation processes ensuring tissue health and body homeostasis.15 Apart from hydrolysis of 
dietary RNA, these enzymes participate in a wide variety of biological functions, including 
neurotoxicity, angiogenesis (blood vessel formation), immuno-modulatory, anti-pathogen and 
anti-tumor activities.8, 16, 17 Described below are the highlights of common features of the eight 
canonical hRNases with regard to their respective sequences, structure, biochemical 






Figure 1.4: Location of hRNases on human chromosome 14. hRNase1-8 perform 
ribonuclease function and degrade RNA molecules. hRNases 9-13 lack the residues required for 
enzymatic function and therefore do not catalyze RNase reaction. hRNase10 is towards the 





 Human RNase 1 (hRNase1) is expressed in a wide variety of human organs and tissues. 14, 18-
22 Apart from hydrolysis of RNA, hRNase1 has significant physiological implications in the 
regulation of vascular homeostasis due to its wide extracellular distribution.8, 23 In addition to 
cleavage of single-stranded RNA (ssRNA) this enzyme has been reported to hydrolyze double-
stranded RNA (dsRNA) molecule as well as DNA (deoxyribonucleic acid):RNA hybrids. 24 Due to 
its catalytic versatility, hRNase1 is reported to act as an extracellular RNA scavenger and 
inactivates human immunodeficiency virus  (HIV),25 participate in inflammatory and immune 
response by promoting maturation and activation of dendritic cells as well as subsequent 
production of different cytokines.26 Evidence indicate that hRNase1 important for normalization of 
serum viscosity and clearance of perivascular pathogenic polynucleotides. Further, it is reported 
that hRNase1 enters human cells and catalyze the cleavage of RNA, leading to cell death.27, 28 
Utilizing this ability, Raines and co-workers have demonstrated the potential of hRNase1 as a 
chemotherapeutic agent that is toxic to tumor cells.29  
 
Human RNase 2 (hRNase2), also known as eosinophil-derived neurotoxin (EDN) is found in 
spleen, liver, kidney, placenta, and urine.30-34  It has also been found in the secondary granules 
of eosinophil granulocytes. hRNase2 shares ~32% primary structure identity to hRNase18. It is 
reported to be inactive towards poly (A) and dsRNA and does not hydrolyze 2’:3’-cyclic 
nucleotides.35 hRNase2/EDN show neurotoxic potency and has a specific antiviral action against 
respiratory syncytial virus (RSV) 36, 37, HIV-I 38 and hepatitis B DNA virus 39. Its anti-viral activity is 
reported to be dependent on its ribonucleolytic activity. However, it does not display any 
bactericidal activity. Studies also suggest that hRNase2 might trigger an inflammatory response 
that activates killer cells or cell death pathways.16 Alternatively, hRNase2 can participate in further 
modulating the immune response by degrading the viral RNA in the cytoplasm of infected cells.15  
 
Human RNase 3 (hRNase3), also known as eosinophil cationic protein (ECP) is the other major 
secretory protein of the human eosinophil granule and is released upon cell 
activation/stimulation.40 hRNase3 shares ~26% primary structure identity to hRNase1 while it is ~ 
67 % similar to hRNase2.8 It is about two orders of magnitude less active on yeast tRNA as 
compared to hRNase1 and hRNase2.35, 41 hRNase3 displays anthelminthic, bactericidal, antiviral 
and antiparasitic activities.42 The ribonucleolytic activity of hRNase3 does not appear to be 
necessary for cytotoxicity or bactericidal activity, while it is essential of the antiviral activity. 
hRNase3’s high toxic activity has been demonstrated in vitro against Schistosoma mansoni, 





hRNase3/ECP is reported to correlate with its membrane disruption capability and is linked to 
aromatic and cationic residues located on the surface of the protein.42, 44 Although not completely 
understood, a stepwise mechanism of hRNase3 antibacterial activity is proposed.15, 45 hRNase3 
binds to the surface  of bacteria promoting conformational changes in the protein. All rearranged 
hRNase3 molecules bind to each other leading to agglutination of bacteria. The protein then forms 
amyloid-like aggregation that disrupts the lipopolysaccharide bilayer, resulting in possible 
membrane disruption in bacteria.  
 
Human RNase 4 (hRNase4), is detected in several somatic tissues including liver, pancreas, 
lung, heart, kidney, and placenta.8, 43 Cytoplasmic granules of monocytes also express this 
enzyme. This enzyme has the shortest amino acid sequence (119 residues) in this family and 
shares about 90% sequence identity with bovine ribonuclease A (bRNaseA), the prototypical 
member of the RNase superfamily. It is structurally more like hRNase1 (43% identity) than to 
hRNase2 (31% identity) but shares some catalytic properties with both RNase types. Like 
hRNase1 it shows hydrolytic activity towards 2’:3’-cyclic nucleotides.46 Although considerable 
work has been undertaken to interpret its biological properties, its specific biological function 
remains unknown. Nearly ubiquitous distribution of hRNase4 suggests a housekeeping role for 
this enzyme. Interestingly, hRNase4 has also been found in the soluble factors secreted by T-
cells showing anti-HIV activity further suggesting its involvement in host defense activities.47 
Additionally, it is reported that hRNase4 prevent the degeneration of neuron by promoting 
angiogenesis, neurogenesis, and promotes the neuronal survival under stress.48 Expression of 
hRNase4 is reduced in amyotrophic lateral sclerosis (ALS) affected patients,48 however a direct 
link between ALS and hRNase4 is yet to be established.  
 
Human RNase 5 (hRNase5), was first isolated from tumor cells and later found in a wide variety 
of tissues and organs.49, 50 This enzyme is a potent inducer angiogenesis, and therefore it is also 
called as angiogenin. hRNase5 is structurally similar to bRNaseA and hRNase1 however it has a 
million-fold lower ribonucleolytic activity than that of bRNaseA.8 Although hRNase5 exhibits 
extremely weak ribonucleolytic activity, it is still essential for angiogenesis. Studies report that 
hRNase5 undergoes nuclear translocation to stimulate blood vessel growth and plays an essential 
role in cell proliferation.51 A recent work correlated elevated hRNase5 expression in some tumor 
cell lines with the promotion of cell proliferation and development of malignant cancer.52 An 
association between ANG and cancer has been observed in more than 20 clinical studies to date. 





hRNase5 can lead to immune-related diseases, such as ALS.53 Recent studies report the 
involvement of hRNase5 in cell defense against stress and microbicidal activities. 
 
Human RNase 6 (hRNase6), also referred to as RNase K6, is found in neutrophils and 
monocytes and therefore proposed to have host defense functions.54 The amino acid sequence 
of hRNase6 is ~43% identical to hRNase2 and ~38% identical to hRNase1. Its ribonucleolytic 
activity towards yeast tRNA is 40 folds lower than hRNase2.8 RNase6 has been reported to 
display a high antimicrobial activity in vivo and it showed very low cytotoxicity levels against 
mammalian cells.55 It is also suggested to play an essential role in bacterial clearance at the 
urinary tract. Boix et al. recently proposed the antimicrobial mechanism of action.56 Highly cationic 
hRNase6 first interacts with the negatively charged envelopes of the bacterial cell subsequently 
leading membrane destabilization and bacterial agglutination. The investigators also found that 
the N-terminal domain of the protein retains the antimicrobial properties of the whole protein.57 
This suggests the possibility of using the scaffold of hRNase6 for developing peptide-based 
antimicrobial agents in the future. 
 
Human RNase 7 (hRNase7), is expressed in various epithelial tissues and organs. It was 
detected in skin as well as in the respiratory tract, genitourinary tract, liver, kidney, skeletal 
muscle, and heart.58, 59 The catalytic activity of hRNase7 is 50 fold higher hRNase3 and 8 fold 
lower than hRNase1.8 hRNase7 is reported to have potent bactericidal activity against several 
Gram-positive and Gram-negative bacteria. It is therefore called as epithelial-derived 
antimicrobial protein.55 Recent studies have reported the ability of hRNase7 to permeate the 
bacterial membranes. Specific lysine residues (K1, K3, K111, and K112) were identified to be 
crucial for its antimicrobial mechanism of action, and ribonucleolytic activity was not essential for 
its antibacterial action.60, 61 
 
Human RNase 8 (hRNase8), is the most recently discovered active human RNase and is 
expressed uniquely in the placenta. It is reported to have antimicrobial activity against various 
bacteria including Candida albicans and does not affect the human cells, suggesting that it plays 
a role in protecting the placenta against infections.62 Its reported ribonucleolytic activity against 
yeast tRNA is two folds lower than that of hRNase7.8 At present, no information regarding 






1.3 Biochemical and biophysical characterization of RNases 
The physical, chemical and enzymatic properties of the bovine RNase (bRNaseA) have been 
extensively characterized.7, 63, 64 However, comparatively lesser information is available for 
recently discovered human RNases. In this section, the biochemical and biophysical properties 
bRNaseA and hRNases is summarized. bRNaseA is a catanionic protein (pI = 9.63) at 
physiological pH. It has several positively charged residues (10 lysine and 4 arginine residues) 
that enable its binding to RNA (a polyanion). In other words, bRNaseA has smaller number of 
hydrophobic groups, especially aliphatic ones. Its low hydrophobic content may also serve to 
reduce the physical repulsion between highly charged groups (its own and those of its substrate 
RNA) and regions of low dielectric constant (the nonpolar residues). Similar to bRNaseA, 
hRNases also have high isoelectric points and net positive charges (with pI values between 8.69 
– 10.12).16 These properties are associated with antibacterial activity and strong interactions with 
their negatively charged polynucleotide substrates. However, each hRNases varies in its 
nucleotide substrate preference and ribonucleolytic activity.  
 
1.3.A Substrate binding and specificity  
Binding of single-stranded nucleotides to bRNaseA involves up to seven coulombic interactions 
suggesting that the enzyme-substrate interaction extends well beyond the scissile bond.7 
Structural and kinetic studies, using different oligonucleotides substrates and polynucleotides (as 
homologous to the RNA substrate) reveal the existence of several substrate binding sub-sites 65 
that make up the active site in the structure of RNases as shown in Figure 1.5. The amino acid 
residues that form the sub-sites for bRNaseA have been well defined. The B1 sub-site consisting 
of residues Thr45 and Asp83 appear to bind only pyrimidine bases. Thr45 sterically hinders the 
binding of purine base in B1 sub-site and mediates pyrimidine specificity by forming a hydrogen 
bond. Thr45 can act as a donor or acceptor depending upon the binding nucleotide, and the 
conformation of Asp83 is responsible for switching this role of Thr45.66 Additionally, Phe120 
contributes to pyrimidine binding in B1 sub-site by forming a van der Waals contact and acts as a 
hydrophobic mattress for the base. Phe120 also plays an important role in stabilizing the TS 
intermediate in catalysis by forming a hydrogen bond with non-bridging oxygen of the reactive 
phosphoryl group.7 The B2 sub-site, comprising of residues Gln69, Asn71 and Glu111, has a 
preference of adenine base.9, 67 The difference in the specificities of B1 and B2 sub-sites makes 
RNases a distributive enzyme, that binds a polymeric substrate, catalyzes a chemical reaction 






Three other enzymatic sub-sites P0, P1, and P2 interacts with the phosphoryl groups of the bound 
RNA substrate. The P1 sub-site comprising of residues Gln11, His12, Lys41, His119, and Asp121 
forms the active site in bRNaseA (Figure 1.5). The phosphoryl group bound at the P1 site 
participates in the reaction mechanism.7, 9 Site-directed mutagenesis has shown that residues 
Lys7, Arg10, Gln11, His12, Lys41, Thr45, Lys66, Asn71, Asp83, Glu111, His119, Phe120, and 
Asp121 contribute towards substrate binding or turnover in bRNaseA. Substitution of these 
residues has resulted in reduced catalytic activity by ~ 104 fold.7 
 
Sequence alignment for canonical hRNases and bRNaseA show that the residues of main 
phosphate binding P1 sub-sites sites are conserved (Figure 1.2) in all members. The threonine 
residue of B1 sub-site and asparagine of B2 sub-site are also conserved. However, variability is 
observed in other residues of base binding sub-sites which attributes to substrate preference and 
cleavage pattern in RNase homologs. Further, nucleotide binding recognition patterns for 
hRNases has been deduced based on the available protein-ligand complexes in the Protein Data 
Bank (PDB).9 The base preference of select hRNases and bRNaseA is reported in Table 1.1. 
bRNaseA and hRNase1, has a higher preference for cytosine containing substrates. It is reported 
that bRNaseA can hydrolyze cytosine containing substrates at-least 2 folds faster than uridylyl 
substrates.7 Table 1.1 reports that hRNases 2 - 4 have a clear preference for uracil containing 
substrates. Asn71 (bRNaseA numbering) can contribute as both acceptor and donor while 
bonding to adenine base,68 and all hRNases share this purine recognition trait.9, 57, 69, 70 However, 
variations are observed in pyrimidine binding. In hRNase4 the aspartate residue of B1 sub-site is 
not flexible to move and therefore locks the threonine residue as a hydrogen bond acceptor 
facilitating interaction mainly with uracil nucleotide.71 This substitution of Arg101 (in place of 
Lys104 in bRNaseA) prevents the binding of cytosine base in B1 sub-site of hRNase4. Substitution 
of this lysine residue is also found in hRNase2 and 3 increasing their preference for uracil base.72 
In hRNase5, Gln117 is oriented towards the active site in the solved crystal structure and hinders 
the access of the substrate to the pyrimidine binding site suggesting the requirement of 
conformational rearrangement to allow the main base binding.73 Moreover, specific orientation of 
catalytic residues is not favorable for cleavage of RNA resulting in million-fold lower catalytic 
efficiency in hRNase5. Therefore, non-conserved substitutions at binding sub-sites might explain 
the distinct substrate specificities in these homologs reported in Table 1.1. These observations 
should, however, be considered with caution; as many complex structures were solved in non-










Table 1.1: Sub - site base preference in RNases. Preference of B1 and B2 sub-sites is deduced 
from crystal structure and kinetic studies (Adapted from 9) 
 
Enzyme Substrates investigated Preference at B1 sub-site 
Preference at 
B2 sub-site Ref 
hRNase1 Poly(C), Poly(U) C > U A 74 
hRNase2 UpA, UpG Poly(C), Poly(U) U > C A > G 74, 75 
hRNase3 
CpA, UpA, UpG 
Poly(C), Poly(U) 




U >>> C 
(10:1) 













Figure 1.5: Nucleotide binding sub-sites in ribonucleases. either uracil or cytosine can bind 
to B1 sub-site. B2 sub-site has a preference for adenosine in RNase A family. The catalytic 
residues form the phosphate binding sub-site P1. The phosphodiester bond cleave during RNase 
reaction is marked with an arrow. bRNaseA residues that interact with the substrate RNA 






1.3.B Catalytic mechanism of phosphodiester bond cleavage  
RNase catalyze the cleavage of phosphodiester bond (P-O5’) found in the RNA backbone. The 
mechanism of catalysis by RNases has been studied by a number of biochemical and biophysical 
approaches.7, 79-84 The overall RNase reaction have been proposed to involve two separate steps. 
The first (transphosphorylation) step, 3',5'-phosphodiester bond of RNA molecule is cleaved to 
give an oligonucleotide terminating in a pyrimidine 2′,3′-cyclic nucleotide and a 5’ hydroxyl 
terminated fragment; in the second (hydrolysis) step this 2′,3′-cyclic nucleotide is hydrolyzed, by 
water attack, and a terminal 3′-nucleotide is formed (Figure 1.6).7 Two types of mechanisms for 
the transphosphorylation step have been extensively discussed in the literature.7, 85-89 The first is 
the widely accepted classical mechanism that follows a minimal acid/base mechanism with a di-
anionic TS (Figure 1.7).88, 89 The second type of mechanism that has been proposed is based on 
a tri-ester mechanism leading to a monoanionic TS (Figure 1.8).86 This mechanism has received 
less acceptance. The difference in the two proposed mechanisms of transphosphorylation is the 
destination of protons as well as the sequence in which they are transferred.85 
 
The widely accepted mechanism of transphosphorylation step proposes that the reaction is 
catalyzed by concerted general acid/base catalysis by His12 and His119 (in bRNaseA).90, 91 The 
imidazole group of His12 acts as a base that abstracts a proton from the 2’-O of a substrate 
molecule. This nucleophilic oxygen attacks the electrophilic phosphorous and forms a pentavalent 
intermediate. Lys41 directly interacts with the phosphate moiety and stabilizes the pentavalent 
TS intermediate.7, 92 The imidazole group of His119 acts as an acid for the cleavage reaction and 
protonates the 5’O of the leaving group.  
 
An alternative tri-ester mechanism has also been proposed.93 Evidence from experimental 
observations and gas-phase quantum chemistry calculations support this method.94 In this 
mechanism, a proton originating via migration from the O2' hydroxide coordinates with one of the 
nonbridging phosphate oxygen rendering the phosphate neutral, which facilitates nucleophilic 
attack by the 2’-alkoxide to form a phosphate tri-ester like intermediate structure. After the 
formation of the trigonal bipyramidal phosphorane structure, the catalytic proton is abstracted 
from the nonbridging oxygen by the catalytic base His119, leading to the expulsion of the leaving 








Figure 1.6: Mechanism of Ribonuclease function. bRNaseA catalyzed (A) 
Transphosphorylation of 3',5'-phosphodiester bond of RNA molecule leading to a 2′,3′-cyclic 
nucleotide and 5’ hydroxyl terminated fragment. (B) Hydrolysis of 2′,3′-cyclic nucleotide to a 







Figure 1.7: Widely accepted general acid/base mechanism for transesterification step.  
The reactant, product and transitions state (TS) are shown. His12 acts as a general base and 
His119 acts as a general acid. Catalytic residues are numbered according to bRNaseA (This 







After the transphosphorylation step each histidine residues is protonated appropriately to catalyze 
the hydrolysis (Figure 1.6 B) of the bound cyclic intermediate. In the second hydrolysis step, the 
2’,3’ cyclic phosphate is hydrolyzed to a 3' terminal nucleotide.96 The catalytic roles of His12 and 
His119 are now reversed. His119 activates the attack of water by acting as a general base while 
His12 protonates the leaving group acting as a general acid. His119 abstracts the proton from a 
water molecule, activating it for nucleophilic attack. The activated water molecule then attacks the 
cyclic phosphate resulting in the cleavage of the 2',3’ cyclic phosphate intermediate. 
Simultaneously, His12 donates a proton to the leaving group, which is the 3’ oxygen of the cyclic 
intermediate. Finally, the truncated nucleotide with a 3’ terminal phosphate group is released. 
After the process of hydrolysis, the histidine residues return to their initial protonation states 
completing the catalytic cycle. bRNaseA, however, can release the cyclic intermediate rather than 
hydrolyzing it.96, 97 Under such instances, the protonation states of the two histidine residues are 







Figure 1.8: Calculated low energy path for tri-ester like mechanism. This pathway is 
calculated based on a first principle quantum mechanics/molecule mechanics (QM/MM) with 
density function theory (DFT/B3LYP) level of electronic structure calculations. Catalytic residues 






1.3.C Catalytic efficiency  
The rate of enzymatic reaction has been measured for RNases using steady-state kinetics 
experiments. The kinetic parameters; the rate of catalytic turnover (kcat), the amount of substrate 
needed for the enzyme to obtain half of its maximum rate of reaction (KM) and catalytic efficiency 
(ratio of kcat/KM) for bRNaseA and hRNases is reported in Table 1.2. The data in Table 1.2 
indicates that binding affinities differ over several orders of magnitude between these RNases. 
Further, catalytic efficiencies for these homologs differ by as much as 106-fold. However, these 
kinetic assays have been performed under different experimental conditions (pH, temperature, 
buffer) and using variety of substrates with different nucleotide sequences with variable lengths 
resulting in diverse binding affinities and catalytic efficiencies. Therefore, these differences should 
be carefully considered when comparing the efficiency in these homologs.  
 
1.4 Role of dynamics in enzyme function  
The role of enzyme structure as a scaffold to facilitate the catalyzed reaction is well established. 
The active site of enzyme provides a complementary structural and electrostatic environment to 
preferentially bind specific substrates and/or cofactors and subsequently stabilize the TS allowing 
the reactions to proceed at a much faster rate than in solution.98 This perspective, however, fails 
to explain many phenomena observed in enzyme structure and function; First, the allosteric and 
cooperative effects of residues outside the active site; many studies report significant changes in 
catalytic efficiency of enzymes pertaining to mutations in distal residues. 99, 100 Second, the impact 
of bulk and hydration shell in enzyme activity.101 Third, large rate-enhancement achieved by 
structurally similar enzymes, for example, the members of the RNase family share conserved 
structural scaffold and catalytic machinery, yet their catalytic efficiency differs by a million folds 
(Table 1.2). And finally, efforts towards designing proteins with active sites environment similar to 
natural enzymes have not been very successful.102 Therefore, the rate enhancements by 
enzymes and their reaction mechanisms cannot be fully explained by the structural effects alone. 
In addition to the role of direct structural interactions, several other factors contribute to catalysis 
for example networks of hydrogen bond and long-range effects.103, 104 
 
The emergence of new information has allowed enzymes to be viewed beyond a single rigid 
structural scaffold. Evidence from multiple experimental and computational techniques show 





Table 1.2: Summary of reported substrate binding affinities and enzyme activity. In addition 
to hRNases 1-6, the parameters for bRNaseA are also shown for comparison. tRNA denotes 
substrate of non-specific sequence obtained from cellular tRNA.  
 
Protein Substrate KM (mM) kcat (s-1) kcat/KM (s
-1M-1) x 
106 Temp. (K) Ref. 
hRNase1 Poly(C) 0.10 ± 0.013 2416.67 ± 33.3 1.48 ± 0.11 310 105 
hRNase1 tRNA 4.0 64.8 0.0.162  106 
hRNase2 tRNA 0.0007 0.91 0.13  107 
hRNase2 tRNA 0.00336 ± 0.00015 31.37 ± 0.96 9.34 ± 0.17  
108 
hRNase2 tRNA 0.0128 3.7 3.2 310 109 
hRNase2 Poly(U) 80 ± 7 190 ± 11   108 
hRNase2 tRNA 2.5 ± 0.21 20 ± 0.65   108 
hRNase2 tRNA 0.0036 ± 0.00015 31.37 ± 0.96 9.34 ± 0.17  
70 
hRNase2 Poly(U) 53.05 ± 4.04 1248.93 ± 12.10 4.79 ± 0.52  70 
hRNase3 CpA 1.7±0.3 0.55±0.06 0.000323 298 57 
hRNase3 UpA 2.7±0.66 1.22±0.12 0.000447 298 57 
hRNase3 C > p 3±0.53 0.0032±0.00051 1.07×10−6 298 57 
hRNase3 C > p 1.5 0.014 0.000011 298 110 
hRNase3 U > p 1.0 0.0043 0.000004 298 110 
hRNase3 CpA 2.4 4.2 0.001750 298 110 
hRNase3 UpA 5.4 6.2 0.001150 298 110 
hRNase3 (Up)2 U > p 1.4 0.56 0.000400 298 110 
hRNase3 (Up)3 U > p 0.7 1.2 0.001714 298 110 
hRNase3 (Up)4 U > p 0.17 1.4 0.008235 298 110 
hRNase3 ytRNA 0.0041 0.0024 0.000590 298 110 
hRNase3 Poly(U) 253 ± 10 36 ± 0.4 0.00014 ± 0.000005  
111 
hRNase4 UpA   0.25 298 112 
hRNase4 CpA   0.00066   
hRNase5 CpA   0.0000122 ± 0.0000002 298 
69, 113 
hRNase5 CpG   0.000004 ± 0.0000001 298 
69, 113 
hRNase5 CpC   0.0000013 ± 0.0000001 298 
69, 113 
hRNase5 CpU   0.0000006 ± 0.0000001 298 
69, 113 
hRNase5 UpA   0.0000007 ± 0.0000001 298 
69, 113 
hRNase5 UpG   0.00000013 ± 0.00000002 298 
69, 113 
hRNase5 UpC   0.00000006 ± 0.00000001 298 
69, 113 






Table 1.2 continued 
Protein Substrate KM (mM) kcat (s-1) kcat/KM (s
-1M-1) x 
106 Temp. (K) Ref. 
hRNase5 pCpA   0.000019 ± 0.000001 298 
69, 113 
hRNase5 CpAp   0.000110 ± 0.000005 298 
69, 113 
hRNase5 CpApG   0.000055 ± 0.000002 298 
69, 113 
hRNase5 CpApA   0.000044 ± 0.000002 298 
69, 113 
hRNase5 CpApU   0.000030 ± 0.000001 298 
69, 113 
hRNase5 CpApC   0.000021 ± 0.000001 298 
69, 113 
hRNase5 CpA   0.0000024 ± 0.0000001 298 
69, 113 
hRNase5 CpAp   0.000017 ± 0.0000001 298 
69, 113 
hRNase5 CpApG   0.0000117 ± 0.0000003 298 
69, 113 
hRNase5 CpA   0.0000040 ± 0.0000001 298 
69, 113 
hRNase5 CpAp   0.000033 ± 0.0000002 298 
69, 113 
hRNase5 CpApG   0.000016 ± 0.0000004 298 
69, 113 
hRNase6 tRNA 0.005 0.13 0.000026 298 54, 57 
hRNase6 UpA 2.63±0.3 12.9±1.1 0.0049 298 57 
hRNase6 CpA 1.22±0.2 1.08±0.1 0.000885 298 57 
hRNase6 C>p 2.06±0.3 0.00325 ± 0.06 1.6 ×10−6 298 57 
hRNase7 ytRNA 0.0022 5.1 2.3 310 58 
bRNaseA UpA 0.20 ± 0.06 347 ± 40 1.7 ± 0.3 298 114 
bRNaseA UpA 0.33 1920 5.8 298 115 
bRNaseA UpA 0.62 ± 0.09 1400 ± 150 2.3 ± 0.4 298 116 
bRNaseA UpA 0.7 2690 3.0 ± 0.1 298 117 
bRNaseA CpA 0.5 2300 6.4 ± 0.7 298 117 
bRNaseA C > p 1.06±0.1 2.28±0.18 0.00215 298 57 
bRNaseA Poly(C) 0.047 ± 0.011 190 ± 11 4.0 ± 1.0 283 118 
bRNaseA Poly(C) 0.089 ± 0.009 507 ± 15 5.7 ± 0.5 298 114 
bRNaseA Poly(C) 0.0331 ± 2.6 368.0 ± 11.0 11.2 ± 0.6  119 
bRNaseA Poly(U) 0.06 24 0.4 298 115 
bRNaseA Poly(C) 0.034 510 15 298 115 
bRNaseA Poly(U) 0.06 ± 0.01 24 ± 15 0.4 ± 0.3 298 116 
bRNaseA Poly(C) 0.034 ± 0.002 510 ± 10 15 ± 1 298 116 
bRNaseA Poly(A) 0.080 ± 0.009 0.023 ± 0.001 0.00028 ± 0.00004 298 
116 






conformations.120-122 Alternate conformations are sampled as a result of internal motions in the 
enzymes driven by the surrounding environment and temperature.123 Internal protein motions 
occurring at all time scales is known as protein dynamics. These motions associated with protein 
dynamics occur on a wide range of time-scales ranging from femtosecond to millisecond (fs - ms). 
Fast motions governing side chain and backbone rearrangements occur at picosecond to 
nanosecond (ps - ns) time scales and allow sampling of conformations in the near vicinity. Large 
conformational changes are slow motions that occur mainly at longer time-scales microsecond to 
millisecond (μs - ms) and are associated with overcoming large energy barriers allowing inter-
conversion between different group of populations (Figure 1.9).104, 124, 125  
 
Studies report that enzyme landscape is full of conformational states, which are sampled over 
different time-scales.126, 127 The conformational fluctuations occurring at the time scale of reaction 
allow the enzyme to access the region of conformational landscape that contains the correct 
structural and dynamical features to promote specific interactions between reactants.128 In other 
words, the rate of the various events in the enzyme cycle is connected to the rate of sampling of 
correct motions/conformations. Only a small fraction of the conformations sampled by an enzyme 
facilitate in substrate (and/or cofactor) binding, reactant ground state stabilization, the chemical 
step of conversion, and product release along the catalytic cycle. These function promoting 
conformations are called as conformational sub-states.129 Conformational sub-states promote 
specific interactions between reactants in various stages of the catalytic cycle. Accessing such 
conformational sub-states is not a random event but form an integral part of enzymes function. 
 
A number of studies summarizing the contribution of dynamical motions and conformational 
fluctuations in enzyme catalysis have reported the presences of complex residue networks in 
enzyme structure that connects the surface loop regions to the active site by a series of hydrogen 
bonds and hydrophobic interactions.103, 130, 131 Conformational fluctuations in these network 
residues introduce favorable changes in the active site allowing the enzyme to become more 
productive. Another vital role of these network pathways is to couple the surrounding solvent to 
enzyme function. The motions on the surface of the enzyme harness energy from the surrounding 
solvent which is eventually fed into the global conformational fluctuation of the enzyme providing 
energy for overcoming the activation energy barrier.104, 132 The presence of such networks and 








Figure 1.9: Schematic representation of conformational landscape of protein. The arrows 
correspond to the conformational fluctuations within and between the distinct sub-states. Faster 
time-scales (ps - ns) allow conformational sampling within a well. Conformational fluctuations at 
slower time-scales (µs - ms) allow interconversion between two conformational states A (lower 







1.4.A Dynamics in ribonucleases 
The effect of protein motion on different aspects of enzyme function and protein complex 
formation in a variety of systems has become accessible through NMR relaxation experiments.134, 
135 Based on NMR dispersion relaxation experiments Loria and coworkers found that bRNaseA 
was rigid (absence of internal motions) at lower time-scales (ps - ns). However, residues in 
bRNaseA were dynamic at the µs to ms time-scale and showed chemical exchange in 15N-CPMG 
NMR experiments, i.e., displayed dynamic behavior. These residues also included the residues 
that form the B1, B2 and P0 sub-sites in bRNaseA. The average chemical exchange rate (kex) 
quantified for dynamic residues in CPMG experiments was 1640 s-1 which is similar to the rate of 
catalytic turnover in bRNaseA (1900 s-1), suggesting a possible correlation between enzyme 
dynamics and catalysis in bRNaseA.136 
 
Further Loria and coworkers identified that mutations in distal residues His48 and loop1 (Figure 
1.3) residues resulted in the loss of ms motions and 10-fold decrease in catalytic activity of 
bRNaseA suggesting that motions in RNase A were functionally relevant and more widespread 
than the active site.137 Additionally, their studies highlight the importance of H-bonding interactions 
in the propagation of functional motions in bRNaseA. His48 was eventually shown to be an 
important conformational switch that controls distal motions that are essential for optimal product 
release.138 Doucet et al. in their work demonstrated that altering one methyl ~10 Å away from the 
active site significantly alters conformational dynamics of bRNaseA on ns - ms time-scale. This 
change in the dynamics of the enzyme affects ligand binding and specificity.139 Further studies on 
bRNaseA motion using NMR and computer simulations reveal that RNase does not undergo large 
conformational changes as observed in highly flexible proteins/enzymes. Flexibility in bRNaseA 
propels subtle movements of the loops and secondary structure elements. The movements play 
a crucial role in important steps of enzymatic cycle which is substrate recognition, catalysis, and/or 
product release. Human homologs of bRNaseA have also been subjected to dynamic 
investigation.139-143 
 
Global and local motions in hRNases are closely related to dynamics observed in bRNaseA, and 
similar motions are observed for the conserved catalytic residues in some members.140 In 
hRNase1, catalytic residue His119 is flexible and undergoes chemical exchange.  NMR studies 
revealed that loop 4 in hRNase1 is highly flexible in the absence of ligand consistent with motions 
observed in bRNaseA; however, it becomes rigid upon inhibitor binding.141 NMR studies of 





higher-than average residue motion of this loop consistent with bRNaseA.142, 144 However, their 
rate of conformational exchange varies significantly from bRNaseA. Further, experimental 
evidence also illustrates that the millisecond motions essential to product release in bRNaseA are 
absent from hRNase3. In hRNase5 the V1 and V2 domains undergo large breathing motions on 
the ns time-scale, like the hinge-bending motions observed in the bRNaseA143. Like bRNaseA 
His114 (bRNaseA His119) and Lys40 (bRNaseA Lys41) residues were dynamic, while His13 was 
found to be very rigid on NMR time-scales.145 Considerable flexibility is observed in loop4 on the 
ns time-scale which contributes towards purine selection in hRNase5. However, at ms time-scale, 
hRNase5 is a more conformationally restrained as compared to other homologs.146 While the 
conservation of global, collective flexibility manifested by RNases has been appreciated for this 
enzyme fold, the differences in their dynamical signatures at functionally relevant time-scale have 
not yet been analyzed in detail. Correlating the subtle difference in the dynamics of these human 
homologs with their catalytic efficiency would provide a better understanding of the role of 
conformational motions in enzyme functions. 
 
1.5 Methods for studying protein dynamics 
Internal dynamics and conformational sub-states associated with the function of an enzyme can 
be identified and characterized using experimental and computer simulations discussed below  
 
1.5.A Molecular dynamics simulations 
Experimental techniques like NMR,147, 148 single molecule Fröster Resonance Energy Transfer 
(smFRET),149 small angle scattering (X-ray and neutron),150, 151 electron paramagnetic resonance 
(EPR) spectroscopy,152 hydrogen/deuterium exchange mass spectroscopy (HD/X-MS)153 have 
been useful in identify global motions and conformational fluctuations in proteins. However, these 
techniques cannot capture the behavior of proteins at the full atomic detail and over time. 
Molecular dynamics (MD) is a computer simulation method for studying the physical movements 
of individual atoms in a biological macromolecule that cannot be observed directly in laboratory 
experiments. MD simulations have played an important role in increasing our understanding of 
the dynamical aspects of protein structure and function.154-156   
 
MD simulations provides a detailed picture of atomic-level motions or particles and molecules as 





and velocity of each atom are updated, and this process is iteratively repeated through time. The 
inter-atomic forces between the particles are calculated using interatomic potentials collectively 
referred to as molecular mechanics force fields.158 A typical force field incorporates electrostatic 
(coulombic) interactions between atoms, spring-like terms that model the preferred length of each 
covalent bonds, angles, dihedrals and other types of non-bonded interactions. The timestep 
between each step in a MD simulation is in femtoseconds. Therefore, interactions between atoms 
are computed for millions and billions of steps to understand the structurally important motions at 
functionally relevant time-scales. This makes MD simulations computationally demanding.  
 
Conformational motions in proteins are observed over a wide range of time scales (fs-s).159 
Historically, the time-scales accessible by MD simulation have been shorter than the time-scales 
at which biomolecular events of interest take place. However, recent advances in computer 
hardware, software, and simulation algorithms have enabled sampling of biomolecules at the 
functionally relevant μs - ms time-scales in a regular manner. Improvements in force fields and 
advances in sampling techniques have also made significant contributions towards overcoming 
barriers and sampling the vast conformational landscape of biomolecules.160-162 Careful analysis 
of the conformational snapshots sampled during MD simulation can provide information about 
underlying low-frequency motions which corresponds to significant conformational changes 
relevant to the function of biomolecule under investigation. MD simulations can also be used to 
understand how a biomolecule will respond to perturbation like removal or change of ligand, 
mutation of residues, post-translational modifications, change in protonation state of important 
amino acids, temperature, pressure, pH, voltage etc. MD simulations can further capture elements 
required for understanding the molecular basis of important functional processes like ligand 
binding,163 protein folding,164 and allostery.165 
 
Simulations have proven valuable in deciphering functional mechanisms of biomolecules, in 
uncovering the structural basis function, however, a number of choices have to be made when 
using MD simulations.166 Starting from the hardware to use (central processing unit (CPU) vs. 
graphical processing unit (GPU)), the software package and its version, the forcefield (AMBER,158 
CHARMM,167 GROMOS,168 OPLS169) to simulation conditions (like temperature or pressure) and 
choice of starting structure can have a significant effect of the computed trajectory. While each of 
these components has its own strengths and weaknesses, they could significantly affect the 
results. Therefore, it is essential to perform multiple simulations and ensure reproducibility in the 





meticulously, considering various sources of error that might affect the results and results should 
be compared with experimental data if available. Using MD simulation, we are interested in 
understanding the biophysical and biochemical basis of substrate binding and product release in 
human homologs of RNase family members.  
 
1.5.B Hybrid QM/MM 
Limitations of classical MD simulations include that no covalent bonds can be formed or broken 
during the simulations. Therefore, MD simulations cannot be employed for modeling reactions 
that involve changes to covalent bonds or chemical reaction. Quantum-mechanical (QM) methods 
are used to model chemical reactions and other electronic processes in biomolecular systems. 
However, QM methods are computationally expensive and can practically be applied to systems 
which typically consists of up to a few hundred atoms at most. The modeling of enzyme reactions 
(in explicit solvent) requires methods that can treat thousands of atoms. Thus, to model the 
reaction mechanism of large biomolecules like enzyme systems the preferred approach is to use 
the hybrid QM/MM approach.170-173  This approach combines the use of QM method for active site 
region and an MM treatment for the surrounding protein and solvent. With a reasonable 
computational effort hybrid QM/MM method provide the necessary accuracy to model reactive 
biomolecular systems.  
 
Like MD simulations proper design and execution of QM/MM simulations are very important.174, 
175 A wide variety of QM methods is available, from fast semi-empirical methods (AM1,176 PM3,177 
SCC-DFTB178), to highly accurate but computationally expensive electronic structure methods 
(DFT 179 and ab-initio180). It is equally important to carefully choose the MM force field that can 
accurately treat the atoms outside the QM region and their interactions with the QM atoms. The 
method to treat covalent bonds that cross the QM/MM boundary is an important consideration in 
QM/MM simulations. Methods like introducing additional link atoms, hybrid orbitals on MM atoms 
or a pseudobond to replace the QM-MM covalent bond has provided reasonable results.170, 181, 182 
 
Further depending on the scientific question, (relative) potential energies, or alternatively free 
energies, for the reaction can be obtained. A potential energy profile or the  minimum energy 
pathway of a reaction can be determined by minimizing the energy of the system at several points 
along the reaction coordinate. Deriving free energy profiles using QM/MM methods are generally 





QM region using cheap approximate methods that reduces the computational effort considerably. 
Unfortunately, such methods have been subjected to a critical and often controversial discussion 
in the literature. There is a need to further improve the accuracy and sampling achieved by 
QM/MM methods, but the existing methods are already good enough to provide realistic modeling 
of biomolecular reactions. 
 
QM/MM studies have provided detailed mechanistic insights into the enzymatic reactions of 
cytochrome P450,183 peroxidases,184 nitric oxide synthase,185 horseradish peroxidase,186 
chorismite mutase,187, 188 DHFR 146 and many other enzymes. The information obtained from 
QM/MM studies is increasingly allowing the designing of better drug leads, predicting drug 
metabolism, understanding drug resistance, and understanding the effect of mutations (in active-
site and distal) on reactivity.175 In RNases, determination of enzyme reaction pathway and TS 
using accurate QM/MM methods will significantly assist in the design of enzyme for specific 
application, structure-based drug design, and improving structure-activity relationship methods. 
Additionally, obtaining conformational fluctuations associated with the reaction mechanism from 
QM/MM methods will aid in allosteric regulation of enzymatic processes and designing allosteric 
drugs. 
 
1.5.C Quasi Anharmonic Analysis (QAA) 
Experimental techniques, including neutron scattering, have indicated that protein motions are 
anharmonic with multiple wells in the conformational landscape.189 These anharmonic structural 
changes activate functionally relevant motions in proteins. Second order clustering methods are 
unable to identify conformational sub-states of anharmonic protein motions, the use of higher-
order methods is necessary for identifying them. Quasi anharmonic analysis (QAA) uses fourth-
order statistics to describe the atomic fluctuations and summarizes the internal motions relevant 
to protein function.129 
 
In QAA, a coupling matrix which encodes an anharmonic mode of motion describing the higher-
order correlations between different regions of the protein is computed. Anharmonic sources are 
fully decorrelated, and higher-order dependencies in positional fluctuations are minimized. 
Additionally, a linear model is used which ignores any non-linear coupling that may exist in the 





are more relevant to the intrinsic motions of atom-pairs in proteins since the directionality of the 
motions lead to energetically homogeneous sub-states. 
 
In their work Chennubholta, Agarwal and co-workers, have shown that using QAA it is possible 
to identify and characterize conformational sub-states that have low populations in the 
conformational landscape.122, 129 They have demonstrated that the QAA has unique ability to 
distinguish energetically homogenous sub-states. Further QAA allows clean separation between 
the conformational sub-states by projecting the conformations sampled during the MD simulations 
in a lower dimensional space represented by QAA vectors. These conformational sub-states can 
be characterized for any relevant biophysical properties (such as internal energy, distance order 
parameter, or reaction coordinate).  
 
Using series umbrella sampling simulations Chennubholta, Agarwal and co-workers modeled the 
cis/trans isomerization catalyzed by enzyme cyclophilin A (CypA).129 They obtained the 
conformational sub-states along the reaction pathway of CypA by applying QAA to all 
conformations generated from simulations (Figure 1.10). Characterization of conformational sub-
states in CypA indicates the enzyme's intrinsic ability is to explore conformations correspond to 
various sections of the reaction pathway, corresponding to low energy reactant and product states 
as well as the high energy transition state. Analysis of movements that allow interconversion 
between sub-states revealed the structural and dynamical features required to attain the transition 
state.  
 
1.5.D Carr-Purcell-Meiboom-Gill (CPMG) - NMR relaxation dispersion  
NMR spectroscopy represents a powerful technique for studying dynamical features of proteins. 
NMR utilizes the magnetic properties of certain 1H, 13C, 15N and 31P nuclei commonly found in 
proteins.190 These isotopically nuclei are inserted in the protein structure in a non-invasive manner 
serving as site-specific probes of local structure and dynamics.191  Depending on the environment 
of atoms within the protein, the nuclei of individual atoms will absorb different frequencies of radio 
signals. The absorption signals of different nuclei may be perturbed by change in their chemical 
environment over time or in presence of a ligand. The NMR probes are exposed to at least two 
distinct chemical environment in a time dependent manner, a process called as chemical 
exchange.  NMR spectra affected by chemical exchange is then used to determine the change in 





collective behavior of individual nucleotide.192  Therefore NMR spectroscopy is uniquely suited to 
study protein dynamics under equilibrium conditions, with no need for external perturbations such 
as changes of temperature or pressure. 
 
Many biochemical events (including the ribonucleolytic cleavage catalyzed by RNases) occur on 
the µs - ms time-scale, and it is of considerable interest to characterize the conformational 
transitions that are involved in such processes.138, 193-196 Motion in this time-scale window 
generally includes side chain reorientation, loop motion, secondary structure changes and hinged 
domain movements. CPMG relaxation dispersion is a powerful approach to obtaining kinetic, 
thermodynamic and structural information for exchange processes in the 0.3 - 10 ms time window. 
The principle of NMR-CPMG experiment is to refocus exchange broadening (i.e., reduce or 
“disperse” Rex) by applying pulse elements to transverse magnetization during a special relaxation 
delay.197 Relaxation describes how signals change with time. CPMG relaxation dispersion 
experiments most often make use of backbone amide 1H or 15N spin probes, focusing on proton 
or nitrogen magnetization (single-quantum transitions), respectively. 
 
Dynamics on the μs - ms time scale can be characterized in terms of an exchange contribution, 
Rex, to the observed transverse relaxation rate, R2obs, using the following expression:  
 
R2obs  = Rex + R20       (1.1) 
 
Where R20 is the intrinsic relaxation rate of the nuclei under investigation. For a two-site exchange 
Rex depends on the population of the states (𝞺𝞺a, 𝞺𝞺b), the difference in chemical shifts (Δω), the 
exchange rate constant (kex = kf + kr, where kf and kr are the forward and reverse rate constants, 
respectively) and the pulse repetition rate. Primarily recorded as a series of 15N- Heteronuclear 
Single Quantum Coherence (HSQC) experiments, the technique has an extremely good atomic-
scale resolution, allowing the investigation of specific protons and other relevant atoms on 
selected residues in any protein or enzyme amenable to NMR investigation. The chemical shift of 
the investigated atoms can then be determined by combining Δω with information obtained from 
an Heteronuclear Multiple-Quantum Correlation (HMQC) spectrum which in turn can be used to 
determine the solution structure of the excited state.198 The experimental framework outlined 
above has been used extensively to detect motions on the μs - ms time-scale within proteins and 







Figure 1.10: QAA describes conformational sub-states leading to transition state during 
catalysis in cyclophilin A. Two levels of sub-states are shown (A) level 1 and (B) level 2. 
Conformational sub-states with homogenous populations are identified for the reactant (R), 
transition state (T) and product (P). Each colored dot in the top panels corresponds to a single 
conformation and is colored according to the reaction coordinate value in panel D. Arrows indicate 
interconversion between other sub-states and T and the corresponding CypA motions are shown 
below the plots. (C) The identified motions extend from the flexible surface region to the active 
site connected by hydrogen bon networks. (D) Free-energy profile of the CypA reaction. The color 
bar corresponds to reaction coordinate used for coloring conformations in panel A. (This figure is 






1.6 Proposed study  
The overview of the biophysical, biochemical and physiological properties of RNases offer 
promising therapeutic applications in several diseases including amyotrophic lateral sclerosis and 
Parkinson’s Disease. However, an accurate understanding of the enzymatic properties of most 
hRNases is still unavailable. Limited information is available about the mechanistic basis of 
substrate binding and chemical step in various hRNases, while the atomistic details of product 
release step has not yet been investigated. Moreover, the contributions of distal regions in the 
steps of the enzymatic cycle of hRNases remain uncharacterized. It also unexplored which of the 
two proposed mechanism is more relevant to catalysis by hRNases.  
 
The similarity in range of enzyme efficiency and dynamics in these enzymes raises the question 
of the role of dynamics in catalysis and provides a unique opportunity to investigate human 
ribonucleases as prototypical systems for understanding relationship between dynamics and 
enzyme catalysis. Using computational (Classical MD simulations and hybrid QM/MM approach) 
and experimental (NMR, steady-state kinetics) approaches this study quantitatively characterizes 
functionally important dynamics in the catalytic cycle of RNases. As the rate-determining step is 
currently unclear, and also may be different for all hRNases, conformational dynamics is 
characterized in each step of RNase catalytic cycle.  
 
The four steps of the RNase catalytic cycle studied as a part of this thesis are organized in the 
chapters 2-5 (Figure 1.11). Chapter 2 investigates µs - ms dynamics in 23 RNases in their apo 
form using 15N-CPMG NMR experiments and computer simulations. Chapter 3 focuses on 
characterizing the nucleotide substrate binding properties in hRNases using computer simulations 
at the µs time-scales. Chapter 4 concentrates on identifying conformational dynamics and sub-
states associated with product release in RNase family members. Umbrella sampling simulations 
along with quasi-anharmonic analysis (QAA) are employed for this study. In Chapter 5 additional 
aspects of RNase enzyme mechanism are explored, the dynamic properties of RNases in 
presence of ligands (product analogs) is determined using NMR titrations and chemical shift 
perturbation analysis (CHESPA). Conformational fluctuations in the chemical turnover step are 
identified for bRNaseA using hybrid QM/MM and Nudged Elastic Band (NEB) simulations. In 
addition, kinetic parameters for hRNases are obtained using steady-state kinetic experiments. 
Finally, the major findings of this thesis are summarized in chapter 6 with suggestion for future 






Figure 1.11: Schematic representation of the RNase catalytic cycle and proposed work. (A) 
Simple scheme indicating steps involved in an enzyme’s catalytic cycle. MD = modeled using 
classical simulations. QM/MM = modeled with hybrid quantum-classical simulations. (B) Summary 
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2.1 Abstract  
Enzyme superfamily members that share common chemical and/or biological functions also share 
common features. Conservation of structural features such as critical active-site residues and the 
entire protein fold, even in cases of low sequence similarity, is well known. However, the link 
between function and dynamics is not well understood. We present a systematic characterization 
of the intrinsic atomic-scale dynamics of over twenty members of the pancreatic-type ribonuclease 
(RNase) superfamily, which share a common structural fold. This study is motivated by the fact 
that the range of chemical activity as well as molecular motions exhibited by RNase homologs 
span >105 fold. Dynamics on the microsecond-millisecond time-scale was characterized using a 
combination of nuclear magnetic resonance (NMR) relaxation dispersion experiments and 
computer simulations. Phylogenetic clustering of the RNases led to the grouping of sequences 
into sub-families, with members within sub-families sharing similar biological functions. Detailed 
characterization of the dynamical properties of the diverse RNases showed conserved dynamical 
traits for enzymes grouped into functionally distinct sub-families. These results suggest that 
selective pressure for the conservation of dynamical behavior, among other factors, may be linked 
to the distinct chemical and biological functions in an enzyme superfamily. 
 
2.2 Introduction 
The linkage between dynamics and enzyme catalysis has been intensely debated 201. Enzymes, 
like other molecules, experience internal motions over a wide range of time-scales. These motions 
are driven by temperature and surrounding environment, including the solvent 202, 203. Evidence 
continues to emerge from an increasing number of systems emphasizing the involvement of 
dynamics in enzyme function 127, 204-206. However, the presence of motions even near/in the active 
site, or their occurrence at time-scales that coincide with rate-limiting events in enzyme 
mechanisms, does not automatically imply that these motions play a role in enzyme function 207. 
One of the challenges associated with investigating enzyme dynamics is that structure and 
dynamics are inter-related, thus making it difficult to decouple their individual contributions to 
enzyme catalysis.  
 
The enzyme fold has been proposed to serve as a scaffold which enables optimal positioning of 
the catalytic residues to provide a unique environment, which is very different from solvent, and 





Catalytically important residues are conserved across enzymes that share the same fold and 
catalyze the same (or similar) chemical reaction 209. It has been suggested that if dynamics plays 
a functional role in enzyme catalysis, then it must also be subjected to evolutionary pressure and 
be conserved as a part of the enzyme fold topology 210. Therefore, characterization of dynamics 
of enzymes within a superfamily could provide vital information on the evolutionary conservation 
of dynamics (or lack thereof) among structural and functional homologs that catalyze the same 
chemical reaction. This approach could provide much needed information for teasing apart the 
role of structure and dynamics in enzyme catalysis.  
 
Pancreatic-type ribonucleases (RNases) are a superfamily of enzymes found in bacteria and 
vertebrates that catalyze the hydrolysis and transphosphorylation of ribonucleic acid (RNA) 
substrates 211-213. Nearly 650 sequences corresponding to members of this superfamily are found 
in the Pfam database 214. Eight catalytically active canonical RNases (and five supplemental 
pseudo-genes that lack the conserved active-site residues essential for ribonucleolytic activity) 
were identified in the initial sequencing of the human genome 211. All structurally characterized 
RNases display a conserved structural fold and share the common chemical function of cleaving 
the phosphodiester bond of ribonucleic acid (RNA) substrates, albeit with varying degrees of 
catalytic efficiencies and specificities. The canonical RNases have further been reported to 
perform a variety of biological functions such as angiogenesis, anti-pathogenicity and immuno-
suppressivity, in addition to the common ribonucleolytic activity 211. While the biological functions 
are broadly known and have been characterized for some members identified in the human 
genome, a significant number of members remain largely uncharacterized to date. The unique 
similarity in structure (fold), whilst displaying significant diversity in function, makes the RNase 
superfamily an excellent candidate for characterizing the effect of conserved dynamics on 
function. 
 
A variety of biophysical, NMR and computational approaches have indicated the role of 
conformational dynamics in regulating catalysis in bovine RNase A (BtRA), the archetypal 
member of this family 215. Millisecond motions of a loop located over 20 Å away from the active 
site, suggested to be propagated by a conserved hydrogen-bonding network 136, 138, 215, were 
shown to be essential for efficient catalysis 216. Mutations disrupting this hydrogen bonding 
network were shown to result in the uncoupling of dynamics on the catalytic time-scale and a 
corresponding decrease in the catalytic turnover 138. Further, reduced catalytic efficiency relative 





hydrogen bonding network 137, 138, 216. Interestingly, the global conformational exchange rates of 
the diverse RNase members vary over five orders of magnitude (microseconds to 100s of 
milliseconds) coinciding with the range of substrate turnover (and chemical efficiency), which also 
varies up to five orders of magnitude between the most efficient and least efficient members of 
the human canonical forms 215. For example, human RNase 5 (angiogenin), which lacks the 
dynamical loop 4 region of RNase A shown to impact catalysis, displays 105 fold reduction in 
ribonucleolytic activity compared to RNase A 217. 
 
As a step towards characterizing the relationship between dynamics, chemical and biological 
functions of various members of this broad vertebrate family, we performed a systematic 
characterization of the intrinsic dynamics of over 20 RNase homologs. The selected RNases 
correspond to a representative set of homologous vertebrate sequences whose structures have 
been determined previously by X-ray crystallography or NMR and are available in the protein data 
bank. Using a combination of NMR and computational approaches, we characterized the 
dynamics of these proteins over the microsecond to millisecond (µs-ms) time-scale to probe the 
relationship between sequence diversity and dynamics, and its correlation with the designated 
biological functions. The present study focuses on characterizing and comparing the intrinsic 
dynamics of apo proteins, as these enzymes bind to and catalyze a wide variety of RNA 
substrates. Our results show that while the diverse RNase homologs used for the analysis share 
a common structural fold, the dynamical properties of these proteins vary significantly. Clustering 
superfamily members into evolutionarily distinct sub-families showed conservation of dynamical 
properties within sub-family members and notable variations between different sub-families. 
Categorizing homologous RNase superfamily sequences into sub-families, which also exhibit 
similar dynamics, provides a unique opportunity for further investigation to tease apart the role of 
structure and dynamics in enzyme function.  
 
2.3 Materials and methods 
Genes, Expression and Purification: Escherichia coli codon-optimized sequences of Pongo 
pygmaeus ribonuclease 3 (PpR3) and Macaca fascicularis ribonuclease 3 (MfR3) (UniProt entries 
P47781 and P47779) were synthesized in IPTG-inducible pJExpress414 vectors containing the 
ampicillin resistance gene (DNA2.0, Newark, CA). These vectors were transformed into E. coli 
BL21 (DE3) for all protein expression experiments. All human RNases were cloned, expressed, 





expression and purification was conducted as described previously 138, 142, with the following 
modifications. The temperature was lowered to 30°C following addition of IPTG, the volume of 
culture media was of 1 L, and bacteria were grown overnight before being harvested by 
centrifugation. Protein concentrations were determined using extinction coefficients of 11,960 and 
14,940 M-1cm-1, respectively, as estimated by ExPASy ProtParam. 
 
Solution NMR Experiments: 2D 15N-HSQC, 3D-HNCACB and 3D-CBCA(CO)NH assignment 
experiments were performed on a Varian INOVA 500 MHz spectrometer (298 K), while 15N-CPMG 
relaxation dispersion experiments were performed on the same spectrometer as well as a Varian 
INOVA 800 MHz spectrometer (298 K), as described earlier 138, 142, 219. NMR processing and 
analysis was performed using NMRPipe 220, CcpNmr Analysis 221 and Sparky 222. 
 
Phylogenetic analysis: Multiple sequence alignment of the 23 RNase sequences was performed 
using ClustalΩ 223. A complete list of sequences and sequence identifiers is provided in Table 2.1. 
The phylogenetic tree of the aligned sequences was determined based on maximum likelihood 
approach using RaxML v8.0.26 with the WAG amino acid substitution model 224. Reliability of the 
branching was assessed using the bootstrapping method over 100 iterations. The resulting 
phylogenetic tree in Newick format was visualized using Figtree v1.4.2 
(http://tree.bio.ed.ac.uk/software/figtree/). 
 
System preparation for computer simulations: Coordinates of 21 RNases were obtained from 
the corresponding PDB files for the apo model preparations (see Table 2.1). The structures for 
two Hominidae RNase 3 are not available; therefore, homology models were generated as 
described below. System preparation for molecular dynamics (MD) simulations were performed 
using the leap module in AMBER 225 v14 and AMBER's ff14SB force-field. Equilibrated systems 
were used for each of the 23 proteins to run a total of 1μs of production MD under constant energy 
conditions (NVE ensemble). A PME cut-off of 8 Å was used as suggested by AMBER input files 
for GPU-enabled simulations 226. To address an important concern regarding the possible bias of 
results from a single MD trajectory and ensure reproducibility, for each of the 23 systems two 
independent MD trajectories each 0.5 μs were performed. 
 
Homology modeling of Hominidae RNase 3 sequences: Structures of two Hominidae RNase 
3 sequences, Pongo pygmaeus (PpR3) and Macaca fascicularis (MfR3), were generated through 





and 85.8% sequence identity with human RNase 3 (PDB ID: 1QMT), which was used as the 
template for modeling. The automodel option in MODELLER was used to generate models, of 
which two models with the lowest DOPE scores were chosen for each of the two sequences.   
 
Molecular dynamics simulations: The protein systems were neutralized by the addition of 
counter ions and the resulting systems were then immersed in a rectangular box of SPC/E water, 
with a 10 Å minimum distance between the protein and the edge of the periodic box. The prepared 
systems were equilibrated using a protocol described previously 129. The equilibrated system was 
used for each of the 23 proteins to run a total of 1 μs of production MD (two independent 0.5 μs 
MD trajectories, see details below) under constant energy conditions (NVE ensemble). The 
Particle-mesh Ewald (PME) method was used for long-range electrostatics and a time-step of 2 
femtoseconds was used during production runs. Coordinates of the system were saved every 5 
picoseconds, for a total of 200,000 conformational snapshots for each protein (as a sum of 
100,000 snapshots from each independent trajectory). All simulations were performed using 
graphical processing units (GPU) enabled version of AMBER’s MD simulation engine pmemd 
(v14). A PME cut-off of 8 Å was used as suggested by AMBER input files for GPU-enabled 
simulations 226. To address an important concern regarding the possible bias of results from a 
single MD trajectory and ensure reproducibility, for each of the 23 systems two independent MD 
trajectories each 0.5 μs were performed. The first trajectory after equilibration was used for 
production at 300 K, while for the second trajectory the structure was slowly heated to 310 K using 
MD with 50,000 steps and minimized to generate conformational and structural diversity. 
Production run for the second trajectory was also performed at 300 K. 
 
RMSF and RMSF10 calculations: All-atoms root-mean-square fluctuations (RMSF) were 
computed based on the conformational snapshots collected during the MD simulations. To identify 
global motions on slower time-scales from MD, for each of the 23 systems we separately 
computed and aggregated the fluctuations associated with the first (slowest) 10 quasi-harmonic 
modes (RMSF10). It is well known that slowest 10 modes contribute to the majority of fluctuations 
in proteins (>80%)  and the use of RMSF10, instead of all modes (RMSF), removes the faster 
stochastic motions of the protein, allowing focus on intrinsic dynamics of proteins 228. Both these 
calculations were performed using AMBER’s ptraj analysis program. All trajectory conformations 
were first aligned to a common structure, to remove any translation and overall molecular rotation 






 Table 2.1: PDB IDs of RNase homologs used for dynamical characterization  
 
PDB code Abbreviation Species RNase type 
7RSA BtRA Bos taurus RNase A 
2K11 HsR1 Homo sapiens RNase 1 
3TSR MmR1 Mus musculus RNase 1 
1RRA RnRA Rattus norvegicus RNase A 
1GQV HsR2 Homo sapiens  RNase 2 
1QMT HsR3 Homo sapiens RNase 3 
PpECP* PpR3 Pongo pygmaeus  RNase 3 
MfECP* MfR3 Macaca fascicularis  RNase 3 
2HKY HsR7 Homo sapiens RNase 7 
RNase6#1 HsR6 Homo sapiens RNase 6 
1ANG HsR5 Homo sapiens Angiogenin 
1AGI BtR5 Bos taurus Angiogenin 
2BWK MmR5 Mus musculus Angiogenin 
4QFI RnR5 Rattus norvegicus Angiogenin 
3ZBV MmR52 Mus musculus Angiogenin 
3ZBW MmR53 Mus musculus Angiogenin    
1RNF HsR4 Homo sapiens RNase 4 
1KM9 RcRx Rana catesbeiana Bullfrog RNase 
3SNF RpRx Rana pipiens Onconase 
4PER GgR5 Gallus gallus Angiogenin 
2VQ9 DrR1 Danio rerio RNase ZF-3E 
3LJE DrR5 Danio rerio Angiogenin 
2ZPO CmRx Chelonia mydas Turtle RNase 
 
* = Homology model, # = Structure not deposited 
1 The crystal structure of human RNase 6 was obtained in our collaborators research group. While 
this structure has not yet been deposited in the PDB, it shows a significant structural identity with 






Quantitative comparison of dynamical properties: Pearson’s correlations were used for the 
quantitative characterization of dynamical similarities (and differences) between protein pairs. 
Correlation between RMSFs for each residue ia  and ib  of RNases A and B, respectively, were 

























     (2.1) 
where n corresponds to the number of residues including the gaps in the alignment. a  and b
correspond to the average RMSF values for RNase A and B. Pairwise-correlations were 
calculated for each of the 23 RNases using RMSF10 excluding residues corresponding to gaps 
in the pairwise alignment. Average correlations within and between sub-families were calculated 
by averaging correlation coefficients of sequences being compared. 
 
2.4 Results 
2.4.A Phylogenetic analysis of ribonuclease superfamily 
As a representative set of the pancreatic ribonuclease superfamily, 21 diverse RNases, whose 
three-dimensional structures are available in the protein data bank, were selected for detailed 
dynamical characterization. Human RNases 1-7 were included in this analysis. Additionally, two 
Hominidae RNase 3 sequences that are closely related to human RNase 3 were also analyzed 
using structures generated based on homology modeling. A list of all RNase sequences and 
sequence identifiers is provided in Table 2.1. Comparison of the 23 RNase dataset shows that 
the sequences share an average sequence identity of ~37.4%, and an average RMSD of 2.47 Å 
for the alignment of all backbone atoms of the 21 members with solved structures. Sequence and 
structural alignments indicated that most variable regions are, unsurprisingly, associated with loop 
regions of the protein fold (Figure 2.1 A, B). Catalytic triad residues (H12, K41 and H119, bovine 
RNase A residue sequence numbering), which are essential for the ribonucleolytic activity, are 
conserved in all 23 proteins analyzed.  
 
Phylogenetic analysis of the 23 RNase sequences led to the identification of four distinct 
sequence clusters, henceforth referred to as sub-families (Figure 2.1 C). The RNase A-like sub-





primary function is associated with the cleavage of RNA substrates. Human and bovine 
ribonucleases of this sub-family are the most efficient ribonucleolytic catalysts characterized to 
date within the RNase superfamily. Members of the Eosinophil associated ribonuclease-like 
(EAR-like) sub-family (6 members) are characterized by insertion of a loop (L7), and have been 
suggested to play an important role in host defense and inflammatory response 229, 230, in addition 
to preserving the common ribonucleolytic function. Members of this sub-family show catalytic 
turnover rates 5- to >400-fold lower relative to BtRA, for those with known catalytic turnover rates 
(data not shown).  
 
The Angiogenin-like sub-family (6 members) is characterized by a truncated loop 4 (L4), a loop 
region that displays conformational dynamics on the millisecond time-scale in bovine RNase A 
and was shown to play an important role in its ribonucleolytic function. Catalytic efficiency of 
human angiogenin (HsR5) is 105-fold lower than bovine RNase A. However, its ribonucleolytic 
activity was shown to be essential for biological function (angiogenesis) 231.. Previous studies also 
showed that replacing the truncated loop 4 of HsR5 with that of bovine RNase A increases 
catalytic efficiency of this chimeric protein by over 200-fold 232, while swapping loop 4 from RNase 
A with that of HsR5 reduced the activity of this chimera by 60-fold 233. The other seven RNases 
not forming a part of the three groups described above were classified as Others, and include 
sequences that are not necessarily closely related to each other. The functional characteristics of 
this cluster are not well understood and could therefore display functional and dynamical 
properties similar to the three sub-families described above. 
 
2.4.B Conformational dynamics on the microsecond-millisecond (μs - ms) time-scale 
The time-scale of catalysis varies widely in the RNase superfamily. BtRA is known to catalyze 
cleavage of RNA with a kcat ~1700 s-1, with product release being the rate-limiting step of the 
reaction 137, 216. Other members are slower catalysts, showing up to 105-fold weaker catalytic 
efficiency (kcat/KM). We used a combination of NMR relaxation dispersion CPMG experiments and 
MD simulations to probe the μs - ms dynamical properties of these enzymes. Figure 2.2 shows 
the conformational exchange of various RNases from each of the four sub-families probed using 
15N-CPMG relaxation dispersion experiments. Residues exhibiting conformational exchange on 
the µs-ms time-scale are represented as spheres. Comparison of millisecond motions of these 






Figure 2.1: Structural and phylogenetic analysis of RNase homologs. (A) Consensus 
sequence alignment of the 23 RNases, with respective sequence identifiers displayed to the left. 
Detailed information about the sequences is provided in Table 2.1. The secondary structural 
elements α-helices (orange rectangles), β-strands (cyan arrows) and loop regions (L), 
corresponding to the bovine RNase A structure, are displayed above the alignment. Conserved 
active-site residues H12, K41 and H119 (BtRA numbering) are identified with an asterisk above 
the alignment. BtRA (PDB ID 7RSA) sequence numbering (BtRA#) is shown at the top and 
consensus sequence numbering (Cons#) below the multiple sequence alignment. A list of all 
consensus sequence positions is presented in Figure 2.10 (See Appendix 2.7). Gaps in the 
alignment are represented using dotted lines. Alignment was prepared using EsPript 11. (B) 
Structural alignment of RNase homologs. Structures include 7RSA (green); 1QMT (blue), 2HKY 
(cyan); 1ANG (salmon); 3SNF (yellow) and 1RNF (gold). The V1 and V2 arms as identified using 
boxes with dotted lines. Active-site residues are displayed as sticks and labeled with BtRA 
numbering. (C)  Phylogenetic clustering of the 23 RNases generated based on maximum 






for members from different sub-families. In contrast, residues exhibiting conformational exchange 
are clustered in the same regions for four members within a sub-family (Figure 2.2 A).Members 
of the EAR-like RNase sub-family display motions primarily clustered in the V1 arm and loop 4. 
In contrast, BtRA from the RNase A-like sub-family showed conformational exchange in both V1 
and V2 arms, including loops L1 and L4 (Figure 2.2 B). Human RNase 5 (HsR5) of the angiogenin-
like sub-family exhibits no conformational exchange on the CPMG time-scale (Figure 2.2 C), 
confirming results from a previous report 146. To investigate whether HsR5 experiences motions 
on a faster µs - ms time-scale window than the one probed by the CPMG experiment, we also 
analyzed elevated transverse relaxation rates at short spin-echo pulse delays in the CPMG 
relaxation dispersion profiles (i.e. R2, eff at νCPMG = 1600 s-1, or τcp = 0.625 ms). Analysis for apo 
and ligand-bound HsR5 showed that only one residue per state exhibited elevated R2, eff values 
(Asn68 in the apo form, and Asn109 in the ligand-bound form), which could indicate that these 
two residues experience conformational exchange on a faster µs - ms time-scale (Figure 2.3). 
Overall, these observations further confirm that HsR5 is a fairly rigid protein on the µs - ms time-
scale and that no significant conformational exchange is observed on this regime. Human RNase 
4 (HsR4), from the Others cluster, displayed extensive conformational exchange throughout the 
protein (Figure 2.2 D). NMR data from other members of the RNase sub-family is presently 
unavailable on the μs - ms time-scale.  
 
Interestingly, insertion of loop 1 (L1) from an EAR-like RNase (HsR3) into BtRA (BtRAHsR3, Figure 
2.2 B) 138, 142 switched the dynamical profile of BtRA into that of HsR3 (Figure 2.2 A) in the chimeric 
protein. The motivation for the design of this chimera was to develop and characterize a control 
system for investigating the dependence of dynamics on a region based on type of residues rather 
than secondary structure. Previous studies showed a detailed comparison of the rates of ligand 
binding and release 138, in addition to conformational exchange profiles of BtRA, BtRAHsR3, and 
HsR3 142. To gain insights into changes in the relaxation dispersion of these enzymes in the L1 
region, here we compared the fitted relaxation dispersions for residues of loop 1 from HsR3 (EAR-
like sub-family) with BtRA (RNase A-like sub-family) and the chimera BtRAHsR3 (Figure 2.4 A). Our 
results show that loop 1 residues of BtRA exhibit a two-site conformational exchange at these 
positions, as observed from the presence of relaxation dispersion profiles (solid lines in Figure 
2.4, left panel). In contrast, no motions on this time-scale were observed for loop 1 positions in 
HsR3 and the chimera BtRAHsR3, as seen from the flat dispersion profiles (shown as dashed lines 
in Figure 2.4 A, middle and right panels). Residues in structurally equivalent positions in the three 







Figure 2.2: Millisecond conformational exchange in Hominidae and bovine RNases. 
Cartoon representation of (A) EAR-like sub-family members - H. sapiens EDN (HsR2), H. sapiens 
ECP (HsR3), P. pygmaeus ECP (PpR3), M. fascicularis ECP (MfR3); (B) RNase A-like sub-family 
member B. taurus RNase A (BtRA) and the BtRAHsR3 chimera 210; (C)  Angiogenin-like sub-family 
member H. sapiens angiogenin (HsR5); and (D) H. sapiens RNase 4 (HsR4) from the Others 
cluster. Structures are colored based on the phylogenetic group shown in Figure 2.1 C. Residues 
identified by NMR as undergoing conformational exchange on the millisecond time-scale are 
depicted as spheres and numbered according to their position in the sequence alignment (see 
Figure 2.1) to facilitate comparison. Conformational exchange was probed by 15N-CPMG NMR 
relaxation dispersion experiments at 500 and 800 MHz (298 K). Residues were considered for 
further analysis only if the difference in measured R2 (1/τcp) values at fast (τcp = 0.625 ms) and 
slow (τcp = 10 ms) refocusing pulse delays was greater than 2 s-1, similar to previous reports 138, 
142. BtRAHsR3, which displays sub-sector conformational exchange similar to HsR3, is an artificial 
chimeric hybrid of BtRA in which the 12-residue long loop 1 of BtRA (14-DSSTSAASSSNY-25, 
BtRA numbering) was replaced by the 6-residue long loop 1 of HsR3 (17-SLNPPR-22, HsR3 
numbering) 136, 142, 219. Structures color-coded based on conformational exchange rates are shown 







Figure 2.3: Conformational exchange in HsR5 residues. Transverse relaxation rates (R2) at 
νCPMG = 1600 s-1 (τcp = 0.625 ms) in free and ligand-bound HsR5. R2,eff values at νCPMG = 1600 s-1 
are shown for all assigned residues of apo (left) and 3’-UMP-bound (right) HsR5. Dashed lines 
indicate the average R2,eff value and dotted lines indicate standard deviation. Residues exhibiting 
elevated R2,eff are identified on each graph. Upon closer examination of the full relaxation 
dispersion curves for these residues, most were disregarded since their R2,eff values were either 
inconsistently elevated and/or simply resulted from bad raw data. Only two residues displayed 
consistently elevated values: Asn68 in the apo protein, and Asn109 in the 3’-UMP bound protein. 
This could indicate the presence of dynamics at positions Asn68 (free form) and Asn109 (3’-UMP-
bound form) on a microsecond time-scale faster than that measurable by CPMG experiments. 
These observations further confirm the lack of conformational exchange on the CPMG time-scale, 
and the overall likelihood that no significant functional dynamics is observed on the faster 








Figure 2.4: Dynamical effects of loop 1 swapping on BtRA. (A) Relaxation dispersion profiles 
of various loop 1 residues obtained from 15N-CPMG experiments at 800 MHz and 25°C for bovine 
RNase A (BtRA), human RNase 3 (HsR3) and a previously described 138 chimera of RNase A 
(BtRAHsR3) in which loop 1 has been replaced by the corresponding residues of HsR3. 15N-CPMG 
data was also acquired at 500 and/or 600 MHz for these proteins (not shown for clarity). Solid 
curves are shown for residues displaying conformational exchange, and dashed curves belong to 
non-exchanging residues. Curves of the same color represent structurally equivalent residues in 
the sequence alignment. (B) Compounded 1H-15N chemical shift variations 234 induced on BtRA 
by loop 1 swapping in BtRAHsR3. Residues in gray are either unassigned or belong to the swapped 
loop. Chemical shift variations for each residue are indicated by both the color and the width of 







BtRA and the chimera showed that chemical shift variations arising from loop swapping are 
primarily localized in the V2 domain (Figure 2.4 B). However, residues that acquire conformational 
exchange in the V1 domain (Figure 2.2 B) do not exhibit significant chemical shift variations. 
These observations suggest that alterations in regions displaying functionally relevant motions 
results in the modulation or loss of conformational exchange for residues in these regions. Overall, 
these results suggest that conformational exchange profiles are conserved between members 
within the EAR-like sub-family, perhaps suggesting a role in the shared biological or chemical 
function, while distinctly different dynamical fluctuations are observed for functionally distinct 
homologs from other phylogenetic clusters. 
 
2.4.C Conformational dynamics on the microsecond (μs) time-scale 
Atomic level dynamical properties of all 23 RNase homologs were probed using MD simulations 
to determine the detailed dynamical characteristics on the μs time-scale (Figure 2.5). Root mean 
square fluctuations (RMSF) associated with the slowest ten quasi-harmonic modes (RMSF10) 
were used to characterize the intrinsic dynamics of the proteins. Previously, such an approach 
was used for other family members and was shown to match the dynamics from NMR studies 
and other techniques 210. One of the issues with comparing dynamical patterns between proteins 
sequences of different lengths is the presence of gaps associated with insertions and deletions. 
To address this, we represented dynamical profiles of consensus sequences that include gaps in 
the multiple sequence alignment (Figure 2.1 A).  
 
A comparison of the conformational dynamics on the μs time-scale showed similarity in the RMSF 
profiles of RNases within the same sub-family members, while differences were observed 
between sub-families (Figure 2.5), consistent with the qualitative comparison of the 
conformational exchange profiles from experiments (Figure 2.2). The RNase A-like proteins, 
which share significant sequence similarity with BtRA, showed greater similarity in dynamical 
patterns between each other. Differences in the dynamical patterns were restricted to the loop L1 
region (residues 20-30, consensus sequence numbering, Figure 2.10 (see Appendix 2.7)), which 
showed the largest fluctuations for most members in this group except for the Mus musculus 
(mouse) RNase A (MmR1), which showed diminished dynamics in this region relative to other 
members. Characterization of hydrogen bonding lifetimes in MmR1 showed the interaction 





simulation ensemble. This strong hydrogen bonding interaction may be dampening the dynamics 
of loop1 observed for MmR1. 
 
EAR-like sub-family members exhibit similar dynamical patterns in all regions. RNases of this 
group are characterized by a truncated loop L1, which incidentally showed the largest fluctuations 
in the RNase A-like sub-family. Swapping loop 1 from HsR3 into BtRA resulted in a chimera 
(BtRAHsR3), which displayed a loss of dynamics in this loop, in addition to an overall reduction in 
the dynamics throughout the protein relative to BtRA (Figure 2.6 A). Human RNase 7 (HsR7) 
showed larger fluctuations throughout the protein while preserving the dynamical profile exhibited 
by other members of the sub-family. Angiogenin-like members are characterized by a truncated 
loop L4, and showed differences in dynamics of loop L2. Members not classified in the groups 
above (clustered into Others), as expected, showed large variations within the group compared 
to members within the other three sub-families. Large dynamical fluctuations were observed in 
loops L2, L4 and L6 for some members of the group, while other members showed deletions in 
these regions.  
 
2.4.D Quantitative characterization of dynamical conservation  
To determine if the similarities (and differences) observed within (between) sub-families are 
statistically significant, we performed a quantitative comparison of the dynamical profiles of 
sequences by performing pairwise correlations for all pairs of sequences (Figure 2.7). The 
pairwise Pearson’s correlation coefficient for all 23 sequences (Figure 2.7 A) showed larger 
correlations between members within, rather than between the three functionally distinct 
phylogenetic sub-families, except the Others cluster which showed small intra-cluster 
correlations. To better elucidate these comparisons within and between sub-families, we 
calculated the average value for these correlations, with the standard deviations presented in 
parentheses (Figures 2.7 B-D). Comparison of these averages showed that correlations within 
sub-families are significantly larger than those between sub-families for the three functionally 
distinct RNase sub-families (Figure 2.7 B). Overall, these observations highlight the conservation 
of dynamical patterns in homologous sequences sharing distinct functional properties, further 
supporting NMR experiments within and between sub-family members. 
 
Sequence and structural alignments showed insertions/deletions of residue positions in different 





Figure 2.5: Microsecond conformational dynamics of RNase homologs. Root mean square 
fluctuations corresponding to the Cα displacements in the top 10 quasi-harmonic modes 
(RMSF10), for the 23 proteins grouped into the four phylogenetic clusters described in Figure 2.1. 
A consensus sequence with gaps is used (see Figure 2.1 A), where gaps are represented as 
dotted regions for each protein. The panel on the right shows representative RNase homologs 
from each phylogenetic group using a tube representation where the thickness of the tube 
corresponds to the flexibility of residues in each protein, with thicker tubes corresponding to 
flexible regions and thinner tubes representing less flexible regions. The dynamical range 
represented using the color spectrum is consistent across all sequences with the blue and red 
ends of the spectrum corresponding to low and high dynamic regions, respectively. The 
representative structures correspond to B. taurus RNase A (BtRA) and H. sapiens RNase 1 
(HsR1); H. sapiens RNase 3 (HsR3) and P. pygmaeus RNase 3 (PpR3); H. sapiens angiogenin 
(HsR5) and Mus musculus RNase 5 (MmR5); and H. sapiens RNase 4 (HsR4) and Rana pipiens 
RNase (RpRx), respectively. N-terminal residues, which showed larger RMSFs (see left panel), 














Figure 2.6: Dynamical properties of BtRAHsR3 chimera. (A) Comparison of the root mean 
squared fluctuations of the ten slowest modes (RMSF10) between BtRA (black) and the chimera 
(red). On the right, RMSFs are shown using a tube representation for BtRA and the chimera, 
where the thickness of the tube corresponds to the flexibility of residues in each protein, with 
thicker tubes corresponding to flexible regions and thinner tubes representing less flexible 
regions. B) Dynamical cross-correlation maps (DCCMs) for BtRA (left), with regions displaying 
significant (anti-)correlations displayed identified using boxes, and the BtRAHsR3 chimera (right). 






and deletions influence the functional identity of these homologous sequences, we calculated the 
average correlations for consensus and non-consensus residue positions separately. Consensus 
positions correspond to residue positions that are preserved in all sequences (86 amino acid 
positions) while non-consensus positions represent positions with insertions or deletions in at 
least one of the sequences in the dataset (66 amino acid positions). A comparison of the 
correlations within sub-families showed similar trends for both consensus and non-consensus 
positions (Figure 2.7 C, D). Interestingly, a comparison of correlations between sub-families for 
non-consensus residues showed markedly smaller correlations (grey in Figure 2.7) between the 
three functionally distinct sub-families, except Angiogenin-like sub-family which showed similar 
average correlations within the sub-family and with RNase A-like sub-family on this time-scale 
(Figure 2.7 D). 
 
Overall, these observations suggest that non-consensus positions influence the distinct 
dynamical patterns observed among the functionally divergent phylogenetic sub-families. It could 
potentially be counter-argued that dynamical patterns will always be most influenced at non-
consensus residue positions when comparing phylogenetically distinct proteins. However, it is 
important to remember that the physicochemical identity of residues determines the extent and 
nature of dynamical motions and rotameric conformer populations. Experimental characterization 
of the BtRAHsR3 chimera (with L1 loop region from HsR3 inserted into BtRA) revealed significant 
changes in the dynamics of this region and the V2 domain relative to BtRA (Figure 2.4). It is 
tempting to speculate that as loop regions are flexible, any sequence in the L1 loop region of 
BtRA could be expected to show large dynamical motions. On the contrary, the results from 
chimera characterization indicate that L1 loop residues in BtRAHsR3 show dynamical behavior 
similar to L1 in HsR3 rather than BtRA.       
 
Analysis of MD simulations allow the characterization of atomic-scale details, including residue 
level dynamical interactions. A comparison of dynamic residue-residue cross-correlations for the 
different RNase homologs shows distinct variations among members. Detailed characterization 
of dynamical cross-correlations was performed for members with experimental dynamical 
information (correlation maps with black outlines in Figure 2.12 see Appendix 2.7). BtRA of the 
RNase A sub-family showed strong anti-correlations (value < -0.4) for residues 65-72 of loop L4 
(positions 75-84, consensus sequence numbering, Figure 2.10 in Appendix 2.7) with residues 
near the active site and the catalytic K41 (position 51) and correlations (value > 0.4) with residues 






Figure 2.7: Quantitative characterization of dynamical similarities. Pairwise Pearson’s 
correlations for the 23 RNase homologs classified into four phylogenetic clusters. (A) Correlation 
coefficients for each pair of sequences, color coded based on strong correlations (red) to weaker 
or no correlations (grey). (B-D) Average correlations, calculated by averaging the correlation 
coefficients for sequences compared for: all residue positions (B), consensus positions (C), and 
non-consensus positions, corresponding to insertions or deletions in sequences (D). The diagonal 
elements in B-D correspond to correlations within phylogenetic sub-families while off-diagonal 
elements correspond to correlations between the sub-families. Standard deviations for average 
correlation calculations (B-D) are shown in parentheses. Abbreviations R, E, A and O used in B-








residues 105-110 (positions 119-124) and those near catalytic H119. Further, strong correlations 
were observed for residues near, and including H12 (position 17) and residues 13-23 of loop 1 
(positions 18-29) with residues around H48 and T82 (positions 58 and 94, respectively), which 
form a hydrogen bonding network shown previously to be involved in the allosteric modulation of 
catalysis and product release in this enzyme 137, 216. 
 
Interestingly, loop swapping in the chimera (BtRAHsR3) resulted in changes throughout the protein, 
in regions far from loop 1, including significant changes near active-site residues. Specifically, we 
observed a loss of correlated motions between loop 4 and the C-terminal region in the vicinity of 
the active-site residue His119, and loss of anti-correlated motions of loop 4 and the vicinity of 
Lys41 (another active-site residue) and between residues near His119 and Lys41 (Figure 2.6 B). 
HsR3 of the EAR-like sub-family showed strong anti-correlations between residues near the 
catalytic residue H15 and residues surrounding residues 86-97 of loop 6 (positions 99-110, Figure 
2.12) and residues 27-38 (positions 36-51), while correlations were observed with residues 42-46 
of β-strand 1 (positions 55-59). Residues in the vicinity of and including the catalytic K38 (position 
51) showed anti-correlations near residues 60-65 of loop 4 (positions 73-78) and residues near 
catalytic residue H128 (position 142). Further, H128 also showed correlations with residues near 
H15 (position 17) and loop 4, and anti-correlations with residues near K38. Residues 28-36 
(positions 37-49) showed anti-correlations with residues 98-102 (positions 111-115).  
 
Contrary to members from the other phylogenetic sub-families, HsR5 of the Angiogenin-like sub-
family showed significantly weaker (anti)correlations between residues. The lack of 
conformational dynamics of HsR5 and the resulting absence of correlated motions is consistent 
with our observations from relaxation dispersion experiments, which showed the absence of 
motions on the millisecond time-scale in this enzyme (Figure 2.2 C). HsR4 of the Others sub-
family showed numerous dynamic (anti)correlations between different regions of the protein, 
suggesting enhanced correlated dynamics throughout the protein, consistent with NMR relaxation 
dispersion experiments, which showed extensive conformational exchange in this protein (Figure 






2.4.E Faster time-scale conformational dynamics in functionally distinct RNase sub-
families  
To determine if MD simulations capture the motions observed experimentally on the faster ps-ns 
time-scale, we compared the square of the generalized order parameter (S2). Using ShiftX2 (Han 
et al., 2011), we calculated the backbone chemical shifts for two representative members each 
from the three functionally distinct sub-families defined in Figure 2.1 C. NMR chemical shifts for 
the selected RNases were obtained from the BMRB (Ulrich et al., 2008). Order parameters were 
calculated from the chemical shifts using TALOS+ (Shen et al., 2009). Comparison of the order 
parameters showed qualitative agreement between the experimental (black) and MD (red) data 
(Figure 2.8), suggesting that MD simulations capture the motions observed experimentally. 
 
2.5 Discussion  
Increasing evidence from characterization of discrete enzyme systems suggests the important 
role of conformational motions in the catalytic function in these systems 201, 206, 215, 235. Despite 
tremendous progress in our understanding of the role of conformational motions in function, 
evolutionary conservation of dynamical properties on functionally relevant time-scales among 
structural and functional homologs within enzyme families remains largely uncharacterized. 
Numerous studies using normal mode analysis have shown the conservation of backbone 
flexibility in homologous proteins sharing a common structural framework 236-238. Experimental and 
computational approaches further showed the conservation of dynamics in selected proteins 
within enzyme families 142, 237, 239. However, systematic characterization of superfamily-wide 
conservation of dynamical properties on the functionally relevant µs - ms time-scales is limited.  
 
In this study, we combined 15N-CPMG NMR relaxation dispersion experiments and detailed MD 
simulations to systematically characterize dynamical properties of diverse pancreatic-type 
RNases on the μs - ms time-scale. Using a set of >20 representative RNases, chosen based on 
the availability of three-dimensional structures in the protein data bank, we probed the 
conservation of dynamical patterns in the homologous RNases. Phylogenetic analysis led to the 
grouping of sequences into four clusters – 16 of these sequences forming part of three functionally 
distinct sub-families (Figure 2.1 C), where individual members within sub-families also share 
common biological function distinct from those of other sub-families. Little is known about the 







Figure 2.8: Faster time-scale motions in representative RNases. Comparison of the 
calculated order parameters for the experimental (black) and MD (red) data for two representative 
RNases each from the three functionally distinct RNase sub-families (RNase A-like, EAR-like and 







Slowest dynamical modes were previously shown to display the largest evolutionary conservation 
238, with these modes being the most robust to amino acid substitutions 240. Through quantitative 
characterization of the dynamical properties of the slowest modes from MD simulations, we show 
distinct variations in the dynamical patterns between different members of the RNase superfamily. 
Conservation of dynamical patterns was observed for sequences clustered into phylogenetic sub-
families (Figure 2.5) that incidentally also shared similar biological functions. This conservation in 
the dynamical profiles within sub-families was also observed on the ms time-scale probed by 
NMR for select RNases (Figure 2.2). These observations are consistent with previous studies 
which showed that enzymes sharing similar functions also share similar reaction-promoting 
dynamics 241-243.  
 
Rapid changes through evolution in dynamical properties were previously shown to be linked to 
functional divergence in proteins 244. Sequence and structural alignments of RNases used in this 
study showed variations, corresponding to insertions/deletions, in different regions along the 
primary sequence of RNases (Figure 2.1). A comparison of dynamical patterns of just these non-
consensus amino acid positions showed notable differences between sub-families (Figure 2.7 D). 
These observations suggest that dynamical differences observed between sequences sharing 
distinct functional properties could be linked to the type of residues in non-consensus amino acid 
positions, which may influence the functional identity of these sequences.  
 
The use of chimeric constructs such as BtRAHsR3 investigated in this study serve as an important 
control system. It is widely discussed that the overall enzyme dynamics (particularly at slow time-
scales) is determined by the structural fold. Comparison of the conformational exchange profiles 
for the chimeric and wild-type RNases (Figure 2.2, 2.4) indicate that for enzymes sharing the 
same fold, significant differences could arise from changes in non-conserved or variable regions. 
However, it is not sufficient to say that loop regions are the most dynamical regions. The extent 
and range of motions depends on the nature and type of residues in the loop regions. Indeed, 
characterization of dynamical correlations from molecular dynamics simulations of the BtRAHsR3 
chimera shows the long-range effect of loop 1 swapping on loop 4 and residues in the vicinity of 
active-site residues His119 and Lys41 (Figure 2.6 B).  
 
Each enzyme could provide a unique set of local dynamical motions depending on the sequence 
(such as seen in the case of loop 1 in the two parents and the chimera, Figure 2.4). 





further investigation. Further, it should be noted that even in the conserved regions of fold, 
different family members could exhibit distinct dynamics. For example, see Figure 2.2 and related 
text for differences in the dynamics of the V2 domain in different sub-families. These observations 
open new avenues for probing the effect of conformational exchange associated with loop 
swapping between members from the different sub-families. Of notable interest is the effect on 
the conformational dynamics and catalytic turnover of swapping loop 4 from BtRA on HsR5, which 
is characterized by a truncated loop 4 and a 105-fold lower catalytic efficiency relative to BtRA. 
While swapping the loop 4 residues from HsR5 on to BtRA and vice versa have been performed 
before, the effect of this swapping on the conformational exchange and the resulting impact on 
catalysis have not been characterized 232, 233, 245. 
 
HsR5 exhibits at least 105-fold weaker ribonucleolytic activity than bovine RNase A against 
standard RNA substrates 232, although this ribonucleolytic activity remains essential for 
angiogenesis. This low enzyme activity has been structurally and mutationally rationalized by the 
obstructive positioning of a C-terminal residue segment of HsR5 (residues 116-123, primarily 
Glu117), which is occluding a pyrimidine binding sub-site that is normally solvent exposed in 
homologous RNases 246. This ‘trademark’ blockage of the active site in HsR5 demonstrates that 
a conformational change of this C-terminal tail is required to alleviate the occluded pocket for 
proper RNA substrate recognition and ribonucleolytic activity to occur. Since movement of the C-
terminal tail is essential for the ribonucleolytic activity of HsR5, this was not totally unexpected 
considering that the catalytic rate of this enzyme occurs on a much slower time-scale than its 
RNase homologs. For instance, HsR5 exhibits a kcat/Km = 1.1 M-1s-1 against dinucleotide RNA 
substrate UpA, relative to kcat/Km = 4,000,000 M-1s-1 in RNase A 232. Additionally, no less than 19 
unique protein partners have been experimentally reported to interact with HsR5 for a wide variety 
of biological processes involving cell migration, adhesion, invasion, proliferation, and apoptosis 
52. This could suggest that the ribonucleolytic activity of HsR5 is carefully programmed in the 
cellular context, perhaps only triggered in the presence of the proper protein binding partner 
and/or after translocation to the right cellular compartment. Conformational exchange of the C-
terminal tail could thus be closely modulated or allosterically controlled by an uncharacterized 
protein partner. Although we did not observe 1H-15N HSQC resonances that could indicate 
residues experiencing exchange on a slower time-scale, future chemical exchange saturation 
transfer (CEST), ZZ-exchange, and/or H/D exchange experiments could provide additional clues 






In summary, characterization of dynamical properties of diverse RNases showed their 
conservation among sequences that also share similar biological functions. Interestingly, 
mutations of sub-family sequences in regions showing large dynamical motions have been shown 
to alter their biological function (Table 2.2). The similarity in dynamics for members with common 
biological function requires further investigation, especially for sub-families where the connection 
between the biological and chemical function is unclear. The present results provide vital clues 







Table 2.2: Amino acid substitutions and their effect on the catalytic and biological activities 
of select RNase homologs. 
 
Protein Mutation Localization on structure Effect on kcat/KM Other effects Ref 
HsR3 R121A Loop 7 (V1) No effect Reduced bactericidal activity against Gram-positive S. aureus 
42 
HsR3 W10K Helix 1 2-fold decrease 
Reduced bactericidal activity against 
Gram-positive S. aureus and reduced 
membrane-permeating capacity 
42 
HsR3 R75A/F76A Loop 5 (V1) 2-fold decrease Reduced bactericidal activity against Gram-negative E. coli 
42 
HsR3 R121A/Y122A Loop 7 (V1) 1.25-fold increase 
Reduced bactericidal activity against 
Gram-positive S. aureus 
42 
HsR3 W35A/R36A Loop 2 (V2) 1.6-fold increase 
Reduced bactericidal activity against 





(V2) 2-fold increase 
Reduced bactericidal activity against 
Gram-negative E. coli and reduced 
membrane-permeating capacity 
42 
HsR3 (115-122)EDN Loop 7 (V1) No effect  
42 
HsR3 Δ(115-122) Loop 7 (V1) 1.5-fold decrease Reduced bactericidal activity against Gram-positive S. aureus 
42 
Mouse 




No effect on leukocyte chemotaxis 247 
HsR2 W7A Helix 1  
Abolishment of EDN C-mannosylation 
(W7 was identified as the C-
mannosylation site) 
248 
HsR2 W10A Helix 1  Abolishment of W7 C-mannosylation 248 
HsR2 W10F Helix 1  Partial rescue of W7 C-mannosylation abolishment 
248 
HsR2 R132T β-strand 6 (V1) 12-fold decrease  
249 
HsR2 S64R Loop 4 (V1) 74-fold decrease  249 













R64S/T132R V1 15-fold increase 
No increase in antiviral activity against 
RSV (opposite mutation than in HsR2 
S64R/R132T) 
249 




No antiviral activity against RSV 36 









Table 2.2 continued 
Protein Mutation Localization on structure Effect on kcat/KM Other effects Ref 
HsR3 R97T (natural variant) Loop 6 (V2)  Reduced cytotoxicity and neurotoxicity 
45 
HsR3 R22A Loop 1 (V2) 1.6-fold decrease 
Large reduction in cytotoxicity; small 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; large reduction of 
antiparasitic activity 
111 
HsR3 R34A Loop 2 (V2) 1.25-fold decrease 
Large reduction in cytotoxicity; small 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; large reduction of 
antiparasitic activity 
111 
HsR3 R61A Loop 4 (V1) 1.4-fold decrease 
Reduction in cytotoxicity; small 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; reduction of 
antiparasitic activity 
111 
HsR3 H64A Loop 4 (V1) 1.2-fold increase 
Reduction in cytotoxicity; small 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; reduction of 
antiparasitic activity 
111 
HsR3 R77A Loop 5 (V1) 1.9-fold increase 
Reduction in cytotoxicity; small 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; reduction of 
antiparasitic activity 
111 
HsR3 R22A/R34A V2 2-fold increase 
Large reduction in cytotoxicity; large 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; large reduction of 
antiparasitic activity 
111 
HsR3 R22A/R61A  2-fold increase 
Reduction in cytotoxicity; large 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; reduction of 
antiparasitic activity 
111 
HsR3 R22A/R77A  4-fold increase 
Reduction in cytotoxicity; abolition of 
bactericidal activity against Gram-
negative E. coli; large reduction of 
bactericidal activity against Gram-








Table 2.2 continued  
Protein Mutation Localization on structure Effect on kcat/KM Other effects Ref 
HsR3 R22A/H64A  5-fold increase 
No reduction in cytotoxicity; small 
reduction in bactericidal activity against 
Gram-negative E. coli; no reduction in 
bactericidal activity against Gram-
positive B. subtilis; reduction of 
antiparasitic activity 
111 
HsR3 R34A/H64A  1.25-fold decrease 
Large reduction in cytotoxicity; small 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; large reduction of 
antiparasitic activity 
111 
HsR3 R61A/H64A V1 1.4-fold decrease 
Large reduction in cytotoxicity; large 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-
positive B. subtilis; large reduction of 
antiparasitic activity 
111 
HsR3 H64A/R77A V1 1.25-fold decrease 
Reduction in cytotoxicity; large 
reduction in bactericidal activity against 
Gram-negative E. coli; large reduction in 
bactericidal activity against Gram-













Figure 2.9: Conformational exchange rates of selected RNases. Cartoon representation of 
Homo sapiens EDN (HsR2), Homo sapiens ECP (HsR3), Pongo pygmaeus ECP (PpR3), Macaca 
fascicularis ECP (MfR3), Bos taurus RNase A (BtRA), Homo sapiens angiogenin (HsR5) and 
Homo sapiens RNase 4 (HsR4). Structures are colored using a blue-white-red spectrum 
corresponding to residues exhibiting exchange rates (kex) ranging from 0 to 1000 s-1. Residues 
experiencing enhanced conformational exchange appear in the red end of the spectrum while 
residues displaying no conformational exchange are in the blue end of the spectrum. Exchange 
rates (kex) were calculated for each individual residue by dual fitting 500 and 800 MHz CPMG data 








Figure 2.10: Consensus sequence corresponding to the multiple sequence alignment. 
Sequences for 23 RNases shown in Figure 2.1 A are included. The first column and row labels 








Figure 2.11: µs dynamics of all 23 RNase homologs. RMSFs for each protein from each of the 
four phylogenetic groups are shown using a tube representation where the thickness of the tube 
corresponds to the flexibility of residues in each protein, with thicker tubes corresponding to 
flexible regions and thinner tubes representing less flexible regions. The dynamical ranges 
represented using the color spectrum is consistent across all sequences with the red and blue 
ends of the spectrum corresponding to more and less dynamic regions, respectively. Note that N-








Figure 2.12: Dynamic cross-correlation maps (DCCMs) for the 23 RNase homologs. Values 
>0.4 (blue end of the spectrum) represent correlated motions in the protein, while values < -0.4 
(red end of the spectrum) represent anti-correlated motions. DCCMs identified using black 
outlines are discussed in the section “Microsecond dynamics” of the manuscript. Regions 
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Human genome contains a group of more than a dozen similar genes with diverse biological 
functions including antiviral, antibacterial and angiogenesis activities. The characterized gene 
products of this group show significant sequence similarity and a common structural fold 
associated with binding and cleavage of ribonucleic acid (RNA) substrates. Therefore, these 
proteins have been categorized as members of human pancreatic-type ribonucleases (hRNases). 
hRNases differ in cell/tissue localization and display distinct substrate binding preferences and a 
wide range of ribonucleolytic catalytic efficiencies. Limited information is available about structural 
and dynamical properties that influence this diversity among these homologous RNases. Here, 
we use computer simulations to characterize substrate interactions, electrostatics and dynamical 
properties of hRNases 1-7 associated with binding to two nucleotide substrates (ACAC and 
AUAU). Results indicate that even with complete conservation of active-site catalytic triad 
associated with ribonucleolytic activity, these enzymes show significant differences in substrate 
interactions. Detailed characterization suggests that in addition to binding site electrostatic and 
van der Waals interactions, dynamics of distal regions may also play a role in binding. Another 
key insight is that a small difference in temperature of 300 K (used in experimental studies) and 
310 K (physiological temperature) shows significant changes in enzyme-substrate interactions. 
 
3.2 Introduction 
A set of related human genes encoding for enzymes that cleave ribonucleic acid (RNA) substrates 
also exhibit diverse biological functions such as angiogenesis, antiviral, antibacterial, and/or 
cytotoxic activities. Eight of the encoded enzymes (canonical members) show conservation of two 
active-site histidine residues and a lysine associated with the catalytic mechanism of 
ribonucleolytic cleavage. An additional five catalytically inactive (non-canonical members) 
pseudogenes were also identified in the human genome.5, 231, 250, 251 Collectively, these 13 proteins 
exhibit 28% sequence identity (40% among the 8 canonical members). All structurally 
characterized members share a common structural fold while displaying a diverse range of 
catalytic efficiencies and biological activities.211, 252 These proteins are referred to as human 
ribonucleases (hRNases) due to their conserved fold and ribonucleolytic function, which was first 
discovered and characterized for bovine ribonuclease A (bRNaseA). As enzymes, hRNases 
catalyze the transphosphorylation and hydrolysis of the phosphodiester bond in single-stranded 





broadly, the hRNases and bRNaseA belong to pancreatic-type ribonucleases (RNases) 
superfamily of proteins with about 1500 members, mostly from mammals.  
 
RNase superfamily members bind and catalyze the phosphodiester bond cleavage in a wide 
variety of nucleotide substrates of different lengths and sequences. Substrate binding and kinetic 
assays for some hRNases have been performed using a number of substrates with varying 
nucleotide sequences and lengths, resulting in a wide variety of binding affinities and catalytic 
efficiencies being reported.110, 112, 114, 116, 117, 119, 254-266 Structural studies have provided detailed 
information for binding sites for the phosphate groups (P0, P1, P2), pyrimidine (B1) and purine (B2) 
nucleotide bases  in the active-site of bovine RNase A, the archetypal member of this superfamily 
(Figure 3.1).7 The past studies have suggested substrate preferences at the B1 pyrimidine binding 
site for some of the human RNases: hRNase1 showed a preference for cytosine (C) over uridine 
(U), while hRNases 2, 3, 4 and 6 showed a preference for U over C.211, 254 In contrast, the B2 
purine binding site was shown to prefer adenosine (A) in these  hRNases.9, 211, 254 Substrate 
preferences for the other hRNases remains unclear.41 While RNase homologs exhibit specific 
nucleotide sub-site preferences in the context of structurally distinct active-site pockets, reports 
have illustrated that binding affinities differ over several orders of magnitude between all hRNase 
members (KM ranging from about 2 µM to 250 mM and kcat ranging from 0.003 to 2400 s-1), see 
Table 1.2 in chapter 1 for details.  As hRNases exhibit distinct substrate specificities and bind a 
wide range of non-specific RNA sequences with micromolar affinities, the diverging ribonucleolytic 
preferences and catalytic activities has created challenges in understanding their chemical and 
designated biological functions at the molecular level. Therefore, considerable interest exists in 
the characterization of the structure, dynamics and catalytic mechanisms of hRNases, in order to 
gain a better understanding of their biological functions in the cell. 
 
One of the most intriguing aspects of hRNases is the wide range of catalytic efficiencies 
associated with ribonucleolytic activities observed for these homologs, which differ by as much 
as 106-fold.211, 252 Interestingly, the time-scales associated with their intrinsic dynamics 
(corresponding to large-scale global conformational exchange) also varies over 5-6 orders of 
magnitude.252 The similarity in range of catalytic efficiencies as well as the observed intrinsic 
dynamics raises an interesting question regarding the relevance of dynamics in the catalytic 
mechanism.252 Recently, structural and dynamical characterization of a group of 23 members of 
the RNase superfamily based on nuclear magnetic resonance (NMR) and computational 






Figure 3.1: RNase-substrate binding sub-sites. Schematic representation based on the 
bRNaseA active-site. P0, P1 and P2 represent binding sub-sites for the phosphate groups of the 
RNA substrate backbone, while B1 and B2 correspond to nucleotide base sub-sites. The cleaved 
phosphodiester bond is indicated by an arrow. The nucleotide bases in pockets B1 (cytosine 
drawn, but uracil can also bind) and B2 (adenosine) are rendered based on published information 
about nucleotide preference in bRNaseA; for some hRNases, the information about nucleotide 
preference is unclear. Figure redrawn based on 7. The substrates investigated in this study are 
5’-ACAC-3’ (shown) and 5’-AUAU-3’. In the present work, simplified nucleotides numbering 
scheme A(-2)C/U(-1)A(1)C/U(2) is used with negative numbers corresponding to nucleotides 
away from cleaved phosphodiester bond decreasing in the 5’ direction and positive numbers for 






properties within this enzyme family.267 Members within sub-families, identified based on 
phylogenetic classification, showed similarity in structure, and more interestingly, similarity in 
biological function and intrinsic dynamics. Furthermore, the different sub-families corresponding 
to branches of evolution associated with gene duplication followed by functional adaptation show 
largely different dynamics. For a direct comparison of the catalytic efficiencies and dynamics of 
these hRNases, the use of identical substrates in similar conditions is essential to eliminate effects 
caused by inhomogeneous nucleotide sequences and/or experimental variations. 
 
In this study, we use computer modeling to investigate the binding and interactions of 8 canonical 
members of the RNase superfamily (hRNases 1-7 and bovine RNase A) in the presence of two 
model single-stranded RNA substrates: the tetraribonucleotide sequences ACAC and AUAU. The 
selection of these model substrates is based on previous experimental data on nucleotide 
preferences in the B1/B2 sub-sites  as well as structural and dynamical characterization of 
hRNases from our group.252, 267 Using microsecond time-scale molecular dynamics (MD) 
simulations, we characterized the binding stability, hydrogen bonding, van der Waals and 
electrostatic interactions between the enzymes in complex with the two model substrates. The 
detailed comparative analysis provides new insights into the structural and dynamical properties 
that contribute to enzyme-nucleotide substrate interactions in these RNases. The results indicate 
that while the 8 enzymes display conservation of the catalytic triad and a number of active-site 
residues involved in substrate interactions and stability, their substrate preference and binding 
affinities differ significantly. These results further indicate that, in addition to the conserved 
catalytic triad, other active-site residues play important roles in enzyme-substrate interaction and 
stability, and therefore, could have important consequences for differences in the biological 
function between functional and structural enzyme homologs. Somewhat surprisingly, a 
temperature difference from 300 K to 310 K shows significant differences in substrate stability 
behavior in these enzymes. This is intriguing because the vast majority of prior experimental 
enzyme characterization were performed at room temperature (~300 K), while the relevant 
physiological temperature for these enzymes is closer to the average human (~310 K) and bovine 
(~312 K) body temperatures. These observations highlight the effect of subtle changes in 
temperature on the structural and dynamical properties of enzymes and further illustrate the 
importance of the selection of temperature in experimental and computational studies that are 






3.3 Materials and methods 
Atomic coordinates: Seven human ribonuclease substrate complexes were prepared based on 
X-ray/NMR structures with the following PDB codes: 2K11 (hRNase1),268 1GQV (hRNase2),269 
1QMT (hRNase3),270 1RNF (hRNase4),271 1ANG (hRNase5),272 2HKY (hRNase7)273 and 7RSA 
(bRNaseA),274 while hRNase6 was crystallized in our group.138 The sequence alignment of these 
8 proteins is provided in Figure 1.2 of Chapter 1. hRNase8 was not investigated in this study as 
structural information about this enzyme is not yet available. Each of these proteins were 
investigated complexed with two model substrates AUAU and ACAC, under explicit water 
conditions based on the procedure described below.  
  
Computational systems preparation: Computational system preparation and all-atom MD 
simulations were performed using the AMBER simulation package.275 For preparation of the 
nucleotide substrate, the coordinates for the phosphate and ribose sugar backbone were adopted 
from the DNA ligand (ATAA) in PDB structure 1RCN 276. The nucleotide bases of the substrate 
template were modified to create the desired nucleotide (ACAC or AUAU), using AMBER’s tleap 
modeling preparation module. AMBER’s ff14SB force-field were used for modeling both protein 
residues and RNA substrates. The protein-ligand complex was neutralized with the addition of 
chloride (Cl-) counterions and solvated by immersing in a rectangular box (SPC/E277 water model) 
with periodic boundary conditions. The prepared system was equilibrated using the protocols 
developed in our group and described previously.278, 279 These protocols were effective in fully 
resolving the steric clashes caused by the introduction of modeled substrate in the active site. 
AMBER’s pmemd simulation engine was used for equilibration and production runs, with PME-
method for long range electrostatics280. All hydrogen bonds were constrained using SHAKE281.  
  
Histidine protonation states: There are two conserved histidine residues in the active-site of all 
RNases that participate in the phosphodiester bond cleavage mechanism. The protonation states 
for these residues were determined based on the past pH profiles for bRNaseA as well as 
structural interaction with modeled substrate and other residues;85, 282 the two histidine residues 
His12 and His119 (bRNaseA numbering), were modeled in single (proton on Nẟ1) and double 
protonated states respectively. All the other histidine residues were modeled in single protonated 






MD simulations: Equilibration runs were performed under constant volume and temperature 
(NVT) conditions with a thermostat to bring the system to target temperature of 300 K or 310 K 
for production run (see below). Production runs of 0.5 µs (microsecond) were performed under 
constant volume and energy (NVE) simulation conditions using a 2 femtoseconds (fs) time-step. 
Production runs under NVE ensemble were performed as this ensemble offers better 
computational stability and performance for longer MD simulations.283 All simulations were 
performed using NVIDIA graphics cards with CUDA-enabled version of AMBER’s pmemd MD 
simulation engine. The default precision in the pmemd.cuda_SPFP binary was used from AMBER 
v14 package.  
 
Two independent sets of simulations were performed at 300 K and 310 K (no thermostat was 
applied during production runs). Furthermore, to ensure the reproducibility of the results from this 
study, two independent trajectories were computed at each temperature (labeled as 300 K 1, 300 
K 2, 310 K 1, and 310 K 2 in the remaining text and Table 3.1). For the set 2, after equilibration 
the system was minimized (100,000 steps) followed by MD (1000 ps) to slowly readjust the 
temperature before the production runs were performed. At each temperature, for each of the 
unique RNase-substrate complex, 2,000 structures (1,000 from each trajectory, 500 picoseconds 
apart) were stored and analyzed for structural, electrostatic and dynamical analysis, as described 
below. A subset of stored structures was used for hRNase5 (1,400 structures) and hRNase7 
(1,360 structures) analysis as the substrates were ejected mid-way during the simulations; 
therefore, only the structures where the substrate stays bound in the sub-sites were used for 
analysis. Specifically, only the first 400 structures from hRNase5-AUAU 300 K 2 trajectory and 
first 360 structures from hRNase7-AUAU 300 K 1 trajectory were used for structural (H-bonding) 
and interaction energy analyses as described below. For the two systems where the substrate 
was ejected (hRNase5-AUAU at 300 K and hRNase7-AUAU at 300 K), addition MD simulations 
were performed to ensure the reproducibility of the behavior. To generate the starting coordinate 
for this third set of trajectories for these two systems, the equilibrated structures were heated for 
1000 ps to 305 K (for simulation set for 300 K) and 315 K (for simulation set for 310 K) to generate 
conformational diversity. The ending structures were minimized for 100,000 steps and heated to 
final temperature before production runs were performed similar to the other two sets 
 
Structural analysis using H-bonding patterns: H-bonding interactions between the substrate 
and RNases were analyzed using ptraj, with the following criteria: less than 3.3 Å for donor to 





acceptor. The percentage occupancies of H-bonds, defined as fraction (percentage) of total 
number of structures (as described in last paragraph) where the interaction meets the H-bonding 
criterion mentioned above, were also calculated. 
 
Enzyme-substrate interaction: The energy for the enzyme-substrate interactions (Eenz-subs) were 
calculated as a sum of electrostatic (Eel) and van der Waals energy (Evdw) between atom pairs, 
based on an approach developed in our group.278, 284  
 
∑ +=− )( vdwelsubsenz EEE      (3.1) 
 
Eel is the electrostatic contribution, Evdw is the van der Waals term and the summation runs over 
all atom pairs for the enzyme and nucleotide substrate. The Eel and Evdw terms were computed as 
follows 
      and      (3.2) 
 
where qi , qj are partial charges, and Aij, Bij are Lennard-Jones parameters. These parameters 
were obtained from AMBER ff14SB force field. A distance-dependent dielectric function was used: 
     (3.3) 
 
B=εo-A; εo=78.4 for water; A= -8.5525; 𝜆𝜆=0.003627 and k=7.7839. 
 
All enzyme and substrate (ACAC/AUAU) atom pairs were included in the calculations and 
resulting interaction energies were summed for each residue-nucleotide pair. For each system, 
the reported interaction energies are an average over total number of structures (as described 
above). This method has successfully been used to predict the experimentally obtained binding 
preference/affinities of substrates for a number of proteins including human cyclophilin A, 
xylanases, and maltose binding proteins similar to the substrate preference of hRNases described 
in this study.278, 284, 285 
 
Electrostatic surface calculations: The enzyme electrostatic surface was computed using the 






























The ideal case of using averaged enzyme structure for the entire MD simulation was not feasible 
as the averaged structure shows artificial bonds and angles, particularly to the sampling of 
different conformations over the 0.5 µs simulations. Therefore, a conformation from the MD 
ensemble closest to the averaged structure (with least RMSD to the average) was used to 
generate the electrostatic surface.  
 
RMSF10 calculations: For dynamical analysis, backbone (Cα) and all-atom flexibility of simulation 
trajectories was determined from the root mean square fluctuation (RMSF), computed by 
aggregating the magnitude of displacement eigenmodes computed using the quasi-harmonic 
analysis (QHA) in the ptraj analysis module in AMBER. As described previously,228, 287 only the 
top 10 QHA modes (RMSF10) were used in the analysis to focus on the principal dynamics or long 
time-scale functionally relevant fluctuations in the proteins. For comparison, the results for apo 
systems were obtained from our previous study.267  
 
3.4 Results 
3.4.A Stability of the substrate-bound RNase complexes 
Table 3.1 summarizes the interactions of hRNases 1-7 in complex with model tetranucleotide 
substrates ACAC and AUAU. Starting from the enzyme conformation with substrate-bound in the 
active-site, 0.5 µs MD simulations were used to characterize the stability of interactions between 
the enzyme and nucleotide substrates. Note, the starting coordinates for the substrate phosphate 
and ribose sugar backbone were adopted from a bRNaseA-substrate complex published 
previously (PDB code 1RCN), and the nucleotide bases were added computationally. Two 
independent MD simulation trajectories for each complex were performed, labeled 1 and 2 in 
Table 3.1, to ensure reproducibility of the results reported. The characterization of enzyme-
substrate complex stability is based on interaction analysis between the two central nucleotides 
and enzyme residues. Only the two central nucleotides were considered for stability analysis as 
these nucleotides are adjacent to the phosphodiester bond cleaved by RNases and have well 
defined interactions with active-site residues forming the P1/B1 and P2/B2 binding sites (see Figure 
3.1). The other/terminal two nucleotides in the model substrates do not have well defined 
interactions and show significantly lower stability over the course of the MD simulations. In Table 
3.1, simulation trajectories where the two central nucleotides show stable binding in their 
respective sub-sites (for entire 0.5 µs) are represented with a green box, while trajectories where 





stable nucleotide in the binding sub-site is identified in the yellow boxes of Table 3.1. The cases 
where both the central nucleotides lose all contacts with the sub-site residues and are considered 
to be ejected out of the binding pocket are marked in red boxes. Ejection out of the binding pocket 
is defined as no direct hydrogen bond or van der Waals contact between the enzyme residues 
and the two central nucleotides (any water or ion-mediated indirect interactions were excluded 
from this analysis). 
 
The interaction analysis shows that the majority of RNases show stable nucleotide binding 
throughout the simulations for the two alternate temperatures at 300 K and 310 K, reproduced in 
both the alternative MD trajectories. Notable exceptions include hRNase5 and hRNase7, where 
the substrate AUAU is completely ejected out of the active-site. In the case of hRNase3, the 
enzyme displays interactions with only one of the two central nucleotides, while the second central 
nucleotide is ejected out of the binding pocket (Table 3.1). There are marked differences 
associated with the two temperatures as well as two independent trajectories at each 
temperature, but overall the results are qualitatively similar. Note that these are human proteins 
and 310 K is close to the physiological temperature, while a number of experimental enzyme 
kinetics parameters are reported for these systems at temperature close to 300 K.54, 110, 112, 114, 116, 
117, 254, 255, 264, 265 For hRNase5 and hRNase7, additional data was collected to confirm the 
observations of the ejection of substrate from the active-site. The third MD set (data only collected 
for these two systems) indicated that for hRNase7-AUAU at 300 K, the behavior was reproduced, 
as the substrate was completely ejected from the active-site at 370 ns. For hRNase5-AUAU the 
behavior was partially reproduced, as 3 out of the 4 nucleotides broke all contacts, with only 
central U maintaining contact with the protein. 
 
Characterization of the relative substrate positions and interactions with enzymes over the course 
of MD simulations revealed significant variations among the different RNases. The results are 
depicted in Figure 3.2 for simulations at 300 K and Figure 3.3 for simulations at 310 K (the 
trajectory labeled 1 in Table 3.1 is shown). These figures depict three substrate conformations 
(relative positions); at the start (0 µs, green sticks for carbon), half-way (0.25 µs, yellow sticks for 
carbon) and endpoint (0.5 µs, magenta sticks for carbon) of the simulations. In cases where the 
substrate is completely ejected from the active-site, the mid-way and ending frames have been 






In the cases of bRNaseA, hRNase1, and hRNase6, both model substrates (ACAC and AUAU) 
stay bound in the active-site for the entire 0.5 µs simulations (300 K as well as 310 K), close to 
the original orientation, suggesting equal stability of these substrates in these enzymes. Note that 
the central nucleotides remain close to their initial orientation in the active-site (in P1/B1 and P2/B2 
sites), while the two peripheral nucleotides show considerable variation from their initial 
orientation. In the case of hRNase2, both substrates stay in their initial orientation at 300 K, with 
the central adenosine base showing minor movement out of the B2 pocket while phosphate stays 
bound in the P2 pocket. For simulations at 310 K, substrate ACAC is partially displaced from its 
initial orientation, with the central cytosine in trajectory 1 (adenine in trajectory 2) moving 
completely out of the P1/B1 (P2/B2) pockets (Figure 3.3). In the case of hRNase4, substrate ACAC 
at 300 K stays localized in the active-site while at 310 K adenine leaves the binding pocket; for 
substrate AUAU at both temperature adenosine moves out of its binding pocket. In hRNase5, the 
substrates show considerable movements in simulations at 300 K, particularly in the case of 
AUAU, where the substrate completely leaves the active-site in one of the MD trajectories (labeled 
as trajectory 2 in Table 3.1). For hRNase3 and hRNase7, at least one of the nucleotide binding 
to B1 or B2 site (for both ACAC and AUAU) show significant movement away from the binding 
pocket over the course of MD simulations at both temperatures investigated.  
 
3.4.B Structural interactions 
To quantitatively characterize the substrate interactions with each of the 8 proteins in this study, 
hydrogen bonding interactions were calculated for the ensemble of conformations sampled during 
the MD simulations. The average distance between heavy atoms of the enzyme and substrate 
nucleotide, and percentage occupancy of the hydrogen bonding interactions over the course of 
aggregate 1 µs MD sampling (by combining two simulations labeled as 1 and 2 in Table 3.1) were 
calculated; the results are summarized in Table 3.2 for 300 K and Table 3.3 for 310 K, for the two 
substrates. The results indicate that the conserved catalytic triad (His12, Lys41 and His119, 
bRNaseA numbering) does not form stable hydrogen bonds, and any definite patterns in the H-
bonding interactions between these residues (across all 8 enzymes investigated) and substrates 
were not observed. Among the non-catalytic active-site residues, the equivalent of bRNaseA 
residues Thr45 and Asn71 showed most stable H-bond interactions with the substrates in several 
human RNases. These residues were previously shown to be part of the B1 and B2 binding sites, 
respectively.288 Unsurprisingly, Thr45 and Asn71 are fully conserved in all 8 RNases investigated 





Table 3.1: Stability of nucleotide substrates ACAC and AUAU in the active-site of RNases. 
Stable substrates in the active-site for entire 0.5 µs (500 ns) are colored as green boxes; cases 
where one nucleotide is ejected are colored yellow and the stable nucleotide base is labeled (A – 
adenine, U – uracil, C – cytosine); and cases where both nucleotides are ejected are indicated as 
red boxes (time in nanoseconds when the substrate is fully ejected is specified). Note that only 
the two central nucleotides were considered for this analysis (in red, underlined). a = additional 
(3rd) trajectory indicates that only central U remained in active-site, b = additional (3rd) trajectory 
indicates that the substrate was ejected from active-site at 370 ns. 
 
Enzyme PDB ID 
ACAC AUAU 
300 K 310 K 300 K 310 K 
1 2 1 2 1 2 1 2 
bRNaseA 7RSA         
hRNase1 2K11         
hRNase2 1GQV   A C     
hRNase3 1QMT C A A A U  U A 
hRNase4 1RNF   C  U  U  
hRNase5 1ANG    C A 200 ns a U U 
hRNase6 *         








Figure 3.2: Substrate behavior over the course of 0.5 µs MD simulations. The enzymes are 
shown as gray cartoons and the 3 orientations of the substrate at start (0 µs, green), mid-way 
(0.25 µs, yellow) and end (0.5 µs, magenta) of the simulations are shown as sticks. The results 
for the two substrates ACAC and AUAU are shown separately. The central two nucleotides of the 
substrate that interact with two binding sub-sites (B1/P1 or B2/P2) are shown in dark colors, while 
the two terminal nucleotides (one on each side) are depicted with faded color. The results depicted 
are from the 300 K simulation trajectories and represent the MD simulations set 1. The results 
from trajectory 2 at 300 K are qualitatively similar (Table 3.1). * indicates simulations where the 
substrate is ejected and leaves the active-site; the end and mid-way frames for these cases are 
adjusted accordingly. a indicates that the substrate was stable in depicted trajectory (300 K 1); 







Figure 3.3: Substrate behavior over the course of 0.5 µs MD simulations at 310 K. The 
enzymes are shown as gray cartoons and the 3 relative positions of the substrate at start (0 µs, 
green), mid-way (0.25 µs, yellow) and end (0.5 µs, magenta) of the simulations are shown as 
sticks. The results for the two substrates ACAC and AUAU are shown separately. The central two 
nucleotides of the substrate that interact with two binding sub-sites (B1/P1 or B2/P2) are shown in 
dark colors, while the two terminal nucleotides (one on each side) are depicted with faded color. 
The results depicted are from the 310 K simulation trajectories and represent the MD simulations 






For enzymes bRNaseA, hRNase1, hRNase4 and hRNase6, strong H-bonding interactions are 
observed with both substrates at 300 K (Figure 3.4 and Table 3.2). In this study, strong H-bonds 
are defined as H-bonds with bond length less than 3 Å between the heavy atoms; and H-bond 
occupancies greater than 80% is considered significant. hRNase2 forms at least one H-bond 
interaction with relatively higher occupancy (79.4%) with substrate ACAC while it forms H-bonds 
with AUAU that have lower occupancies. On the other hand, hRNase3 and hRNase7 form H-
bonds with both substrates that have lower occupancies (≤ 70%). It was also observed that 
hRNase5 shows no H-bonding interactions with the substrate AUAU. This might be due to the 
complete ejection of substrate from the binding site of hRNase5 after ~200 ns (0.2 µs) of 
simulation (Table 3.1).  
 
A number of differences were observed when comparing the enzyme-substrate H-bonding 
interactions at experimental (300 K) and physiological (310 K, see Figure 3.5 and Table 3.3) 
temperatures with the most obvious difference in H-bonding pattern appears in hRNase3, 
hRNase5 and hRNase7. Interestingly, hRNases 2 and 3 show lower occupancies with both 
ligands relative to bRNaseA at both temperatures. For hRNase2, strong H-bonding interactions 
with substrate ACAC that were observed at 300 K simulations exhibit lower occupancies at 310 
K. Simulations indicated that hRNase3 does not form any H-bonds with ACAC at 310 K. A 
comparison of the interactions at 310 K suggest significantly more interactions for hRNases 3 and 
4 with the AUAU ligand. Note when compared to lower temperature, hRNase3 forms H-bonding 
interactions with AUAU that have lower occupancies. On the other hand, it is observed that 
hRNase7 does not show any H-bonding interactions with the substrate AUAU at 310 K, although 
stronger H-bonds are observed with ACAC at 310 K, suggesting a potential preference for cytidine 
(C) in the B1 sub-site. hRNase5, which did not show any H-bonding interactions with substrate 
AUAU at 300 K, exhibits H-bonds with substrate AUAU at 310 K through the conserved Asn43 
and Thr44 residues. The time evolution behavior of H-bonds for various complexes is shown in 
Figures 3.12 – 3.19 (Appendix 3.7). 
 
Overall, results suggest that even though all the 8 enzymes have conserved catalytic triad and 
several other conserved residues in the active-site,267 the model substrates show significant 
differences in their interactions with the enzymes, with some of them showing weak interactions 
and/or lower occupancies. An interesting observation is that even for substrates which stay bound 
to the enzymes, the conserved catalytic triad residues do not exhibit strong H-bonding 








Figure 3.4: Hydrogen-bonding interactions between RNases and model substrates at 300 
K. H-bonds (with >45% occupancy) are indicated with black dotted line and averaged bond length 
(Å) and percentage occupancy are shown in red colored text. Enzyme and nucleotide atoms 
participating in the H-bonds are labeled, with enzyme residues shown in blue and substrate 
nucleotides shown in green for carbon atoms, blue for nitrogen, red for oxygen, and orange for 
phosphorus. Enzyme residue numbers correspond to enzyme sequence, while substrate 
nucleotides are numbered as A(-2)C/U(-1)A(1)C/U(2), as described in the legend of Figure 3.1. 
hRNase5-AUAU did not show any H-bonds meeting the criteria and is only shown for comparison. 
Note that the substrates orientation (marked by 3’ and 5’ for bRNaseA) appear opposite to the 
depiction in Figure 3.1, as enzymes are shown from view used commonly in literature. The 








Figure 3.5: Hydrogen-bonding interactions between RNases and model substrates at 310 
K. H-bonds (with >45% occupancy) are indicated with black dotted line and averaged bond length 
(Å) and percentage occupancy are shown in red colored text. Enzyme and nucleotide atoms 
participating in the H-bonds are labeled, with enzyme residues shown in blue and substrate 
nucleotides shown in green for carbon atoms, blue for nitrogen, red for oxygen, and orange for 
phosphorus. Enzyme residue numbers correspond to enzyme sequence, while substrate 
nucleotides are numbered as A(-2)C/U(-1)A(1)C/U(2), as described in the legend of Figure 3.1. Note 
that the substrates orientation (marked by 3’ and 5’ for bRNaseA) appear opposite to the depiction 
in Figure 3.1, as enzymes are shown from view used commonly in literature. The percentage 






Table 3.2: H-bonding properties of bovine and human pancreatic-type RNases at 300 K. 
The H-bonds that meet the criteria of 3.3 Å, angle between 135 - 180° and more than 45% 
occupancy are listed. Results are based on analysis of both the alternate MD trajectories for each 
system (see methods for details).  
 
 ACAC AUAU 




































































































































































Table 3.3: H-bonding properties of bovine and human pancreatic-type RNases at 310 K. 
The H-bonds that meet the criteria of 3.3 Å, angle between 135 - 180° and more than 45% 
occupancy are listed. Note that the results are based on analysis of both MD alternate trajectories 
for each system (see methods for details). 
 
 ACAC AUAU 














































































































































































involved in substrate recognition and stabilization. This suggests that while other conserved 
residues may hold the substrate in place, the catalytic triad shows a large degree of flexibility 
which is possibly required for the catalytical cleavage step. This behavior is different than other 
enzyme systems where it is shown that the catalytic active-site residues are fairly rigid and make 
strong interactions with the substrates.138, 210, 216 Note that the structural analysis based on H-
bonds does not provide information about complete set of interactions between substrate and 
hRNases. It helps in identification of the most important direct hydrophilic interactions; however, 
long range electrostatic and hydrophobic interactions are not captured by H-bonding analysis. In 
RNases particularly the strongly charged phosphate backbone and the hydrophobic interactions 
of the nucleotide base in the binding pocket provide important contributions. Therefore, a detailed 
and quantitative analysis based on full electrostatic and van der Waals interaction energy was 
also performed as described below. 
 
3.4.C Electrostatic interactions 
ssRNA substrates are highly negatively charged molecules, particularly due to the presence of a 
phosphate backbone. It has been documented that long-range electrostatic interactions play an 
important role in the binding of negatively-charged RNA substrates to the highly cationic surface 
of this RNase superfamily.289, 290 For characterizing and comparing the charge distribution on the 
surface of these homologs, the averaged electrostatic surface for each enzyme over the course 
of MD trajectories was calculated (Figure 3.6 for results obtained from simulations at 300 K and 
Figure 3.7 for results from simulations at 310 K). hRNases have been reported to bind to similar 
substrates and share the same overall shape, but the electrostatic surface shows variations due 
to the difference in protein sequence. In addition, the charge distribution also showed differences 
based on the type of bound substrate, possibly indicating changes in orientation of enzyme 
residues on the surface due to the nature of the substrate. The most prominent feature is that all 
RNases in this study have highly positively charged surfaces (blue regions in Figures 3.6 & 3.7). 
This is not surprising as the RNA substrates are negatively charged, and the positively charged 
surface is expected to guide the substrate into the active-site pocket. An interesting observation 
is that the electrostatic surfaces for human enzymes are similar when bound to the two substrates 
ACAC and AUAU, but different in the case of bRNaseA. Note that bRNaseA is catalytically the 
most efficient enzyme (for ribonucleolytic cleavage activity) of 8 enzymes investigated in this 





conformations for optimal electrostatic based on bound substrate and efficiency of ribonucleolytic 
cleavage. 
 
3.4.D Quantitative characterization of interaction energies  
Figure 3.8 depicts an overview of the interaction energy between the enzyme and the model 
substrates, based on the 300 K simulations. The results for 310 K are shown in Figure 3.9. The 
total interaction energy was computed as a sum of van der Waals and electrostatic interaction 
energies between each enzyme residue and each nucleotide of the substrate molecules. Tables 
3.5 and 3.6 (Appendix 3.7) provide the quantitative values, using a cut-off value of < -3 kcal/mol 
per residue-nucleotide pair being considered as significant. Overall, these results from this 
analysis indicate that both model substrates show favorable interactions (blue to yellow regions 
in the figure panels) with the enzyme. Note that H-bonding based structural analysis presented 
above, describes only a sub-set of key interactions but interaction energy analysis provides a 
complete picture. More specifically, favorable interactions with the catalytic His119 (bRNaseA 
numbering) were observed for both the substrates with all RNases. Most RNases also showed 
favorable interactions with Thr45 (bRNaseA numbering) in the β1 strand, a residue shown to bind 
to the pyrimidine nucleotide.9 bRNaseA residue Lys7 further showed favorable interactions with 
both the substrates and Lys66 (from loop L4) with substrate ACAC. Similar interactions were 
observed for hRNase1, which showed additional favorable interactions by Asn71 and Lys7 with 
AUAU. In case of hRNase2 residues Arg133 and Trp8 show additional interactions in case of 
substrate AUAU; the latter residue is previously reported to interact with the ribose group.9 In 
contrast to hRNase2 where a significant number of interactions are present in the region 39-43, 
hRNase3 showed significantly fewer interactions with the two substrates. The interaction energy 
profile of hRNase4 was similar to that observed for bRNaseA for the two substrates. The C-
terminal region of hRNase5 displayed favorable interactions with the nucleotide substrates in 
addition to the catalytic Lys40, however, significantly fewer interactions of hRNase5 were 
observed with AUAU. In contrast to other RNases, hRNase6 showed favorable interactions with 
several residues of loop L4, suggesting a potential effect on the dynamical properties of this loop 
upon substrate binding. hRNase7 showed very few favorable interactions localized to the catalytic 
His124 with substrate AUAU while substrate ACAC showed additional interactions with the Lys39 
and residues of β1 strand. Similar results were observed for all RNases at 310 K except hRNase5 
and hRNase7, which showed more favorable interactions with substrate AUAU. See text in 






Figure 3.6: Electrostatic surface of RNases with the two model substrates at 300 K. Enzyme 
conformation from the MD ensemble closest to the averaged structure for the entire trajectory 
(conformation with smallest RMSD with averaged structure) was used to calculate the 







Figure 3.7: Electrostatic surface of RNases with the two model substrates at 310 K. Enzyme 
conformation from the MD ensemble closest to the averaged structure for the entire trajectory 
(conformation with smallest RMSD with averaged structure) was used to calculate the 






A comparison of the total van der Waals (Evdw) and electrostatic (Eel) energies summed up for the 
enzyme-substrate complexes provide a number of interesting observations (Table 3.4). Even 
though the nucleotide substrates are highly charged molecules (particularly the backbone 
phosphate), the largest contribution to the favorable interactions comes from van der Waals 
interactions, indicating that the active-site residues have preferential interactions with the bases. 
These quantitative estimates provide additional insights, indicating that bRNaseA possibly has a 
slight preference for substrate AUAU relative to ACAC, as Etotal is lower by 3-5 kcal/mol. In the 
case of human enzymes, hRNase1 has a better interaction with ACAC at higher temperature 
(Etotal is lower by ~ 9 kcal/mol); hRNase4, RNase5, RNase6 and RNase7 show a preference for 
ACAC substrate at 300 K, with Etotal lower more than 10 kcal/mol; hRNase3 prefers AUAU at 310 
K (Etotal is lower by almost 9 kcal/mol); while hRNase2 has similar interactions with both 
substrates. An interesting observation is that hRNase5 and hRNase7, particularly for substrate 
AUAU, show very weak interactions compared to all the other enzymes in this study. The reason 
appears to be weak (and even repulsive for hRNase7) electrostatic interactions seen for the 
AUAU model substrate at 300 K. These quantitative estimates are consistent with the 
observations that the substrate is ejected midway during the simulations (note the energies were 
calculated, and averaged, only for conformations where substrates were bound to the enzymes). 
In the cases of hRNase5 and hRNase7, this observation possibly indicates that active-site 
residues other than the conserved catalytic triad may not be optimal for the enzyme-substrate 
interactions (see Figure 3.8 and 3.9, and discussion above). However, as indicated by the H-bond 
analysis with bound substrate, the non-catalytic residues appear to make modest interactions in 
these two enzyme systems, a different behavior from other enzymes investigated in this study. 
Therefore, the binding preference and stable interactions in these two systems may be related to 
non-catalytic residues. This behavior is very different than other enzyme systems such as human 
cyclophilin A, E. coli dihydrofolate reductase and horse liver alcohol dehydrogenase where the 






Figure 3.8: Enzyme-substrate interaction energy at 300 K. Total interaction energy was 
computed as a summation of electrostatic and van der Waals interaction energy between atom 
pairs of enzyme residue and substrate nucleotide (ACAC and AUAU, respectively). The areas of 
largest negative energy (blue) represent favorable interactions, while positive energy (red) 
represents less favorable or unfavorable interactions. For ease of comparison, sequence of the 
model substrate has been adjusted to match the orientation depicted in Figure 3.2 and Figure 3.4 
(CACA and UAUA). Enzyme residues showing total interaction energy (Etotal) contributions < -3 
kcal/mol were considered significant and are marked with ellipses. (See Table 3.5 in Appendix 












Figure 3.9: Enzyme-substrate interaction energy at 310 K Total interaction energy was 
computed as a summation of electrostatic and van der Waals interaction energy between atom 
pairs of enzyme residue and substrate nucleotide (ACAC and AUAU, respectively). The areas of 
largest negative energy (blue) represent favorable interactions, while positive energy (red) 
represents less favorable or unfavorable interactions. For ease of comparison, sequence of the 
model substrate has been adjusted to match the orientation depicted in Figure 3.3 and Figure 3.5 
(CACA and UAUA). Enzyme residues showing total interaction energy (Etotal) contributions < -3 
kcal/mol were considered significant and are marked with ellipses. (See Table 3.6 in Appendix 












Table 3.4: Averaged total interaction energy between nucleotide substrates and RNases. 
The total interaction energy (Etotal) was computed as a sum of van der Waals (Evdw) and 
electrostatics (Eel) energy, averaged over 2,000 snapshots (see Methods for details). Difference 
>5 kcal/mol in Etotal is considered significant for preference of substrate ACAC and AUAU binding 
to the same RNase; such cases are underlined. Note that the case of bRNaseA-ACAC at 300 K 
is close to this criterion (5.1 kcal/mol) but is not marked. The repulsive Evdw observed in case of 
hRNase7-AUAU at 310 K is marked in bold. 
 
 ACAC AUAU 
 300 K 310 K 300 K 310 K 
 Evdw Eel Etotal Evdw Eel Etotal Evdw Eel Etotal Evdw Eel Etotal 
bRNaseA -62.7 -34.4 -97.1 -59.1 -30.0 -89.1 -66.6 -35.5 -102.2 -61.4 -30.7 -92.1 
hRNase1 -64.8 -36.2 -101.0 -69.0 -39.5 -108.5 -65.5 -35.9 -101.4 -64.1 -35.3 -99.4 
hRNase2 -64.1 -44.0 -108.1 -59.4 -45.6 -105.0 -69.0 -36.3 -105.2 -69.9 -36.2 -106.1 
hRNase3 -60.5 -51.9 -112.3 -51.9 -50.3 -102.2 -68.9 -43.1 -111.9 -56.7 -55.1 -111.8 
hRNase4 -70.4 -45.6 -116.0 -66.9 -41.1 -108.1 -68.5 -34.4 -102.9 -69.9 -37.2 -107.1 
hRNase5 -63.7 -36.6 -100.3 -55.9 -32.8 -88.7 -39.9 -8.4 -48.3 -51.9 -30.0 -81.8 
hRNase6 -77.0 -39.8 -116.8 -79.4 -41.5 -120.9 -66.2 -38.1 -104.3 -74.8 -38.9 -113.7 







3.4.E Dynamical characterization of the enzyme-substrate complexes 
The conformational flexibility (or intrinsic dynamics) of the RNases in presence of the two model 
substrates was quantified using quasi-harmonic analysis (QHA) of the snapshots sampled during 
the MD simulations. The aggregated root means square fluctuation of top 10 slowest QHA modes 
(RMSF10) provides a good measure of a protein’s conformational flexibility. Such an analysis has 
been successfully used for relating dynamics to function for a number of other proteins.284, 294 
Figure 3.10 depicts the RMSF10 for the 8 enzymes when bound to the two model substrates, as 
well as enzymes without substrate (apo) at 300 K. The corresponding results from 310 K 
simulations are shown in Figure 3.11. Results indicate that the most significant differences occur 
in the loop regions, similar to apo enzyme systems, as recently reported.267 For RNases, and 
other enzymes, it is widely reported that motions of surface loops play important roles in function 
through various steps in the catalytic cycle.138, 210 
 
The dynamical characterization at 300 K indicates distinct differences in RNases flexibility upon 
ligand binding. The intrinsic dynamics of bRNaseA is very similar for the substrate-bound and the 
apo forms with the largest fluctuations observed for residues of loop L1 (residues 13-21). Note 
that bRNaseA has the highest catalytic activity among these 8 enzymes, and the long-range 
dynamics of loop L1 was previously shown to play a functional role in enzyme activity. 138, 252 
hRNase1 showed overall reduction in fluctuations upon binding of the two substrates with 
additional reduction in fluctuations of loop L1 (residues 13-21) observed in the AUAU-bound state. 
The truncated loop L1 in hRNase2, hRNase3, hRNase6 and hRNase7 displayed diminished 
dynamics in these enzymes relative to bRNaseA. The large fluctuations in L4 (residues 58-71 for 
both enzymes) observed in the apo forms of hRNase2 and hRNase3 were diminished upon 
binding of the two substrates. Further, hRNase3 showed reduced conformational motions of L2 
(residues 35-40) and L4 upon binding of the two substrates while loop 6 (residues 85-94) 
displayed enhanced motions upon binding of AUAU. hRNase4 showed significant reduction in 
the dynamical profile throughout the protein upon binding of the two substrates, consistent with 
similar changes in the conformational exchange patterns observed experimentally (data not 
shown). hRNase5 showed modest changes near L6 (residue 85-94) upon substrate binding. In 
the case of hRNase6, large fluctuations observed in L4 (residues 58-68) in the apo state were 
diminished upon binding of the two substrates. Further, the dynamics observed in loop L7 
(residues 109-119) in the apo and AUAU-bound states was diminished in the ACAC-bound state. 
hRNase7 showed larger fluctuations upon binding of the two substrates in L7 (residues 109-119) 





comparison to fluctuations observed at 300 K, the dynamical profiles at 310 K (Figure 3.11) 
displayed minor differences in the fluctuations of loops of hRNase2, hRNase3 and hRNase4 for 
the two substrates. However, in the case of hRNase7, about a 2-fold increase in fluctuations are 
observed in loop L4 when bound to substrate ACAC, while the fluctuations in loop L7 are 
decreased for substrate AUAU at the higher temperature. 
 
In a joint NMR-computational study of the RNase superfamily, we recently reported that the 
intrinsic dynamics of apo proteins is similar for members within phylogenetic sub-families that 
share common biological activities and different between sub-families.267 Comparison of intrinsic 
dynamics when the two different substrates are bound also provides some unique insights. 
Comparison of members within phylogenetic sub-families showed different dynamical properties 
upon binding of the two substrates. For example, AUAU binding led to reduced flexibility of L1 in 
hRNase1 relative to the apo state, while this change was not observed in bRNase1 at both 300 
K and 310 K. Similarly, a comparison of hRNase2 and hRNase3, which belong to the same 
phylogenetic sub-family, suggests that while regions displaying large fluctuations are similar, 
there are notable differences in the changes in the dynamical profiles upon substrate binding 
between the two enzymes. These observations are consistent with recent studies which showed 
distinctly different effects of ligand binding for members within phylogenetic sub-families.295 
However, further investigations are required, as the current work cannot fully rule out whether the 
observed changes in loop motions help in differentiating binding of substrates or are simply a 






Figure 3.10: Dynamical behavior of RNases bound to model substrates at 300 K. In the left 
panel, for each enzyme-substrate [ACAC (red), AUAU (blue), and apo (black)], the flexibility of Cα 
atoms of each residue calculated from the slowest 10 quasi-harmonic modes (RMSF10) is shown 
as a function of enzyme residue numbering. Secondary structures [alpha-helix (α), beta sheets 
(β) and loops (L)] are identified (top); the important loop regions are highlighted in gray. On the 
right side, RMSF10 are projected on cartoon representations of each enzyme, with flexible loop 
regions identified. The thickness of the cartoon tube corresponds to the amplitude of RMSF10, 
and the color corresponds to the dynamic range observed: least dynamic (0 Å, blue) to most 
dynamic (5 Å, red). These fluctuations are on the same scale, allowing direct comparison between 
different enzymes and substrates. For clarity, fluctuations in the terminal regions are removed 
(bRNase 1-2; hRNase1 1-2 and 126-127; hRNase2 134-135; hRNase3 1-3; hRNase4 1-3; 












Figure 3.11: Dynamical behavior of RNases bound to model substrates at 310 K. In the left 
panel, for each enzyme-substrate [ACAC (red), and AUAU (blue), the flexibility of Cα atoms of 
each residue calculated from the slowest 10 quasi-harmonic modes (RMSF10) is shown as a 
function of enzyme residue numbering. Secondary structures [alpha-helix (α), beta sheets (β) and 
loops (L)] are identified (top); the important loop regions are highlighted in gray. On the right side, 
RMSF10 are projected on cartoon representations of each enzyme, with flexible loop regions 
identified. The thickness of the cartoon tube corresponds to the amplitude of RMSF10, and the 
color corresponds to the dynamic range observed: least dynamic (0 Å, blue) to most dynamic (5 
Å, red). These fluctuations are on the same scale, allowing direct comparison between different 
enzymes and substrates. For clarity, fluctuations in the terminal regions are removed (bRNase 1-
2; hRNase1 1-2 and 125-127; hRNase4 1-3 and 119-120; hRNase5 1-2 and 121-123; hRNase6 













Ribonucleases are a superfamily of enzymes that catalyze the endonucleolytic cleavage of RNA 
substrates. The eight canonical human pancreatic-type RNases, identified in the initial 
sequencing of the human genome, perform distinct biological functions such as anti-
pathogenicity, angiogenesis and host defense, among others.16, 211, 252 In addition, they also share 
the common chemical function of ribonucleolytic activity of RNA substrates of non-specific 
nucleotide sequences. The human RNases investigated so far also display a diverse range of 
substrate specificities and catalytic efficiencies.252 While numerous studies have characterized 
the nucleotide substrate binding properties, rate kinetics and efficiencies of human RNases, these 
studies were performed by different research groups with diverse substrates under various 
experimental conditions. Other studies also attempted to characterize the nucleotide preference 
based on available crystal structures.9 Unfortunately, these comparisons also suffer the same 
limitations due to different substrates and varying conditions. These differences prevent a direct 
comparison of the nucleotide specificities across hRNases, which in turn limits our current 
understanding of the underlying mechanism for the observed nucleotide specificities as well as 
the detailed mechanism of biological and chemical function of these enzymes.  
 
Characterizing the nucleotide binding properties of RNases with the same substrate(s) under 
identical conditions would provide a benchmark for comparison of members of this superfamily. 
This in turn would provide a framework for the systematic identification of structural and energetic 
contributions in the enzyme function. In this study, computer simulations and detailed analysis 
were used for characterization of human RNases 1-7 and bovine RNase A to probe the nucleotide 
binding properties in the presence of two model substrates – ACAC and AUAU. Differences in 
structural stability and hydrogen bonding interactions were characterized (Figure 3.2-3.5, and 
Tables 3.2, 3.3). Further, the interaction energies between enzyme residues and substrate 
nucleotide pairs were calculated (as sum of van der Waals and electrostatics energy, see Figure 
3.8, 3.9 and Table 3.4). The results indicate that both AUAU and ACAC substrates stay either in 
or close to the binding pocket for most enzymes on the microsecond time-scale (Table 3.1). 
hRNase5 and hRNase7, however, show the weakest interactions with substrate AUAU. In one of 
the two alternate trajectories, the substrate was ejected from the binding pockets of these two 
enzymes, consistent with weaker binding affinities 146. Note that we consider the set of two 
alternative trajectories as a representation of the expected behavior. A large set of 





estimates of how often the substrate is ejected out of the pocket; however, we expect the results 
presented here will be qualitatively similar to the results from the bigger set of trajectories. 
 
Detailed description of model substrates ACAC and AUAU interactions with bRNaseA and 
hRNase1-7 are provided in supporting information text. Our results indicate that while all RNases 
used in this work share the conserved active-site catalytic triad (two histidine residues and one 
lysine), subtle changes in the binding site result in distinct binding interactions for the two 
substrates. Interestingly, the non-catalytic active-site residues show the strongest H-bonding 
interactions with the substrates. However, when the detailed interaction energies are calculated, 
some of these residues do not show the most favorable interactions; instead, the catalytic triad 
shows the most favorable interaction energy. One possible interpretation of these results is that 
rigid interactions are required between the enzymes and the substrates for stability. However, the 
interactions with the catalytic triad may need to be flexible for mechanistic aspects. In other words, 
strong H-bonds between the substrate nucleotides and non-catalytic active-site residues holds 
the substrate in place, while the catalytic residues with most favorable interactions need to be 
non-rigid. This is consistent with a number of previous reports, whereby dynamics of several 
conserved catalytic residues play an important role in the mechanism of bovine RNase A.138, 216, 
252 The results reported here require further comparison with experiments to confirm these 
observations. 
 
Substrate preferences of bRNaseA and several human RNases were reported previously using 
a variety of RNA substrates.9, 211, 254 A comparison of the H-bonding properties of the different 
RNases with the two model substrates AUAU and ACAC in this work suggest that bRNaseA and 
hRNase1 show similar H-bonding interactions with the two substrates. Interestingly, the H-
bonding occupancy for hRNase2 and hRNase3 is significantly lower, consistent with the lower 
binding affinities and catalytic rates of these enzymes relative to bRNaseA at 300 K and 310 K. 
Interestingly, hRNase3 shows no interactions with the substrate ACAC at 310 K, suggesting a 
lower preference for this substrate. Similar results are observed for hRNase4 at 310 K, which 
shows a significant increase in H-bonding occupancy for AUAU while a reduction in the 
occupancy is observed for ACAC-bound state. These observations for hRNase3 and hRNase4 at 
310 K are consistent with the substrate preference reported for these enzymes.211, 254 Our results 
further highlight the significant differences in the observed substrate binding properties of the 
different RNases between 300 K and 310 K. These observations suggest the importance of 





properties and enzyme-substrate interactions that are representative of physiological conditions. 
As summarized in Table 1.2 in Chapter 1, the majority of previous studies have been conducted 
at room temperature (298 K). 
 
Overall, the results of this study show that all the 8 investigated RNase family members have 
conserved active-sites residues; however, there is not a uniform preference of a substrate across 
all of these enzymes. The difference in substrate preferences observed in this study are broadly 
consistent with previous observations using a variety of RNase substrates. While our results 
provide structural and energy-based insights that form the basis for this preference for the 
different pyrimidine bases, it is not clear how this relates to the diverse biological functions of 
these RNases. Further investigations are required to gain insights into sequence dependence on 
designated biological functions of host-defense (antibacterial and antiviral), angiogenesis and 
RNA cleavage.  
 
3.6 Summary of observations for each RNases investigated in this 
study 
bRNaseA:  Both the substrates ACAC and AUAU show stable binding in the active-site on the 
microsecond time-scale. The substrates show strong H-bond interactions with residues Thr45, 
Asp71, and Phe120. In addition, Gln11 shows H-bond interaction with substrate AUAU. The 
dynamical motions of the enzyme are similar in the case of two substrates, exhibiting highest 
flexibility in loops L1 and L6. The electrostatic surface of the bRNaseA is mostly positively charged 
but shows slight differences in the case of ACAC and AUAU, which appear to be an anomaly for 
the set of proteins investigated in this study. The residue Lys7, Val43, Thr45, Lys66, His119, and 
Phe120 show large favorable van der Waals and electrostatic interactions with these substrates. 
While the dynamical behavior at the temperatures 300 K and 310 K are qualitatively similar for 
both substrates, the overall strength of the favorable enzyme-substrate interactions increase at 
higher temperature (corresponding to more negative energy in Table 3.4); however, the number 
of H-bond interactions with substrate AUAU are reduced at 310 K.   
 
hRNase1: Similar to the case on bRNaseA, the two substrates ACAC and AUAU show stable 
binding in the active-site of hRNase1 on the microsecond time-scale. However, the substrate 
ACAC forms strong H-bond interactions only with Thr45, while AUAU is observed to form strong 





charged and very similar in the case of both substrates. Residues Arg4, Val43, Thr45, Lys66, 
His119 and Phe120 show the most favorable van der Waals and electrostatic interactions with 
both substrates. The dynamical motions of the enzyme are very similar in the case of two 
substrates, with large flexibility in loop L1; however, this loop shows higher flexibility when bound 
to ACAC than AUAU. An increase in number of H-bonds and their occupancies is observed at 
higher temperature (310 K) for both substrates investigated. The electrostatic and van der Waals 
interactions are more favorable for substrate ACAC and less favorable for substrate AUAU at the 
higher temperature investigated. The dynamical behavior at the temperatures 300 K and 310 K 
are similar in presence of both substrates. 
 
hRNase2: Substrate AUAU shows stable binding in the hRNase2 active site at both 
temperatures, while the substrate ACAC shows stable binding only at 300 K. However, strong 
hydrogen bonds are observed with residues Gln15 and Thr43 in both cases. hRNase2 has mostly 
positively electrostatic surface when bound to both substrates as well. The van der Waals and 
electrostatic interactions show that residues Lys39, Gln41, Thr43 and His130 make the largest 
favorable contributions to interaction energy with both substrates. The dynamical motions of the 
enzyme are observed to be very similar for the two substrates, with high flexibility in loops L4, L6 
and L7. The dynamical behavior is mostly similar at the two temperatures, except for loop L7 
where increased fluctuations are observed with substrate AUAU at 310 K. The H-bond 
occupancies with substrate ACAC is reduced at 310 K as compared to simulations at 300 K. The 
interactions for substrate ACAC are weakened at higher temperature while it remains the same 
for AUAU at both temperatures. 
 
hRNase3: Both the substrates ACAC and AUAU show significantly less stability in the active-site 
of hRNase3 on the microsecond time-scale as compared to the other members of the family 
investigated in this study. Only residue Asn71 (and Thr133 for AUAU) shows hydrogen bonding 
interactions with the substrates. Much like other RNases, the electrostatic surface of the hRNase3 
shows the presence of mostly positively charged residues and is also similar in the case of both 
substrates investigated. Residues Lys39 and His129 make the largest contribution to van der 
Waals and electrostatic interaction energy. The protein dynamics is very similar for the two 
substrates, with largest flexibility in loops L2, L4 and L6; however, loop L6 has higher fluctuation 
when bound to AUAU than ACAC. At 310 K, no strong H-bonds are observed with substrate 
ACAC and the interactions become less favorable; however, the H-bond occupancies for 





Dynamics of the enzyme remains the same for most regions at the two temperatures for both 
substrates. 
 
hRNase4: On the microsecond time-scale, both substrates are mostly stable in the active-site of 
hRNase4. Substrate ACAC forms strong hydrogen bonds with residues Thr45, Asn71, His117 
and Phe118; while substrate AUAU forms hydrogen bonds only with Thr45 and Phe118. The 
electrostatic surface of hRNase4 is also mostly positively charged and similar in the case of both 
substrates. His117 and Phe118 are the largest contributors to van der Waals and electrostatic 
interaction energy with the two substrates. Lys8, Lys41 and Thr45 also make large contributions 
towards electrostatic and van der Waals interaction energy for both substrates. The dynamical 
motions are observed to be very similar for the two substrates. While the dynamical behavior is 
similar at the two temperatures, considerable difference is observed in H-bond occupancies. At 
higher temperature, the number of H-bonds with substrate ACAC is reduced significantly, 
whereas an increase is observed in the H-bonds and their occupancies with substrate AUAU, 
consistent with decrease in the interaction energy (less negative value in Table 3.4) in case of 
ACAC but increase in the case of AUAU. Further, these observations are consistent with the 
preference of the uridine nucleotide in the B1 sub-site reported previously for hRNase4 9. 
 
hRNase5: For hRNase5, substrate ACAC is more stable in the active-site than the substrate 
AUAU on the microsecond time-scale. In one of the trajectories investigated, the substrate AUAU 
is completely ejected out of the active-site. This behavior is different than other hRNases (except 
for hRNase7, as discussed below), where either both or one central nucleotide of the substrate 
stays bound in the active-site. This is also indicated by the observation that substrate ACAC forms 
strong hydrogen bonds with Thr44 and His114, while no hydrogen bonds are observed between 
substrate AUAU and the enzyme. Much like other RNases in this study, the electrostatic surface 
of hRNase5 is also mostly positively charged. Residues Lys40 and His140 make the largest 
contribution to van der Waals and electrostatic interaction energy. The dynamical motions are 
observed to be very similar for the two substrates with flexibility in loops L1, L2 and L6 when 
bound to both substrates. The dynamical behavior at two temperatures 300 K and 310 K is similar. 
At the higher temperature, H-bonds are formed with substrate AUAU, contrary to the observations 
at 300 K. Additionally, an increase in the favorable interaction is observed, while in the case of 






hRNase6: Both the substrates ACAC and AUAU are stable in the hRNase6 active-site on the 
microsecond time-scale. Residue Gln15, Asn69 and Trp11 form strong hydrogen bonds with 
substrate ACAC, while substrate AUAU shows strong hydrogen bonding with Asn65, Arg67 and 
Asn69.  The electrostatic surface of hRNase6 is mostly positively charged and similar in the case 
of both substrates. The van der Waals and electrostatic interactions show that His123 and Leu124 
make the largest favorable contributions to interaction energy in case of both substrates. 
Additionally, large contributions are also observed form residues Asn65, Arg67 and Asn69 in 
presence of both substrates. The dynamical motions are very similar for the two substrates, 
except for loop L7 that shows higher fluctuations when bound to AUAU than ACAC. The 
dynamical behavior and hydrogen bond occupancies are alike at the two temperatures, while the 
favorable interactions become more pronounced at higher temperature for both substrates. 
   
hRNase7: The substrates ACAC and AUAU are less stable in interacting with the active-site of 
hRNase7, forming only one strong hydrogen bond with Thr43 and Leu125, respectively. Similar 
to the case of hRNase7, in one of the trajectories investigated, substrate AUAU is completely 
ejected out of the active-site. The electrostatic surface of hRNase7 appears more positively 
charged when substrate ACAC is bound when compared to AUAU. Residues Lys39 and His124 
make the largest contribution to van der Waals and electrostatic interaction energy. The enzyme 
dynamics is observed to be different for the two substrates with hRNase7: loop L2 and L7 show 
higher fluctuations when bound to ACAC; while loop L6 shows higher fluctuations when bound to 
AUAU. The overall dynamics of hRNase7 at two temperatures 300 K and 310 K is observed to 
be similar, except for loop L4 that shows higher fluctuation when substrate ACAC is bound. 
However, considerable change is observed in H-bond patterns at the two temperatures 
investigated. At higher temperature, more H-bonds with higher occupancies are formed with 
substrate ACAC, while no strong H-bonds are formed with substrate AUAU. Also, considerable 








Table 3.5: Residues showing significant favorable interactions with the substrates at 300 
K. An interaction is considered as significant if the enzyme-nucleotide pair with interaction energy 
< -3 kcal/mol of Etotal. Results for central two nucleotides and terminal nucleotides are shown 
separately. The enzyme residues are listed in the order of decreasing energy of interaction with 














bRNaseA His119 (-10.9, A; 
-4.0, C) 
Thr45 (-4.6, C) 
Phe120 (-4.5, C) 
Val43 (-4.4, C) 
Lys7 (-4.1, A) 
Lys66 (-4.1, C) 
Asn44 (-3.4, C) 
Pro42 (-4.3, A) 
Val43 (-3.0, A) 
Lys7 (-3.3, C) 
His119 (-14.5, A) 
Phe120 (-5.1, U) 
Val43 (-4.7, U) 
Lys7 (-3.5, A) 
Lys41 (-3.4,U) 
Thr45 (-3.3, U) 
 
Pro42 (-3.9, A) 
Val43 (-3.3, A) 
hRNase1 His119 (-11.3, A; 
-3.7, C) 
Arg4 (-4.6, A) 
Lys66 (-4.5, C) 
Thr45 (-4.5, C) 
Val43 (-4.1, C) 
Phe120 (-4.1, C) 
Pro42 (-4.4, A) 
Val43 (-3.2, A) 
His119 (-11.6, A; 
-3.5, U) 
Lys66 (-4.8, U) 
Phe120 (-4.5,U) 
Arg4 (-3.9, A) 
Val43 (-3.9, U) 
Lys7 (-3.7, A) 
Asn71 (-3.7, A) 
Thr45 (-3.4, U) 
Asn44 (-3.0, U) 
Pro42 (-4.5, A) 
Val43 (-3.2, A) 
Lys7 (-3.6 ,U) 
hRNase2 His130 (-11.5, A) 
Lys39 (-7.5, C; 
-4.3, A) 
Gln41 (-5.3, C) 
Thr43 (-4.3, C) 
Asn42 (-3.7, C) 
Arg69 (-3.0, A) 
Arg133 (-4.3, A) His130 (-10.0, A) 
Lys39 (-5.9, U; -
4.7 A) 
Gln41 (-4.9, U) 
Leu131 (-3.8, U) 
Trp8 (-3.4, A) 
Arg133 (-3.1, U) 
Thr43 (-3.1, U) 
Arg133 (-3.8, A) 
Arg37 (-3.2, U) 
Gln41 (-3.0, A) 
hRNase3 His129 (-11.0, A; 
-3.2, C) 
Lys39 (-5.2, C; 
-4.1, A) 
 
Arg2 (-7.8, C) 
Met1 (-6.7, C) 
Gln41 (-3.2, A) 
Arg35 (-3.2, C) 
His129 (-11.8, A; 
-3.8, U) 
Leu130 (-5.4, U) 
Lys39 (-4.7,U) 
 
Met1 (-6.5, U) 
Thr133 (-3.7, A) 
Gln41 (-3.7, A) 
Arg2 (-3.1, U) 
hRNase4 His117 (-15.4, A; 
-7.0, C) 
Phe118 (-6.0, C) 
Lys41 (-5.7, C) 
Arg8 (-3.9, A) 
Lys66 (-3.4, C) 
Thr45 (-3.1, C) 
Phe43 (-5.6, A) His117 (-12.3, A; -
3.6, U) 
Phe118 (-6.2, U) 
Phe43 (-4.4, U) 
Lys41 (-3.9, U) 
Arg8 (-3.8, A) 
Thr45 (-3.6, U) 
Phe43 (-6.3, A) 
Arg8 (-4.4, U) 



















hRNase5 His114 (-14.4, A; 
-4.6, C) 
Lys40 (-5.8, C) 
Gln117 (-5.2, C) 
Leu115 (-4.0, C) 
Thr44 (-3.8, C) 
Arg121 (-3.2, C) 
Arg5 (-6.6, C) 
His8 (-3.4, C) 
His114 (-11.7, A; -
3.2, U) 
Lys40 (-5.3, U) 
 
Arg5 (-7.2, U) 
hRNase6 His123 (-9.8, A; 
-5.4, C) 
Lys8 (-6.2, A) 
Lys39 (-5.5, C) 
Leu124 (-5.3, C) 
Trp11 (-4.0, A) 
Asn69 (-3.4, A) 
His16 (-3.2, C) 
Arg67 (-3.2, A) 
Asn65 (-3.0, A) 
Gln15 (-3.0, C) 
Arg5 (-4.8, C) 
Lys8 (-4.6, C) 
Gln41 (-4.1, A) 
His123 (-11.5, A; 
-5.2, U) 
Lys64 (-5.0, U) 
Lue124 (-4.6, U) 
Asn69 (-3.7, A) 
Asn65 (-3.6, A) 
Arg67 (-3.3, A) 
Arg67 (-3.9, U) 
Lys8 (-3.5, U) 
Gln41 (-3.5, A) 
 
hRNase7 His124 (-7.9, A) 
Thr43 (-4.2, C) 
Lys39 (-4.0, C) 
Asn42 (-3.8, C) 
Leu41 (-3.8, C) 
Leu41 (-5.7, A) 
Arg37 (-3.9, C) 
Met1 (-3.4, C) 
 






Table 3.6: Residues showing significant favorable interactions with the substrates at 310 
K. An interaction is considered as significant if the enzyme-nucleotide pair with interaction energy 
< -3 kcal/mol of Etotal. Results for central two nucleotides and terminal nucleotides are shown 
separately. The enzyme residues are listed in the order of decreasing energy of interaction with 














bRNaseA His119 (-10.2, A; 
-4.0, C) 
Thr45 (-4.4, C) 
Phe120 (-4.2, C) 
Lys66 (-4.1, C) 
Val43 (-4.0, C) 
Lys7 (-3.9, A) 
Asn44 (-3.1, C) 
Pro42 (-3.3, A) His119 (-11.1, A; 
-4.0, U) 
Phe120 (-5.2, U) 
Lys66 (-4.5, U) 
Val43 (-3.8, U) 
Thr45 (-3.3, U) 
Asn71 (-3.1, A) 
 
 
hRNase1 His119 (-11.5, A; 
-4.2, C) 
Lys66 (-5.1, C) 
Thr45 (-4.5, C) 
Phe120 (-4.4, C) 
Val43 (-4.4, C) 
Arg4 (-4.3, A) 
 
Pro42 (-4.4, A) 
Val43 (-3.3, A) 
His119 (-11.6, A; 
-3.5, U) 
Lys66 (-5.3, U) 
Val43 (-4.0, U) 
Phe120 (-3.9, U) 
Lys41 (-3.4, U) 
Thr45 (-3.4, U) 
Arg4 (-3.4, A) 
Asn71 (-3.1, A) 
Pro42 (-4.5, A) 
Lys7 (-3.1, U) 
Val43 (-3.1, A) 
 
hRNase2 His130 (-8.3, A; 
-5.7, C) 
Lys39 (-6.1, C; 
-4.1, A) 
Met1 (-3.3, A) 
Gln41 (-3.1, C) 
Asn40 (-3.02, C) His130 (-11.9, A) 
Lys39 (-5.5, U; 
-4.4, A) 
Arg133 (-4.8, U) 
Gln41 (-4.4, U) 
Arg69 (-4.1, U) 
Arg133 (-4.4, A) 
Gln41 (-3.2, A) 
hRNase3 His129 (-9.8, A) 
Arg35 (-6.6, C) 
Arg8 (-5.4, A) 
Lys39 (-4.8, C) 
Met1 (-4.4, A; 
-4.1, C) 
Arg2 (-4.0, A) 
Met1 (-4.78, C) His129 (-9.3, A; 
-3.7, U) 
Lys39 (-4.9, U; 
-3.6, A) 
Met1 (-3.9, U; 
-3.3, A) 
 
Arg2 (-4.4, U) 
Arg35 (-3.5, U) 
 
hRNase4 His117 (-10.0, A; 
-4.9, C) 
Lys41 (-6.2; C; 
-3.5, A) 
Phe118 (-5.7, C) 
Arg8 (-5.6, A) 
Thr45 (-3.2, C) 
Lys66 (-3.2, C) 
Phe43 (-6.8, A) 
Arg8 (-4.4, C) 
His117 (-11.8, A; 
-4.4, U) 
Phe118 (-6.5, U) 
Arg8 (-4.3, A) 
Lys41 (-4.2, U; 
-3.7, A) 
Phe43 (-4.2, U) 
Thr45 (-3.5, U) 
Phe43 (-5.9, A) 






















hRNase5 His114 (-7.0, A; 
-4.2, C) 
Lys40 (-6.6, C) 
Thr44 (-4.3, C) 
Ile42 (-4.0, C) 
Leu115 (-3.6, C) 
Phe120 (-3.8, C) 
Asn43 (-3.5, C) 
Arg5 (-4.5, C) 
 
Gln117 (-6.8, U) 
His114 (-6.7, A; 
-6.5, U) 
Arg5 (-4.8, A) 
Leu115 (-4.2, U) 
Lys40 (-3.6, U) 
His13 (-3.5, U) 
Asn43 (-3.2, U) 
Arg121 (-3.1, A) 
hRNase6 His123 (-9.2, A; - 
4.5, C) 
Lys39 (-6.6, C) 
Lys8 (-6.6, A) 
Leu124 (-4.5, C) 
Trp11 (-4.1, A) 
Thr43 (-3.8, C) 
Asn69 (-3.6, A) 
Arg67 (-3.4, A) 
Gln15 (-3.3, C) 
Asn65 (-3.1, A) 
Arg5 (-6.4, C) 
Gln41 (-3.5, A) 
Lys8 (-3.4, C) 
His123 (-10.9, A; 
-5.3, U) 
Leu124 (-5.3, U) 
Lys8 (-4.1, A) 
Lys64 (-4.0, U) 
Asn69 (-3.7, A) 
Asn65 (-3.4, A) 
Arg67 (-3.4, A) 
Thr43 (-3.0, U) 
Gln41 (-3.9, A) 
hRNase7 His124 (-9.2, A; 
-4.0, C) 
Lys39 (-5.5, C) 
Thr43 (-4.4, C) 
Leu125 (-4.2, C) 
Leu 41 (-3.5, C) 
Asn 42 (-3.2, C) 
Met1 (-4.6, C) 
Leu41 (-4.7, A) 
Arg37 (-3.6, C) 
Lys2 (-3.9, C) 
His124 (-7.3, A; 
-3.8, U) 
Met1 (-4.7, A) 
Lys64 (-3.9, U) 
Lys39 (-3.7, U) 
Leu125 (-3.2, U) 
 
Trp11 (-4.0,U) 
Met1 (-4.0, U) 









Figure 3.12: Important H-bond behavior over time for bRNaseA-substrate complexes. 
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate 
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the 







Figure 3.13: Important H-bond behavior over time for hRNase1-substrate complexes. 
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate 
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the 







Figure 3.14: Important H-bond behavior over time for hRNase2-substrate complexes. 
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate 
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the 








Figure 3.15: Important H-bond behavior over time for hRNase3-substrate complexes. 
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate 
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the 








Figure 3.16: Important H-bond behavior over time for hRNase4-substrate complexes. 
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate 
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the 








Figure 3.17: Important H-bond behavior over time for hRNase5-substrate complexes. 
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate 
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the 








Figure 3.18: Important H-bond behavior over time for hRNase6-substrate complexes. 
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate 
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the 








Figure 3.19: Important H-bond behavior over time for hRNase7-substrate complexes. 
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate 
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the 






 Conformational Sub-states Associated with 





4.1 Abstract  
Conformational fluctuations between different sub-states with unique configurations allow 
enzymes to efficiently catalyze reactions with high turnover. However, establishing a direct link 
between protein motions and enzymatic function remains challenging. The structural basis of RNA 
hydrolysis has been extensively studied in bovine ribonuclease A (bRNaseA), and product release 
is the suggested rate-limited step. However, conformational motions that affect the turnover rate 
have received relatively little attention for bovine, as well as human ribonucleases  
(hRNases). This work identifies conformational sub-states and conformational fluctuations that 
play a role in product release step in hRNases and bRNaseA. Conformations collected from 
molecular dynamics simulations with umbrella sampling were analyzed using higher order 
statistical clustering method; this method, quasi anharmonic analysis, allows identification of 
conformational sub-states. The results revealed the existence of functionally relevant 
conformational sub-sates in product release step of these closely related enzymes. Enzyme 
residues that interact with cleaved RNA products were also identified. Conformational fluctuations 
were observed in distal regions away from the reactive center of the enzymes. Residues in these 
regions have previously been reported to experience perturbations during 15N-CPMG relaxation 
dispersion experiments, which correspond to the time-scale of RNase function.  
 
4.2 Introduction  
Members of the ribonuclease (RNase) superfamily catalyze the hydrolysis of ribonucleic acid 
(RNA). Bovine ribonuclease A (bRNaseA), which is the prototype of the family, is one of the most 
widely studied enzyme. In recent years, interest in human members of the RNase superfamily 
has increased due to their reported clinical importance and increasing therapeutic applications.15  
A number of studies have focused on the intracellular localization, tissue distribution and 
biological role of human RNases (hRNases).4, 8, 26, 52 Studies have also focused on the structure-
function relationship in these enzymes.72, 296 However, the wide range of catalytic efficiencies  
found in hRNases cannot be explained in terms of structure alone.8 Enzymes are intrinsically 
dynamic, and conformational motions in enzymes are known to play an essential role in their 
function.297-299 The role of dynamics in the catalytic cycle of hRNases has not yet been explored 
in detail. Understanding functionally relevant dynamics in hRNases is will open new avenues for 






Enzymes undergo a wide range of motion in terms of space and time. The time-scales of motion 
in enzymes range from picoseconds to seconds (ps - s).300 The faster atomic fluctuations occur 
on the ps time-scales. Motions in enzyme backbone and amino acid side chains are observed in 
the picoseconds to nanoseconds (ps - ns) time-scales. Conformational rearrangements of loops 
and domains occur on the milliseconds to seconds (ms - s) time-scale.128, 301 Any of these motions 
can be functionally significant and directly related to catalysis.299, 300 These motions promote 
catalysis by allowing the enzymes to overcome the activation barrier and reach its active form. 
The time-scale of catalytically important motion is dependent on the enzyme. Correlation between 
the time-scale of conformational fluctuation and catalytic turnover has been established for a 
number of enzyme systems including bRNaseA.128, 136, 137, 140, 302, 303  
 
The rate of conformational exchange has been shown to correlate with the rate limiting step, 
product release, in bRNaseA.136, 140 The structure of bRNaseA is well-studied by both 
homonuclear solution NMR and X-ray crystallography7. The mechanism of RNA cleavage by 
RNases has been extensively studied by both experimental and theoretical approaches,7, 85 which 
suggest that microsecond to millisecond (µs - ms) motions occur throughout the bRNaseA 
enzyme, including fluctuations in the active site residues.136, 267 The rate of conformational kinetics 
measured in NMR spin relaxation experiments (average kex = 1600 s-1) is similar to the enzyme 
turnover rate (kcat = 1900 ± 130 s-1).136 Note, that the NMR experiments were performed in the apo 
state. Additionally, NMR line shape analysis of titrations of product analogue (3′-CMP) into 
bRNaseA yields a dissociation constant (koff) of ∼1200 s−1 suggesting that product release (koff) is 
the rate-limiting step in bRNaseA .138 It was further implicated that the motion of loop 1 enables 
efficient release of product, and disrupting these motions results in 10-fold decrease in the product 
release rate.138, 216 These evidences presents a clear connection between enzyme motions, 
catalytic turnover and product release in bRNaseA. 
 
Dynamical fluctuations occurring over a wide range of time-scales allow enzymes to sample a 
wide variety of distinct conformations (also called as conformational sub-states).129, 304 These 
conformational sub states are sometimes rarely populated, high energy states that can contain 
functionally important features.122 Conformational transitions between low energy ground states 
to higher energy sub-states are vital for the events occurring in an enzyme’s reaction pathway; 
substrate recognition and binding, the chemical step and product release.204, 305 Conformational 
fluctuations that govern the catalytic mechanism in enzyme systems like DHFR,306 CypA,204 HIV-





conformational fluctuations in distal regions (sometimes more than 10 Å away from the active site) 
modulate the rate-limiting step. Note that the rate-limiting step is not same for all enzymes, for 
example the rate limiting-step in CypA is the catalytic step, while in DHFR product release is rate-
limiting.  
 
Conformational fluctuations are essential for enzyme function, and therefore characterizing the 
conformational sub-states in the rate limiting step is of paramount importance to understanding 
of the role dynamics in enzyme function. A deeper understanding the conformational motions in 
each step of reaction process of hydrolysis of RNA by these enzymes is essential for the rational 
design of novel therapies toward diseases associated with RNase action. Chapter 3 demonstrates 
the occurrence of conformational motions in the substrate bound form of RNases. Nevertheless, 
detailed characterization of conformational change coupled to the product release in these 
enzymes remains unknown. Very few studies have focused on the release of nucleotide products 
in bRNaseA, and to the best our knowledge none for human RNases. Note, that the rate-limiting 
step in hRNases is still unknown. Therefore, this study is focused on understanding how the 
protein conformations and dynamical properties evolve during product release; what are the key 
residues involved; and whether these motions and residues involved in product release are 
conserved in members of this diverse superfamily.  
 
Studies from chapter 2 report that members of the RNase superfamily can be classified into sub-
families based on their primary sequence and intrinsic dynamics, and the biological function of 
the members within a sub-family is same308. To characterize the role of dynamics in function of 
individual sub-family, it is required to determine the conformational sub-states in at least one 
representative member in each family. Comparative analysis of conformational dynamics 
associated with product release in each sub-family will aid in understanding the role of dynamics 
in the function of the entire RNases superfamily. The select RNases in this study include hRNase3 
from the EAR-like sub-family, hRNase5 from the Angiogenin sub-family and bRNaseA from the 
RNase A-like sub-family. Conformational sub-sates in these enzymes occurring during product 
release are characterized using quasi anharmonic analysis (QAA)129, a higher order statistical 
method, with conformations obtained from umbrella sampling molecular dynamics simulations. 
Conformational transitions associated with product release provide insights into the existence of 






4.3 Materials and methods 
Modeling enzyme-product(s) complexes: The cleaved nucleotide products (Figure 4.1) were 
modeled into the active site of two human ribonucleases, hRNase3 (PDB ID: 1QMT270) and 
hRNase5 (PDB ID: 1ANG309), as well as the active site of bRNaseA (PDB ID: 7RSA274). The 
coordinates for the phosphate and ribose sugar backbone for the products were adopted from the 
DNA ligand in the crystal structure of bRNaseA (PDB id 1RCN).276 The nucleotide bases of the 
substrate were modified to match the desired nucleotide using AMBER’s310 xleap modeling and 
preparation module. The parameters for both protein residues and RNA products were obtained 
from AMBER’s ff14SB force-field.311  
 
Histidine protonation states: The two catalytic histidine residues, His12 and His119 (bRNaseA 
numbering), were modeled in single and double protonated states respectively in all three 
RNases. The protonation states for these residues were determined based on pH profiles for 
bRNaseA,282 as well as structural interaction with the modeled substrates and products.85 All the 
other histidine residues were modeled in the single protonated state for all three RNases. 
 
Umbrella sampling simulations: All modeled complexes were neutralized with the addition of 
chloride (Cl-) counterions and subsequently solvated in a SPC/E 277 water box with 15 Å distance 
between the edges on all sides of the protein and the water box. Periodic boundary conditions 
were applied, and the solvated complexes were equilibrated using a previously described 
protocol.312, 313 To monitor the release of product from the active site of RNases, the distance 
between the geometric center of mass (COM) of the side chain of three catalytic residues (two 
histidine residues and one lysine residue) and COM of each of the products were increased from 
4 Å up to 18 Å (Figure 4.2 & 4.3). Ten ns of distance restrained simulations were performed to 
increase the distance between the two COMs in 1 Å increments and generate starting points for 
15 windows. This increase in the distance between the two COMs is referred to as the reaction 
coordinate of the product release pathway. Conformations in each window along the reaction 
coordinate were sampled for a total of 70 ns with an appropriate biasing harmonic potential to 
ensure a reasonable overlap for all windows. Distance restraints were applied between the two 
COMs and a 2 femtoseconds (fs) time-step was used. All hydrogen atoms involved in bonds were 
constrained with the SHAKE 281 algorithm. All simulations were performed at 300 K using 
AMBER’s pmemd.sander simulation engine.314 Time-averaged distance restraints between the 





product(s) complex, 3500 structures (20 picoseconds apart) were saved and analyzed for 
structural effects and conformational dynamics as described below. 
 
Analysis: To obtain an accurate description of the conformational dynamics associated with the 
product release process, continuous sampling along the reaction coordinate is required. To 
ensure a reasonable overlap for all windows along the reaction coordinate, the distribution 
probability of all the time-averaged distance restraints values between the two COMs were binned 
into histograms. Using xmgrace315 plotting too histograms were binned from 3 – 20 Å into 1000 
bins. Additionally, to ensure that the enzyme samples reasonable conformations in all windows 
along the reaction coordinate, the root mean square deviation (RMSD), referenced to the first 
structure of first window (4 Å) in the reaction coordinate, were computed for all trajectories. 
RMSDs were computed from the simulation trajectories using AMBER’s cpptraj program. 316 
Simulation trajectories where the RMSD was beyond 4 Å were repeated until the sampled 
conformations had RMSD below the cutoff. Hydrogen atoms were excluded in the RMSD 
calculations. 
 
Hydrogen bond interactions: Hydrogen bond (H-bond) interactions between the RNases and 
the product nucleotides were computed using AMBER’s cpptraj program. H-bonds with bond 
length less than 3.3 Å for the donor to acceptor heavy atom distance at an angle between 135° 
and 180° between the donor-hydrogen-acceptor were considered for analysis. The percentage 
occupancies of H-bonds, defined as a fraction (percentage) of the total number of structures 
where the interaction meets the H-bond criterion mentioned above, were also calculated. 
 
Hydrophobic interactions: Hydrophobic interactions between the substrate and backbone 
atoms of hydrophobic residues glycine, alanine, valine, leucine, isoleucine, proline, 
phenylalanine, methionine, tryptophan, and tyrosine were computed using AMBER’s cpptraj 
program. A distance cutoff of 4.5 Å was used. Hydrophobic interactions that were present in more 
than 50% of all simulation snapshots were considered for analysis.  
 
Potential of mean force along the reaction coordinate: To remove the biasing due to harmonic 
restraints in the umbrella sampling, the potential of mean force (PMF) was computed using the 
weighted histogram analysis method (WHAM). The weighted histogram calculation was 
performed from 4 - 20 Å with 1000 bins. All calculation were performed at 300 K. WHAM version 






Figure 4.1: Schematic representation of ribonuclease reaction. Tetranucleotide RNA 
substrate (AUAU) is shown on right and cleaved products are shown on left. A- Adenine, U – 









Figure 4.2: Representation of geometric center of mass (COM) of catalytic residues and 
products. Enzyme ribonuclease is shown as a gray ribbon, while the catalytic triad residues are 
shown as sticks; COM of catalytic residues are represented in cyan sphere. The two products 
obtained after cleavage of tetranucleotide substrate are shown as sticks, and their respective 
COMs are shown as cyan spheres. 5’ A - 5’ Adenine, 3’ U - 3’ Uracil, U-p - Uracil with phosphate 








Figure 4.3: Schematics of product release umbrella sampling simulations. Enzyme 
ribonuclease (RNase) is represent as a pink sphere, the catalytic triad is represented as a green 
sphere, the cleaved products are represented as blue rectangles and the center of mass (COM) 
of catalytic triad and products are represented as cyan spheres. Dotted arrows represent the 







Intrinsic dynamics along the reaction coordinate: The simulation trajectories from 15 windows 
along the reaction coordinate were group into three categories; the first includes simulation 
trajectories from windows 4 Å to 8 Å, i.e. when the products are in the near vicinity of the 
catalytic triad residues. The second includes simulation trajectories from windows 9 Å to 13 Å, 
when the products are on the surface of the protein, but not in direct contact with the catalytic 
triad residues. And third is when the products are in the bulk solvent (14 – 18 Å), making no 
direct contact with the enzyme. The fluctuations of Cα atoms for all residues were computed to 
analyze the intrinsic dynamics profile for each of the three categories. An aggregate of root mean 
square fluctuation (RMSF) of the top 10 (RMSF10) quasi-harmonic analysis (QHA) modes were 
used in the analysis to focus on the principal dynamics. The magnitude of displacement 
eigenmodes of QHA were computed using AMBER’s cpptraj program. 
 
Conformational sub-states using quasi-anharmonic analysis (QAA): The 52,500 
conformational snapshots obtained from the umbrella sampling simulations were used for QAA.129 
The original 3N dimensional space for the Cα atoms was projected onto 100 - dimensional space 
using QHA modes and then analyzed using QAA. This method provides an exploration of a non-
equilibrium process as compared to the equilibrium state that is explored in free MD. Using a 
mixture of gaussian modes three clusters representing various regions of the reaction coordinate 
were identified. The three QAA-independent component vectors were analyzed in detail to 
characterize the conformational sub-states associated with the release of products in each of the 
three RNases studies. Note that the protein Cα atom positions were used for this analysis. 
 
4.4 Results 
4.4.A Evaluating the conformational coverage of umbrella sampling simulations  
Umbrella sampling simulations along the reaction coordinate pertaining to product release were 
performed for hRNase3, hRNase5 and bRNaseA. Conformations obtained from the simulation 
trajectories were binned into histograms to ensure continuous sampling along the reaction 
coordinate. Histogram binning was based on the distance between the COMs of the catalytic triad 
and the nucleotide bases of the product(s). In general, all binned histograms followed a gaussian 
distribution for both products of all three enzymes (Figure 4.4). For hRNase3 and bRNaseA, the 
histogram binning show overlap in adjacent windows, indicating continuous and ample sampling 





around 8 Å, indicating that additional sampling is required. The sampling for other areas of the 
hRNase5 reaction coordinate falls within the acceptable limits.  
 
To ensure that the force constants and restraints applied in the umbrella sampling simulations do 
not render the enzyme structure unphysical, RMSD with reference to the first structure of the first 
window (4 Å) were computed for individual trajectories (Figure 4.5) of all the windows along the 
reaction coordinate. For all three RNases the maximum RMSD for the conformations sampled in 
the trajectory was less than 4 Å. A visual inspection of equally space conformations from the 
simulation trajectories ensured that each of the three enzymes adopts its near-native structure. 
The cysteine residues continued to form disulfide bonds during all simulations maintaining the 
signature kidney shape fold of these enzymes.    
 
4.4.B Computational Analysis of enzyme-product interactions  
To quantitatively characterize the non-bonded interactions of product nucleotides with the enzyme 
residues along the reaction coordinate, H-bond and hydrophobic interactions were calculated for 
all conformations of the umbrella sampling simulations. The average distance between heavy 
atoms of the enzyme and product nucleotide, and the percentage occupancy of the H-bonds along 
the reaction coordinate were calculated (Table 4.1). Weak interactions of the product nucleotides 
with hydrophobic amino acids are reported in Table 4.2. These H-bond and hydrophobic 
interactions have been reported to increase the binding between protein and ligands, be essential 
for full activity of enzymes and be an important aspect of rational design of potential drugs.318-322 
Thus, product nucleotides must overcome these interactions to completely release themselves 
from the enzyme after catalysis.  
 
The results indicate occurrence of more H-bonds in all three enzymes when the products are in 
the near vicinity of the catalytic triad (4 - 8 Å). Most of the residues listed in Table 4.1 in the 4 - 8 
Å trajectories were reported to strongly interact with the substrate nucleotides (Chapter 3, Table 
3.2). As seen in Chapter 3, the substrate nucleotides strongly interacted with the residues of their 
respective sub-sites (B1 and B2) for all three enzymes. These interactions remain conserved until 
the products are in the near vicinity of the catalytic triad. In other words, same interactions are 
present for the substrate and products, until the products leave the near vicinity of the catalytic 
triad. The B1 sub-site residues Thr44 (for hRNase5) and Thr45 (for bRNaseA) and the B2 sub-site 







Figure 4.4: Overlap of histograms between umbrella sampling windows. To ensure a 
reasonable overlap for all windows along the reaction coordinate (4 -18 Å of COM spacing), the 
distribution probability of all the time-averaged distance restraints values between the two COMs 
were binned into histograms. Using xmgrace plotting tool histograms were binned from 3 – 20 Å 







Figure 4.5: Root men square deviation of protein structures along the reaction coordinate. 
The RMSD of the protein atoms (excluding hydrogens) with respect to the first structure of the 





products residues. The catalytic residue His129 (hRNase3), His114(hRNase5) and His119 
(bRNaseA) form strong H-bonds when the product nucleotides are close to the active site. Note 
that this observation is contradictory to our observation of the substrate bound state where the 
catalytic triad residues do not form strong H-bonds with the substrate nucleotide. Therefore, upon 
hydrolysis of the phosphodiester bond, the catalytic histidine residue interacts with the newly 
formed product.     
 
When the product nucleotides move along the reaction coordinate, 9 - 13 Å away from the COM 
of the catalytic triad, they interact with the surface of the enzyme. At this point along the reaction 
coordinate, H-bonds between the products and most residues of the active site and the binding 
sub-sites (B1 and B2) are lost for all three RNases. In hRNase3, product nucleotides form new 
interactions with resides Arg2, Arg8 (N terminal helix) and Arg35. In hRnase5, one of the 
nucleotide products interacts with C-terminal residues Phe120 and Arg121. These residues are 
away from the catalytic triad, on the surface of enzyme, suggesting possible interaction of the 
product nucleotide with other regions of the enzyme before they are completely dissociated and 
released in the bulk solvent. Such interactions are not observed for bRNaseA. Table 4.2 reports 
a number of hydrophobic interactions for hRNase3 and bRNaseA when the products are in near 





coordination. Comparatively, the extent of hydrophobic interactions is lesser for hRNase5. Finally, 
when the product nucleotides are more than 13 Å away on the reaction coordinate they do not 
form any H-bonds or hydrophobic contacts with the enzyme residues suggesting that they are 
completely released from the enzyme into the bulk solvent.   
 
4.4.C Conformational dynamics associated product release 
The conformational dynamics of RNases during the product release were quantified by QHA of 
the conformations obtained from the umbrella sampling simulations along the reaction coordinate. 
RMSF10 , the aggregate root means square fluctuation of the top 10 slowest QHA modes, provides 
a good measure of a protein’s conformational flexibility.284, 294 RMSF10 was computed for all the 
three categories of the reaction coordinate; when the products are in near vicinity of the catalytic 
triad (4 - 8 Å), when the products are on/near the surface of the enzyme (9 -13 Å), and when the 
products are in bulk solvent making no contact with the enzyme (14 -18 Å). The RMSF10 profiles 
of the product release simulations indicate that the most significant differences in dynamics occur 
in the loop regions of RNases (Figure 4.6), similar to the apo and substrate bound studies 
(Chapters 2 and 3).  
 
The dynamical characterization along the reaction coordinate indicates distinct differences in 
flexibility of the three RNases during product release. Difference in flexibility along the reaction 
coordinate is also observed for hRNase3, hRNase5 and bRNaseA. Specifically, in hRNase3, loop 
L4 (residues 58-71) has higher fluctuations when the products are in the near vicinity (4 - 8 Å), of 
the catalytic triad. As the products move away (9Å and beyond) from the catalytic triad along the 
reaction coordinate, dynamics in L4 decrease considerably. Dynamical fluctuations in L4 is 
considerably lower in hRNase5 and bRNaseA for all three categories of the reaction coordinate. 
In hRNase5, loops L1, L4 and L6 show fluctuations of equal magnitude throughout the reaction 
coordinate. In bRNaseA, loop L1 (residues 13-21) exhibits considerably higher fluctuations when 
the products are in the near vicinity of the catalytic triad. Motions in L1 subside when the products 
move away from the catalytic triad. Loop L1 of bRNaseA has been shown to affect product 
dissociation, and thereby modulate the catalytic efficiency.138 Loop L1 displays considerably lower 
fluctuations in hRNase5 while it is truncated in hRNase3. For all the three enzymes, fluctuations 







Table 4.1: H-bonding interaction of pancreatic-type RNases with product nucleotides. The H-bonds that meet the criteria of 3.3 
Å, angle between 135 - 180° and more than 45% occupancy are listed. P1 - product 1; P2 - product 2; A5’ - 5’ adenine nucleotide; U3’ 




hRNase3 hRNase5 bRNaseA 
















U-p (OP1) (P1) 
U3’ (OP2) (P2) 




Asn71 (Oδ1) A5’ (N6) (P2) 2.88 (52.17) 
5    Thr44 (N) U-p (O2) (P1) 2.85 (63.71)    
6 Val128 (O) Arg2 (N) 
A5’ (O5') (P2) 
U3’ (OP1) (P2) 
2.69 (72.14) 








U-p (N3) (P1) 
U-p (ON2) 
(P1) 
A5’ (N1) (P2) 










A5’ (O5') (P2) 
A5’ (N6) (P2) 











U-p (O2) (P1) 
U-p (ON2) 
(P1) 
A5’ (O5') (P2) 
U-p (ON3) 
(P1) 
U-p (N3) (P1) 












U-p (O4) (P1) 
U-p (O2) (P1) 
A5’ (N6) (P2) 





Asn71 (Oδ1) A5’ (N6) (P2) 2.87 (54.43) 
9 Arg35 (Nε) Arg35 (NH2) 
U-p (ON3) (P1) 
U-p (ON1) (P1) 
2.81 (70.89) 





U3’ (OP2) (P2) 
U3’ (OP1) (P2) 




   Asn71 (Nδ2) A5’ (N1) (P2) 2.90 (57.86) 
 





Table 4.1 continued 
RC 
(Å) 
hRNase3 hRNase5 bRNaseA 



















U3’ (OP2) (P2) 
U3’ (OP1) (P2) 
U3’ (OP1) (P2) 
U-p (ON2) (P1) 
U-p (OP2) (P1) 












U3’ (OP2) (P2) 
U3’ (OP1) (P2) 






U-p (N3) (P1) 
U-p (ON2) (P1) 
2.84 (60.34) 






U-p (ON3) (P1) 
U-p (O2) (P1) 
U3’ (OP1) (P2) 





      
14 -
18 No Bonds 
 






Table 4.2: Interaction of product nucleotides with hydrophobic amino acids. Contacts less 
than 4.5 Å with hydrophobic residues are listed. P1 - product 1; P2 - product 2; A5’ - 5’ adenine 
nucleotide; U3’ - 3’ uracil nucleotide; U-p - Uracil nucleotide with the cleaved phosphate group 





hRNase3 hRNase5 bRNaseA 




























































































10 Met1 Leu69 
U-p (P1) 























13 Met1 U3’ (P2)   Val118 A5’ (P2) 







Figure 4.6: Conformational dynamics along the reaction coordinate. The conformational 
flexibility of the Cα atoms of each residue is obtained from the aggregate root mean square 
fluctuations from the top 10 modes (RMSF10). The 2D plots represent the RMSF10 as a function 
of enzyme residues. The important loop regions are highlighted in pink. RMSF10 are also projected 
on cartoon representations of each enzyme, with flexible loop regions identified. The thickness of 
the cartoon tube corresponds to the amplitude of RMSF10, and the color corresponds to the 





4.4.D Conformational sub-states associated with product release 
QAA was employed to obtain insights into the conformational sub-states associated with the 
release of products in the members of RNase superfamily. The original 3N-dimensional space for 
the Cα atoms of 52,500 conformations obtained from the umbrella sampling simulations along the 
reaction coordinate were projected onto 100-dimensional space using QHA modes for QAA. 
Using a mixture of gaussian modes, three clusters representing the three categories of reaction 
coordinate (mentioned above) were identified from QAA (Figure 4.7). Interestingly, these clusters 
identified using QAA contain homogenous populations of conformational sub-states. Motion 
involved in product release along the reaction coordinate are illustrated in wireframe, showing 
only the Cα trace of the enzyme residues, and colored according to their respective sub-states.  
 
QAA applied to umbrella sampling simulations along the reaction coordinate of product release 
for the three RNases reveal the existence of distinct sub-states for these closely related enzymes. 
Moreover, the conformational sub-states also differ among the reaction coordinate for the three 
RNases studied here. In the modes, when the products are in near vicinity of the catalytic triad 
(blue conformations in Fig 4.7), large dynamical fluctuations are observed in loop L4 of hRNase3 
and in loop L1 of bRNaseA. However, motions in these loops subside in other modes along the 
reaction coordinate for both hRNase3 and bRNaseA. There were no particular region showing 
motions with large change in amplitude in hRNase5.  
 
4.4.E Potential of Mean Force (PMF) 
The free energy profile of product(s) release along the reaction coordinate was calculated using 
WHAM and is represented in Figure 4.8. For all three enzymes studied here the free energy profile 
is different for both products. Energy difference between the release of two products is 2 folds for 
hRNase3 and 3 folds for hRNase5 and bRNaseA. Also, there is a difference of ~ 4 kcal/mol in the 
release of product 1 (Figures 4.1 and 4.2) from bRNaseA and hRNase5. The free energy for 
release of product 1 increases along the reaction coordinate (7 Å - 18 Å) for hRNase5, suggesting 
that additional energy is required to drive release of product 1 and the process is less likely to be 
spontaneous. On the other hand, there is a decrease in the free energy for release product 1 in 
bRNaseA, suggesting that product 1 suggesting that release of this product is more spontaneous 
in bRNaseA as compared to hRNase5. The free energy for release of product 2 decreases for 
both hRnase3 and hRNase5. However, this observation also contrary for bRNaseA where the 






Figure 4.7: Conformational sub-states associated with release of products in 
ribonucleases. Higher order statistical clustering of conformations sampled in the molecular 
dynamics trajectories is shown in the box plots above. Each dot corresponds to a single 
conformation and is colored according to the reaction coordinate (see color bar). The ellipses 
represent conformational sub-states identified along the reaction coordinate. The black arrows 
indicate transitions from heterogenous population to a well-defined homogenous sub-state. 𝛾𝛾 
represents anharmonic modes identified by QAA and the subscripts denotes the rank of the QAA 
vector. Motions along the anharmonic mode (𝛾𝛾) are illustrated in the panels below in a wire frame 








Figure 4.8: Free energy profile of product release. The potential for mean force along the 
reaction coordinate was constructed using WHAM. The free energy profile for product 1 is shown 
in solid lines and for product 2 is shown in dotted lines. Results are shown for hRNase3 (red), 






energetics of product(s) release is different for hRNases when compared to bRNaseA. Note, 
when the product(s) are in the bulk solvent (> 14 Å) away from the catalytic residues, they are 
free to diffuse in the simulation box. However due to limited size of the simulation box the product 
nucleotides stay close to the enzyme surface. This can certainly affect the shape of the PMF.   
 
It is reported that a decrease of 1.37 kcal/mol in activation energy results in 10 fold improvement 
in the rate constant.323 The free energy of product release for hRNase5 is 4.5 kcal/mol more than 
bRNaseA (Figure 4.8). Suggesting a ~104 folds difference in the activation energy between these 
two enzymes. This observation corresponds with the 105 folds difference in catalytic efficiency 
between bRNaseA and hRNase5, with bRNaseA being the faster enzyme. However, whether this 
difference in the catalytic efficiency is due to difference in activation energy required for product 







Enzymes are not rigid structures but sample an ensemble of conformations driven by internal 
motions occurring over a wide range of length and time-scales. The role of these conformational 
fluctuations in enzyme catalysis has been recognized, and in some cases even considered vital 
for the designated function.324, 325 Experimental characterization of conformations sampled by 
enzymes provide information only on a narrow time-scale window, with low a probability of finding 
functionally relevant conformational sub-states.326 Computer simulations, enhanced sampling 
techniques and higher order statistical methods have enabled the identification of functionally 
important conformational fluctuations and sub-states over a wide range of time-scales.129   
 
In this study, we observed that there were strong non-bonded interactions between the products 
and the residues lining the active site. When the product nucleotides are in the near vicinity of the 
catalytic triad (4 - 8 Å), the enzyme residues of all three RNases (Tables 4.1 and 4.2) strongly 
interacts with the cleaved products. As the product nucleotides move 9 - 13 Å away from the 
catalytic triad, the number of residues interacting with the product nucleotides decrease 
substantially. Further down the reaction coordinate (beyond 13 Å), the product nucleotide 
overcomes these strong interactions to completely release themselves into the bulk solvent. Many 
of these residues have been previously identified as part of networks of amino acid residues that 
show conformational exchange upon binding of single nucleotides in these RNases.146, 327 
However, mutagenesis studies and further experiments are necessary to gain insights into the 
individual contribution of these residues to the catalytic turnover of select RNases.  
 
In hRNase3, the product nucleotides interact with the residues on the surface of enzyme, away 
from the catalytic triad, suggesting possible interaction of the product nucleotide with other regions 
of the enzyme before they are completely dissociated and released in the bulk solvent. However, 
such interactions in distal regions are not observed for bRNaseA, suggesting that distal residues 
on the surface of this faster enzymes do not interact with the cleaved products post catalysis.  
 
This study characterizes the internal dynamics in the product release step of three RNases. The 
RMSF10 profiles indicate that the most significant differences in dynamics occur in the loop regions 
for these RNases (Figure 4.6). This further implies that loop regions, which are energetically more 
favorable to movements within a protein structure, play a major role in catalysis.328 However, for 





marked difference in the conformational dynamics of product release in RNases. Long range 
effects in RNases have also been identified to modulate ligand binding, and these effects were 
also distinct for individual RNases.139, 146, 327  As seen in chapter 2, the three RNases studied here 
belong to different phylogenetic sub-family with unique function, distinctness in their 
conformational motions suggests that the even closely related RNases are uniquely adapted to 
their respective functions. These observations are also consistent with previous studies which 
show that enzymes/proteins sharing common fold can also have diverse functions and 
dynamics.285, 329 
 
This study further characterizes the conformational sub-states and motions associated with the 
product release step in RNase family members, using atomistic umbrella sampling molecular 
dynamics simulations and QAA. QAA has been used to study the conformational sub-states and 
conformational fluctuation for a number of protein systems 129, 284, 330 and the motions identified by 
QAA are intrinsic property of each protein studied. The results from this study indicate the 
presence of separate conformational sub-states in the three RNases studies here (Figure 4.7). In 
these sub-states, loops L4 of hRNase3 and L1 of bRNaseA, show fluctuations with high 
amplitude, suggesting a potential role of these loops in product release. It is also interesting to 
note that the conformational dynamics in product release are significantly different for members 
of the individual phylogenetic sub-family. Further, conformational exchange probed by 15N-CPMG 
relaxation dispersion experiments on the micro-millisecond time-scale were compared to the 
conformational fluctuations observed in the product release step from QAA (Figure 4.9). The 
residues of the functionally important loops, L4 in hRNase3 and L1 in bRNaseA, that show 
conformational fluctuations in product release simulations also undergo conformational exchange 
in 15N-CPMG experiments of apo protein. This observation supports the suggestion that free 
protein can samples conformations that resemble the ligand bound conformations.285, 331   
 
Overall this study identified structural and dynamical features important product release in RNase 
family members. Modulating the dynamical fluctuations identified here, can help fine-tuning the 
conformational landscape of these enzymes to favor efficient catalysis. Subsequent experimental 
effort will be required to bring home the points raised by this computational study and to prove 
that modulating internal dynamics in these enzymes can greatly enhance their catalytic 
efficiencies. Apart from modulating enzyme function, insights gained form this work will have 
implications in the design of novel inhibitors and modulators of RNase function in the context of 





umbrella sampling simulations combined with QAA technique can generate reliable results for the 
study of product release in proteins at the atomistic level and can therefore be applied to study 







Figure 4.9: Comparison of computational conformational sub-states and NMR 
conformational exchange. Conformations sampled along reaction coordinate allowed 
identification of conformational sub-states (top panel) and transitions into these states (wire 
frames) as products move from active sites into bulk solvent. Residues that experience ms 
conformational exchange in NMR 15N-CPMG experiments are shown as spheres. Results are 






 Specialized Techniques to Identify 
Conformational Fluctuations Associated with 






Part of this chapter is a slightly revised version of a manuscript by title “Ligand-Induced Variations 
in Structural and Dynamical Properties Within an Enzyme Superfamily” published in the journal, 
Frontiers in Molecular Biosciences in June 2018 
 
Reprinted (adapted) with permission from Chitra Narayanan,1 David N. Bernard,1 Khushboo 
Bafna,2 Donald Gagné,1 Pratul K. Agarwal,3,4 and Nicolas Doucet1,5,* 
 
1INRS-Institut Armand-Frappier, Université du Québec, 531 Boul. des Prairies, Laval, Québec 
H7V 1B7, Canada.  
2Genome Science and Technology, University of Tennessee, Knoxville, TN 37996, USA.  
3Computational Biology Institute and Computer Science and Engineering Division, Oak Ridge 
National Laboratory, Oak Ridge, TN, United States 
4Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, 
Knoxville, Tennessee, 37996, USA.  
5PROTEO, the Quebec Network for Research on Protein Function, Structure, and Engineering, 
1045 Avenue de la Médecine, Université Laval, Québec, QC, G1V 0A6, Canada.  
 
DOI : 10.3389/fmolb.2018.00054 
 
*Corresponding authors.  
 
This author contributed the following to the manuscript: (1) Calculating compounded chemical 
shifts (2) Chemical shift projection analysis, calculating projection angle and fractional shift and 







It is now widely accepted that enzymes are dynamic entities and conformational fluctuations in 
enzymes is essential for efficient catalysis. Whether these conformational fluctuations affect 
one/all step of the enzymes’ catalytic cycle is still a point of debate. By combining NMR chemical 
shift titration experiments with the chemical shift projection analysis (CHESPA) this study 
characterizes the dynamics in ribonucleases (RNases) during ligand binding. Results indicate that 
members of the hRNase family display discrete chemical shift perturbations upon ligand binding. 
The amino acid networks exhibiting long range dynamics upon ligand binding are unique to each 
of the RNases analyzed. In addition, steady-state kinetic parameters for RNases was obtained. 
The results reveal that catalytic efficiency in the human homologs differs by a more than 105 folds. 
Further using hybrid quantum classical simulations (QM/MM) and QAA, conformational sub-states 
and dynamics associated with the chemical (RNA cleavage) step of RNase function are identified. 
Interestingly the dynamics in bRNaseA during the chemical step were considerably reduced and 
the conformational sub-states did not show high amplitude motions even for functionally important 
loops. These observations suggest that high amplitude motions in RNase function facilitate the 
formation of transition state species while the actual chemical step is a result of reaction-ready 
active site configuration. 
 
5.2 Introduction 
Enzymes are biological macromolecules that enhance the rate of reaction in a cell by >1020 
folds.333 Catalytic cycle of enzymes involves several steps, including substrate recognition and 
binding to the active-site, chemical step involving the conversion of substrate to product(s), and 
product(s) release. Any of these steps could be the rate-limiting step affecting the overall rate of 
catalytic turnover in enzyme function.297, 334 An enzyme progresses through these steps in its 
catalytic cycle by the virtue of conformational fluctuation occurring over a wide range of time-
scales.128 These conformational fluctuations affect structural rearrangement of the ligand binding 
site allowing the reactive partners to orient themselves for the catalytic process.335 Evidence from 
computational and experimental approaches have revealed the existence of correlation between 
rate of catalytic turnover and time-scale of conformational flexibility in a number of enzyme 






Members of the RNase enzymes family cleave 3’- 5’ phosphodiester bond in ribonucleic acid 
(RNA) substrates.7 In humans, eight functionally important RNases (hRNases 1-8) have been 
identified.5, 8 All RNases have a conserved kidney shaped fold, catalytic residues (2 histidine and 
one lysine) and possess two-nucleotide base binding sub-sites that interact with the substrate 
molecules. A pyrimidine base binds in the B1 sub-site and a purine base binds in the B2 sub-site 
of RNases.7, 270 However, they display a wide range of substrate specificities and the catalytic 
efficiency in these enzymes differ by a million fold.9, 57, 58, 69, 105, 107, 112, 114, 117 In addition, recent 
studies report the existence of diverse biological function in the human members. In humans, 
RNases have evolved to perform other biological functions such as host defense, 
immunosuppressivity, angiogenesis, and antipathogenic activity.8, 72 The detailed understanding 
of factors  that contribute to the divergence of function in these structurally related enzymes 
remains limited. The existence of distinct dynamic behavior within hRNases (Chapter 2, 3 and 4) 
suggest a significant role of dynamics in facilitating their diverse catalytic efficiencies and 
biological functions.  
  
Efforts have been made to relate dynamics with ribonucleolytic function in bRNaseA. NMR 
experiments reveal the existence of ms time-scale conformational motions in RNases which also 
corresponds to the time-scale of catalytic turnover reported for bRNaseA.136 It was further 
uncovered that conformational motions in bRNaseA corresponds to the product release step. 
Conformational exchange during product release was observed in residues of distal loop.25 
Mutating these distal residues not only reduced the global motions in bRNaseA but also 
decreased the rate of product release by 10 folds.138, 216 These evidences suggest a possible role 
of conformational fluctuations in function of bRNaseA, particularly the product release step. 
Whether the motions in distal regions also affect the chemical step of bRNaseA needs to be 
examined. Moreover, the effect of dynamics in ligand binding and chemical step of hRNases has 
not been characterized in such details. Therefore, several areas where dynamics could potentially 
play a promoting role in the function of hRNases and bRNaseA remain unexplored. This study 
aims to compare and characterize the structural and conformational changes associated with 
ligand binding for select hRNases. Further, this study seeks to address if RNases have specific 
motions corresponding to the chemical step in their enzymatic cycle and identify whether these 
motions are localized around the active site or occur in the distal regions of the enzyme. And 






The rate of catalytic turnover in these structurally related RNases varies by a million-fold.9, 57, 58, 69, 
105, 107, 112, 114, 117 However, these studies were performed by different groups under different 
experimental conditions using a wide variety of substrates ranging from dinucleotide RNA 
substrates to tRNA of unknown sequence and lengths. The diversity in the previously used 
method for characterizing kinetic rates for RNases rather makes it difficult to comparatively 
analyze the difference in the efficiency of these enzyme. For quantitative and relevant 
comparisons, it is essential to remove the errors and variations that could be imparted due to 
differences in experimental conditions. And therefore, this study systematically characterizes the 
kinetic rates in hRNases and bRNaseA under same experimental conditions and with same 
dinucleotide substrate (UpA).  
 
In this study, three aspects of RNase function were investigated: Kinetic parameters for various 
hRNases were obtained using steady-state kinetics with same substrate (UpA) under identical 
conditions; Conformational dynamics induced by ligand binding in the members of the RNase 
family were probed by NMR titrations and chemical shift projection analysis (CHESPA); 
Conformational dynamics and sub-states associated with phosphor-diester bond cleavage (the 
chemical step) were identified using hybrid QM/MM modeling of the reaction pathway and quasi 
anharmonic analysis (QAA). 
 
5.3 Materials and methods  
Michaelis-Menten steady-state kinetics: The rate of enzymatic reaction is measures over a 
range of substrate concentration ([S]). The initial rate V0 increases with the increase in [S].  
However, as [S] gets higher, the enzyme becomes saturated with substrate and the initial rate 
reaches Vmax, the enzyme's maximum rate. At Vmax, increase in substrate concentration does not 
cause any increase in reaction rate as there is no more enzyme (E) available for reacting with 
substrate (S). Using the steady-state method kinetic parameters are obtained from the  Michaelis-
Menten equation described below (Eq 5.1). However, the Michaelis-Menten equation is based on 
two assumptions; first, the concentration of the substrate-bound enzyme changes much more 
slowly than those of the product and substrate and thus the change over time of the complex can 









v =  𝑉𝑉𝑚𝑚𝑚𝑚𝑚𝑚 [S]
𝐾𝐾𝑀𝑀+[S]
      5.1 
Where  
𝑉𝑉𝑚𝑚𝑚𝑚𝑚𝑚 =  𝑘𝑘𝑐𝑐𝑚𝑚𝑐𝑐 [E]      5.2 
KM is the Michaelis constant, experimentally defined as the concentration at which the rate of the 
enzyme reaction is half Vmax. kcat  denotes the maximum number of enzymatic reactions catalyzed 
per second also called turnover number. 
 
Steady-state kinetic parameters (kcat and KM) were obtained on a Perkin Elmer Lambda 35 UV-
vis spectrophotometer. Activity of RNases was measured in 50 mM sodium acetate, 1 mM EDTA 
at pH 5.5 and 25°C. Dinucleotide substrate UpA was obtained from Dharmacon at GE Healthcare. 
The concentration of UpA was measured using the extinction coefficient 24600 M-1cm-1 supplied 
from Dharmacon. Change in UpA absorbance was measured in 1 or 2 mm path length cuvettes 
at 286 nm for 10 mins. Enzyme and substrate concentrations used for the study are indicated in 
Table 5.1, and all measurements were performed in duplicate. Water was incubated with 1% 
DEPC for 1 hr and autoclaved. All equipments were cleaned with DEPC-treated water before 
starting the experiment to inhibit the environmental contaminant RNases from interfering with the 
kinetic assay. Buffer was made with DEPC treated water as well. The data were fitted to Michaelis-





Table 5.1: Enzyme concentrations and range of substrate (UpA) concentrations used in 





Range of UpA 
concentration 
(mM) 
bRNaseA 0.002 0.1 – 1.5 
hRNase2 0.05 0.0 – 3.0 
hRNase3 1.0 0.5 – 4.2 
hRNase4 0.05 0.3 – 2.1 
hRNase5 9.0 0.8 – 4.0 






NMR chemical shift titrations: NMR chemical shifts of atoms are sensitive to changes in their 
chemical environment and are therefore used to detect structural and conformational changes 
associated with ligand binding. In this study, NMR chemical shift titration experiments were 
performed to compare and characterize the effect ligand binding (two ligands, 3′-UMP and 5′-
AMP) on the conformational properties of the five RNases, hRNase2, hRNase3, hRNase4, 
hRNase5 and bRNaseA. All RNases were expressed and purified in our collaborator Dr. Nicolas 
Doucet’s group using the protocols described in 138, 142, 146, 327. 15N-carr-purcell-meiboom-gill 
(CPMG) NMR relaxation experiments and NMR titration experiments were also performed in Dr. 
Nicolas Doucet’s group as described in 327.  
 
Chemical shift perturbations (Δδobs): were calculated as the difference in the weighted average 





     5.3 
 
Chemical shift projection analysis (CHESPA): CHESPA was performed based on the protocol 
described by Selvaratnam et al.336 The chemical shift perturbations (Δδobs) of the ligand-bound 
state relative to the apo state corresponds to the shifts for the highest enzyme: ligand molar ratios 
for each enzyme. For all enzymes studied, residues with a chemical shift variation Δδobs > 0.05 
ppm were selected for further analysis. The two CHESPA parameters, projection angle (cos(θ)) 
and fractional shift (X), were calculated according to the equations (5.4 and 5.5 respectively) 
below using the 1H and 15N peak coordinates in their free (apo) form and upon binding to the two 
mononucleotide ligands, 3′-UMP (vector A) and 5′-AMP (vector B) at saturation conditions (Figure 
5.1). 
 
cos(θ) = Α∙Β|Α|∙|Β|       5.4 
 
X= Α∙Β|Β|2       5.5 
 
The projection angle (θ) is defined as the angle between the chemical shift peak displacements 





vector) and 5′-AMP (B vector) relative to the apo state. The fractional shift (X) corresponds to the 
magnitude of displacement of A relative to B. 
 
Residues that show a gain (or loss) of millisecond exchanges in both the 3′-UMP- and 5′-AMP-
bound states relative to the apo state are defined as displaying coordinated changes in motions 
(Figure 5.2 A). Residues displaying a gain (or loss) of dynamics in only one of the two (5′-AMP or 
3′-UMP) ligand-bound states relative to the apo state are defined as displaying uncoordinated 
changes (Figure 5.2 B).  
 
Reaction pathway sampling using Hybrid quantum mechanics/molecular mechanics 
(QM/MM) and nudged elastic band (NEB) method: RNA cleavage step for bRNaseA was 
modeled using hybrid QM/MM and NEB method in AMBER.310 In NEB method, the pathway for 
conformational change between two end points is calculated using a series of images (called as 
nodes) of the molecule/system. Each image between the end points is connected to the previous 
and next image by springs that force each node to remain at an average separation between its 
partner images along the current path preventing the nodes from sliding onto each other. 
Minimization of the nodes between the end points provides a minimum energy pathway. Further 
optimization using simulated annealing estimates the global minimum energy pathway. The result 
is a minimum potential energy path that represents the conformational change between the two 
endpoint structures, independent of time-scale. The NEB337 method requires the users to define 
the start and end points of the reaction pathways to be studied. Also, the pathway endpoints are 
fixed during the NEB simulation in AMBER. Therefore, the reactant state (RS) and product state 
(PS) were modeled and extensively simulated to obtain a desirable start and end points for the 
QM/MM-NEB simulations.   
 
Structure preparation of RS and PS: The catalytic mechanism of phosphodiester cleavage has 
been well studied for bRNaseA.85 Based on these studies, the reactant and product states for 
bRNaseA were modeled (Figure 5.3). Since there are no published X-ray structures of bRNaseA 
with substrate, tetranucleotide substrate was modeled in the active site of bRNaseA as mention 
in chapter 3. The bRNaseA enzyme with cleaved product(s) was modeled as mention in chapter 
4. The RS and PS complexes were solvated in a SPC/E277 water box with periodic boundary 
conditions and neutralized with the addition of chloride (Cl-) counterions. The systems were 
equilibrated using the previously described protocol.338 PME-method339 was implemented for long 







Figure 5.1:Illustration of the CHESPA approach. The 1H-15N peak is represented for apo 
(gray), and bound forms 5’-AMP (blue) and 3’-UMP (orange), respectively. Arrows indicate the 
movement of the 1H-15N chemical shift for each peak from its apo (in red) to its saturated position 
(blue and orange). The compounded chemical shift upon ligand binding is calculated as the 
magnitude of vectors A and B, respectively (see text for details). θ represents the angle between 







Figure 5.2: The NMR chemical shift projection analysis (CHESPA). Graphical representation 
of scenarios representing (A) coordinated and (B) uncoordinated displacements of the chemical 







Figure 5.3: Starting structures for enzyme-substrate and enzyme-products complexes. The 
computationally modeled structures for QM/MM-NEB simulation are shown; bRNaseA (gray 
ribbon), substrate (green sticks), products (yellow and light green sticks) and water molecules 






Production runs of 0.5 µs (microsecond) were performed under constant volume and energy 
(NVE) conditions using a 2 femtoseconds (fs) time-step. Simulations to obtain starting 
conformation of RS and PS systems were performed using NVIDIA graphics cards with CUDA-
enabled version of AMBER’s pmemd MD simulation engine. The default precision in the 
pmemd.cuda_SPFP binary was used from AMBER v14 package.310 The final structures of the 
production trajectories were used as input for QM/MM optimization.  
 
Structure preparation of RS and PS for QM/MM optimization: A QM region and a MM region 
were identified for RS and PS. The QM region includes 47 atoms selected from the side chains 
of three catalytic residues (two histidine and one lysine residues), ribose sugar rings of the two 
nucleotides next to the cleaved phosphate group, and three water molecules (Figure 5.4). The 
remaining parts of the tetra-nucleotide substrate, enzyme, counterions and the water box were 
modeled as classical region and treated by molecular mechanics (AMBER’s ff14SB311 force field). 
A total of 38162 atoms constitute the MM region. QM/MM optimization of RS and PS was 





of calculation was chosen because of its manageable computational complexity. QM compatible 
PME approach was used for calculating the long-range QM-MM electrostatic and forces. The 
optimized QM/MM structures of the RS and PS were used as endpoints for reaction pathway 
sampling using QM/MM-NEB method.  
 
Reaction pathway sampling using QM/MM - NEB method: NEB methods attempts to find the 
lowest pathway on the potential energy surface between the two endpoints provided. The NEB 
protocol created six additional replicates (making a total of 8 nodes including the two endpoints 
provided) that will stretch along our pathway and be joined by springs. First all eight nodes were 
heated from 0 – 300 K in 20,000 steps with a 0.1 fs timestep. During the heating process hydrogen 
atoms were not constrained by SHAKE. Relatively small spring constant of 10 kcal/mol/Å2 was 
used. Next simulated annealing was performed with the temperature profile increasing from 300 
K to 500 K and back to 300 K. A total of 150 ps MD was performed in this step with a time-step 
of 0.25 fs. In the next  step the system was cooled down, so that that images freeze out along 
the low energy pathway. The nodes were cooled in 2 stages. At first stage the nodes were 
gradually cooled from 300 K to 0 K step over 6 ps. Finally, a long cooling was performed at 0 K 
for 10 ps with a time-step of 0.1 fs. Conformations were saved after every 10 steps per NEB node. 
Final QM/MM - NEB production run was performed for 200,000 steps at the time step of 1 fs for 
all 8 NEB nodes. Coordinates were saved after every 2 ps.  
 
Intrinsic dynamics: The intrinsic dynamics in bRNaseA during the chemical step was deduced 
from the root mean square fluctuations of the Cα atoms of the top 10 QHA modes (RMSF10). 228, 
287 Fluctuations were computed using the ptraj analysis module in AMBER.342 Conformations form 
only the final production trajectory of all 8 NEB nodes were used for RMSF10 calculations. For 
comparison RMSF10 results for apo, substrate bound and product release simulations from 
chapters 2, 3 and 4 respectively were used. 
 
Conformational sub-states using quasi anharmonic analysis (QAA): The 80000 
conformations (10000 conformations per NEB node) obtained from the hybrid QM/MM and NEB 
simulations were used for QAA.129 The original 3N dimensional space for the Cα atoms was 
projected onto 60 - dimensional space using QHA modes and then analyzed using QAA. Using a 
mixture of gaussian modes three clusters representing distinct NEB nodes were identified. The 
three QAA independent component vectors were analyzed in detail to characterize the 






Figure 5.4: Reactive center for reactant and product states. The side chain of catalytic 
residues and the sugar-phosphate backbone that form the reactive center for the RS and PS are 
shown. Atoms included in the QM region (blue) and MM region (black) are identified. Note that 
water molecules that form the part of the QM region are not shown to increase the clarity of the 






5.4 Results  
5.4.A Elucidating the differences in kinetics parameters for human ribonucleases 
Kinetic parameters (kcat and KM) for cleavage of dinucleotide substrate UpA by hRNases and 
bRNaseA were obtained using Michaelis-Menten steady-state kinetics at pH 5.5 and 25 °C. To 
facilitate comparison between the different enzymes the enzymatic activity of the hRNases was 
quantified using the same substrate UpA. The kinetic parameters of bRNaseA was quantified for 
reference. The results indicate that all RNases were able to cleave UpA, as expected for the 
canonical members of this superfamily.8 Most RNases exhibited KMs above 1 mM, with bRNaseA, 
hRNase2, hRNase4, hRNase6 showing better affinities (Table 5.2). hRNase2 showed the highest 
kcat (~88 s-1) among hRNases and a catalytic turnover ~ 6 times lower than bRNaseA. The catalytic 
efficiency (kcat/KM) of hRNase3 was three to four orders of magnitude lower than that of the 
bRNaseA. Approximately 104-fold difference was observed in the kcat values, between the fastest 
(bRNaseA) and the slowest (hRNase5) enzyme. Together, these results indicate a nearly 105-
fold difference in catalytic efficiency (kcat/KM) between hRNases, further exemplifying the distinct 






Table 5.2: Comparing the steady-state kinetic parameters for RNases. The parameters were 
obtained at pH 5.5, 25 °C substrate concentration was varied, and the data were fitted to 
Michaelis-Menten equation. 
 
Enzyme KM (µM) kcat(s-1) kcat/KM (M-1s-1) 
bRNaseA 120 ± 40 450 ± 30 3.8 ± 0.7 x 106 
hRNase2 520 ± 50 88 + 3 1.7 ± 0.2 x 105 
hRNase3*   6.7 ± 1.6 x 102 
hRNase4 440 ±160 16 ± 2 3.7 ± 0.6 x 104 
hRNase5 2500 ± 880 0.031 ± 0.006 12 ± 2 
hRNase6 140 ± 10 5.7 ± 0.1 4.1 ± 1.3 x 104 






5.4.B Ligand-induced variations in structural and dynamical properties of RNases 
The effect of binding of two mononucleotide ligands 3’-UMP and 5’-AMP (also product analogs), 
on conformational properties of RNases was probed using NMR shift titrations. The compounded 
chemical shift changes Δδobs (at the highest ligand concentration) upon binding of 3’-UMP and 5’-
AMP for the five RNases studied (hRNase2, hRNase3, hRNase4, hRNase5, bRNaseA) are 
shown in Figure 5.5. Residues displaying Δδobs > 0.1 ppm for all RNases are reported in Table 
5.3. Notable differences were observed in the number of residues affected upon binding of 3’-
UMP to the functionally distinct RNases. In bRNaseA, 21 residues displayed Δδobs > 0.1 ppm and 
largest chemical shift perturbations were observed near the residues Thr45, His119 and Lys41 
primarily the B1 pyrimidine binding sub-site. Additional large perturbations (Δδobs > 0.1 ppm) were 
observed for some residues far from the active site, suggesting long-range conformational 
changes or motions in these regions upon 3’-UMP binding. Similar to bRNaseA, in hRNase2 large 
perturbations were observed in residues near the B1 sub-site, as well as residues of distal loops 
(Ser64 and Lys66 of L4 and Cys37 of L2). However, the total number of residues that displayed 
Δδobs > 0.1 ppm were less when compared to bRNaseA. Further, in hRNase4 only few residues, 
primarily localized to the pyrimidine binding B1 sub-site, displayed chemical shift perturbations 
upon ligand binding. This observation is significantly different from its behavior in apo state, where 
most residues undergo conformational exchange.267 On the contrary, in hRNase3 perturbations 
were dispersed throughout the protein with large chemical shift variations in loops L4 (positions 
67–76) and L5 (positions 80–83). These loops however were minimally perturbed in the other 
RNases upon binding of 3’-UMP.  In contrast to bRNaseA, the catalytic residues of hRNase3 
(Lys39 and His128) did not display significant perturbations upon 3’-UMP binding. Similarly, in 
hRNase5, residues in the B1 sub-site did show perturbations while residues far from the active 
site were affected.  
 
Titration of ligand 5′-AMP resulted in perturbations of residues near the purine binding sub-site 
(B2) in all RNases, except hRNase5. In, bRNaseA, hRNase2 and hRNase4 residues of loop L4 
displayed significant perturbations. Loop L4 has previously been reported to interact with the 
purine base. Additional perturbations are observed in N-terminal alpha helix in hRNase2 and C-
terminal regions of hRNase4. In contrast perturbations in L4 were diminished in hRNase3 upon 
binding of 5’-AMP and even fewer residues displayed perturbations relative to 3’-UMP binding. In 







Figure 5.5: Effect of ligand binding on functionally distinct RNases. Compounded chemical 
shift perturbations (Δδobs) relative to the apo form upon binding of two mononucleotides 3’-UMP 
and 5’-AMP are plotted as function of consensus sequence. Chemical shift perturbations were 
calculated by comparing the shifts at the largest enzyme:ligand molar ratios relative to the apo 
state for each enzyme.  Δδobs are depicted on the 3D structures using the putty representation to 
the right of the plots, the width of the tube corresponds to larger Δδobs. The 3’-UMP and 5’-AMP 
ligands are shown in the structures of bRNaseA only, they bind at same site in other RNases. 
Catalytic residues (His12, Lys41, His119, bRNaseA numbering) are highlighted using gray lines. 
Secondary structure of bRNaseA is shown on top of the graphs. The consensus sequence 








Table 5.3: Chemical shift perturbations upon ligand binding. Residues displaying ∆δobs ≥ 0.1 
ppm upon 3’-UMP and 5’-AMP binding to RNases is reported. 
 
Residues displaying Δδobs ≥ 0.1 ppm upon 3’-UMP binding 
bRNaseA hRNase2 hRNase3 hRNase4 hRNase5 
Residue Δδobs Residue Δδobs Residue Δδobs Residue Δδobs Residue Δδobs 
11 0.145 7 0.147 4 0.281 5 0.105 11 0.125 
12 0.137 11 0.241 11 0.134 20 0.125 42 0.172 
17 0.149 15 0.195 14 0.194 42 0.349 50 0.113 
41 0.223 16 0.102 16 0.162 44 0.310 51 0.157 
44 0.490 37 0.229 31 0.129 103 0.114 53 0.120 
45 1.197 42 0.213 40 0.335 116 0.127 56 0.124 
46 0.258 43 0.247 48 0.118 117 0.261 61 0.107 
47 0.110 64 0.145 55 0.109 118 0.121 65 0.125 
51 0.180 66 0.101 57 0.105   72 0.106 
66 0.152 82 0.162 62 0.123   84 0.159 
82 0.163 83 0.209 64 0.302   103 0.137 
96 0.149 103 0.108 66 0.238     
97 0.108 129 0.249 69 0.113     
99 0.101 130 0.477 75 0.279     
100 0.130 131 0.361 77 0.189     
101 0.187   84 0.346     
105 0.107   129 0.568     
119 0.225   130 0.136     
120 0.403         
122 0.206         
 
Residues displaying Δδobs ≥ 0.1 ppm upon 5’-AMP binding 
bRNaseA hRNase2 hRNase3 hRNase4 hRNase5 
Residue Δδobs Residue Δδobs Residue Δδobs Residue Δδobs Residue Δδobs 
11 0.166 7 0.101 10 0.279 5 0.183 12 0.122 
43 0.107 8 0.208 41 0.112 11 0.100 14 0.179 
45 0.227 11 0.244 64 0.118 20 0.118 25 0.158 
46 0.133 14 0.250 110 0.132 44 0.125 106 0.106 
51 0.239 15 0.164 128 0.235 50 0.158 117 0.112 
58 0.249 39 0.109 129 0.169 66 0.178   
64 0.134 64 0.211 130 0.194 68 0.228   
65 0.450 66 0.101   70 0.201   
66 0.193 82 0.100   71 0.157   
68 0.139 83 0.105   115 0.110   
69 0.145 95 0.190   116 0.137   
71 0.190 128 0.236   117 0.625   
72 0.194 129 0.460   118 0.152   
101 0.116 130 0.332   119 0.208   
112 0.104 131 0.464       
118 0.149         
119 0.259         
120 0.325         






chemical shift perturbations, suggesting few interactions with 5’-AMP. Overall, these observations 
indicate that closely related RNases display distinctly different conformational rearrangements of 
local chemical environment upon binding of the two single-nucleotide RNA product mimics. These 
observations further confirm the difference in affinity of these RNase for a common ligand as seen 
in Chapter 2. Additional dynamics in distal regions is different for these enzymes even though 
they share the same fold, consistent with our observation of distinct conformational sub-states in 
product release (Chapter4).  
 
The structural rearrangements and local/global conformational motions in proteins that occur 
upon ligand binding can be identified by probing the changes in chemical shift perturbations. In 
this study, the chemical shift projection analysis (CHESPA) is employed to delineate the changes 
associated with 3’-UMP and 5’-AMP binding to RNases. The schematic representation of the 
CHESPA approach is shown in Figure 5.1. The projection angle and fractional shift determined 
for each of the five RNases is shown in Figure 5.6. The projection angle (θ) is the angle between 
the chemical shift peak displacements (for residues with Δδobs > 0.05 ppm at the highest ligand 
concentration) upon binding of 3’-UMP and 5’-AMP (represented by A vector B vector respectively 
in Figure 5.1) relative to the apo state. The fractional shift (X) corresponds to the magnitude of 
displacement of A vector relative to B vector. Chemical shift changes are defined as coordinated 
when cos(θ) ≥ 0.9 and the chemical shift perturbations upon binding of the two ligands is similar, 
and uncoordinated when cos(θ) < 0.9. Residues that display coordinated chemical shift 
displacements also showed fractional shift (X) ≥ 1, suggesting similar or larger changes in 
magnitude upon binding of 3′-UMP relative to 5′-AMP in all RNases. 
 
Most residues of bRNaseA were involved in both 3’-UMP and 5’-AMP ligand binding. Lys66 (P0), 
Thr45 (B1) and the catalytic His12, showed coordinated displacements (Figure 5.6). While, the 
residues His119 and Lys41 (of active-site), Lys7 (P1) binding site, Thr17 (loop 1) and residues of 
the C-terminal 𝛽𝛽 strand showed uncoordinated displacements of the chemical shifts, indicating 
the different effects upon binding of the two ligands (Figure 5.6). In hRNase2, residues in the 
ligand binding sites displayed both coordinated and uncoordinated displacements, with residues 
of loop L4 displaying uncoordinated displacements. Uncoordinated displacements were observed 
throughout hRNase3, with the exception of residues Gln4 and His15 that displayed coordinated 
behavior. The effect of ligand binding on hRNase3 was markedly different from hRNase2 and 
bRNaseA. The active site residues of hRNase4 showed coordinated chemical shift 







Figure 5.6: Chemical shift projection analysis of ligand binding to RNases. The projection 
angle (cos(θ), left) and the fractional shift (X, right), calculated for residues with Δδobs > 0.05 ppm 
at the highest ligand concentration are shown. Coordinated (cos(θ) ~ 0.9, green) and 
uncoordinated (cos(θ) < 0.9, red) residues are identified on the three-dimensional structures of 
individual RNases using tube representations. Residues displaying positive and negative 
fractional shifts are displayed using black and white bars, respectively. Catalytic residues (His12, 
Lys41, His119, bRNaseA numbering) are highlighted using gray lines. Secondary structure of 
bRNaseA is shown on top of the graphs. The consensus sequence (obtained including gaps in 






Effect of ligand binding in hRNase4 was quite similar to bRNaseA. Coordinated chemical shift 
displacements were predominant in the V1 domain of hRNase5, consistent with previous 
observations146 while uncoordinated displacements were observed for residues His8, Ser28 and 
His84 (Figure 5.6). Overall, these results suggest that subtle variations in the ligand binding 
pocket or the active-site environment in these closely related RNases can lead to significantly 
different long-range effects throughout the structures upon ligand binding. 
 
5.4.C Conformational dynamics in the chemical step of bRNaseA 
The conformational flexibility (or intrinsic dynamics) of bRNaseA during the chemical (RNA 
cleavage) step was quantified using the aggregated root means square fluctuation of top 10 
slowest QHA modes (RMSF10) sampled in the hybrid QM/MM - NEB simulations. QM/MM 
simulations have been previously used to identify conformational fluctuations in enzymatic 
systems.343 The conformational fluctuations in the chemical step of bRNaseA is shown in Figure 
5.7. The dynamics of bRNaseA in the chemical step is further compared to fluctuations observed 
in the apo state, substrate bound and product release simulations (Figure 5.7 B). Higher 
fluctuations are observed in the loop regions particularly loops L1 and L4, as compared to other 
secondary structure elements (Figure 5.7 A). Loop L1 is previously reported to play a role in 
bRNaseA function.138 Residues of Loop L4 (particularly Asn71) are reported to interact with purine 
residue of RNA substrate (Chapter 3). These loops are therefore functionally important in 
bRNaseA catalytic cycle and continue to be dynamic in the chemical step. However, fluctuations 
in these loops is considerably reduced for the chemical step when compared to other steps of the 
bRNaseA catalytic cycle (Figure 5.7 B). This variation in the fluctuations could be due to the 
difference in simulation methods used for each step. Dynamics for apo, and substrate bound 
systems were computed using long time-scale classical MD simulations, product release 
simulations were performed with umbrella sampling simulation, while the dynamics in chemical 
step is computed using hybrid QM/MM method which are relatively of shorter. Further, the amount 
of sampling varies in the computed trajectory of each step. Therefore, in order to firmly conclude 
that the reduced dynamics in chemical step is not by chance but a feature of bRNaseA function 






Figure 5.7: Dynamical behaviour of bRNaseA in the chemical step. Root mean square 
fluctuations corresponding to the Cα displacements in the top 10 quasi-harmonic modes (RMSF10) 
for bRNaseA (A) RMSF10 is projected on cartoon representations of the enzyme (B) Comparison 
of conformational dynamics in each step of the bRNaseA catalytic cycle; apo enzyme (red), 
substrate bound (orange), chemical step (turquoise) and product release (green). Flexible loop 








5.4.D Conformational sub-states in the chemical step of bRNaseA function 
The RNA cleavage step in bRNaseA was modelled using hybrid QM/MM and NEB simulations in 
AMBER simulation package. Eight nodes were computed along the pathway from reactant to 
product states (Figures 5.3 and 5.4). QAA was used to determine the conformational sub-states 
in the chemical step of bRNaseA. Coordinates of 80800 conformations obtained along reaction 
pathway were projected on to 60-dimensional space using QHA for QAA. Using a mixture of 
gaussian modes, three clusters representing three nodes of the NEB pathway were identified 
(Figure 5.8). Conformational sub-states in bRNaseA during the cleavage of RNA molecule are 
illustrated in wireframe, showing only the Cα trace of the enzyme residues, and colored according 
to their respective sub-states. Detailed analysis of the conformational fluctuations reveals that no 
particular region in the enzyme show motions with large amplitude in the conformational sub-
states identified along the chemical step pathway from reactant to product states. Whereas the 
conformational sub-states associated with the product release step revealed the existence of high 
amplitude fluctuation in loop L1 of bRNaseA (Figure 4.7). This variation in conformational motions 
associated with chemical step in bRNaseA could be characteristic of intrinsic dynamics in the 
catalytic pathway. Suggesting that functionally relevant conformational sub-states with high 
amplitude of fluctuations are present in product release rather than the chemical step. However, 
it is quite possible that reduced motions in the chemical step are a result of scarce sampling in 
the QM/MM - NEB method. Therefor to validate the preliminary findings of this study, profound 
sampling of the NEB nodes in the chemical step pathway is required.  
 
5.5 Discussion 
The rate of enzymatic reactions is traditionally measured during the steady-state period. During 
this time the reaction rate changes relatively slowly and therefore steady-state kinetics methods 
provide a good approximation of the catalytic efficiency. To facilitate comparison between the 
different hRNases the enzymatic activity of these enzymes was quantified using the same 
substrate and the kinetic parameters of bRNaseA was quantified for reference (Table 5.3). The 
results indicate that the catalytic efficiency in hRNases vary by ~105 fold with hRNase5 being the 
slowest enzyme. While hRNase2 is fastest among all hRNases compared in this study, it is 
however ~20 times slower than bRNaseA. And hRNase5 is ~ 106 folds slower than bRNaseA. 
These observations correlate to the previously identified kinetic parameters (Table 1.2) for these 








Figure 5.8: Conformational sub-states in the chemical step of bRNaseA function. Quasi 
anharmonic analysis was used for higher order statistical clustering of conformations sampled in 
the QM/MM-NEB simulations is shown in the box plots above Each dot corresponds to a single 
conformation and is colored according to the NEB node it belongs to (see color bar). The ellipses 
represent identified conformational sub-states. The black arrows indicate transitions from 
heterogenous population to a well-defined homogenous sub-state. Motions along the anharmonic 
mode (𝛾𝛾) are illustrated in the panels below in a wire frame representation, showing only the C⍺ 






Characterizing conformational motions that affect enzyme catalysis is essential to understand 
enzyme function.344, 345 These motions are known to occur in each step of the enzymes’ catalytic 
cycle; apo, ligand binding, ground-state, product release and the chemical event itself.346 Ligand 
binding perturbs the energy landscape of the enzymes resulting in conformational changes that 
affect enzyme catalysis. The structural and dynamical changes induced as a result of ligand 
binding have been identified for a few enzymatic systems.235, 331, 347  However how motions in 
RNases facilitate ligand recognition and catalysis remains unknown. It will be interesting to identify 
conformational motion induced by ligand binding in the members of the RNase family, where 
different members have distinct ligand specificities. Comparison of motion in ligand binding would 
further provide information on the role of dynamics in the wide range of specificities and catalytic 
efficiencies in this enzyme family.  
 
In this study, NMR chemical shift titration experiments were combined with the chemical shift 
projection analysis (CHESPA) to characterize conformational motions induced upon binding of 
two mononucleotides (3’-UMP and 5’-AMP) to gain insights into the mechanism and function of 
RNases with different biological functions. Long-range conformational rearrangements are 
observed in hRNase3 upon binding of 3’-UMP consistent with previous studies.142 While, in 
hRNase4 perturbations were confined only to the pyrimidine binding site consistent with the low 
binding affinity observed in this enzyme.327 The results indicate the occurrence of distinct long-
range and local conformational rearrangement in each of the enzyme studied. Further using 
CHESPA, amino acid residues that exhibit long-range coordinated chemical shift perturbations 
upon ligand binding were identified. Interestingly not all RNases displayed the same coordinated 
amino acid perturbations previously shown in hRNase5.146 Difference in the amino acid displaying 
concerted motions was observed even for closely related enzymes, hRNase2 and hRNase3. 
These observations suggest that dynamical pattern in RNases is not conserved and might be 
adapted to the biological function of each enzyme. To confirm if these long-range motions affect 
the function of individual enzyme, further mutagenesis experiments and development of allosteric 
modulators that can directly affect the ribonucleolytic activity or biological function is required.   
 
Evidence suggest millisecond motions affect catalysis by bRNaseA.136 Whether these functionally 
relevant motions occur in one/all steps of the enzymes’ catalytic cycle remains unknown. The 
conformational sub-states that modulate enzyme function are not yet identified for RNases. To 
obtain insights into the conformational dynamics associated with the chemical step the pathway 





order QAA is further employed to identify the conformational sub-states associated with the 
conversion of substrate to products. This type of analysis has not been previously employed for 
other enzyme systems. The conformational sub-states/motions identified from QAA in the 
chemical step show reduced dynamics as compared to apo, substrate bound and product release 
steps (chapters 2, 3, and 4). These observations suggest that motions in RNases might not affect 
the chemical step directly, consistent with the proposition that efficient enzymes minimize dynamic 
coupling in their transition states.348 Previous studies suggest that conformational fluctuations in 
enzymes facilitate the formation of transition state species while the actual chemical step is a 
result of reaction-ready active site configuration.348-350 This argument could stand true for 
bRNaseA, where conformational motions in ground state or product releases effect catalysis, 
while the dynamics is considerably reduced in the chemical step. However, this observation would 
have been more obvious if the time-scales QM/MM simulations and the chemical events were 
same. Therefore, correlations between the identified conformational sub-states/motion and 
chemical step must be interpreted with caution. To identify the direct effect of dynamics on the 
chemical step, the kinetic isotope effect in the chemical step of a ‘dynamic knockout’ (mutations 













The motivation of the work described in this thesis was to characterize the role of internal motions 
in the function of closely related RNases family, including human RNases. Dynamical features 
that allow the progress of enzymes’ catalytic cycle through various stages were identified for 
several hRNases and bRNaseA, using a combination of computational and experimental 
methods. The major contributions of the work are summarized below. 
 
In chapter 2, sequence base phylogenetic analysis classifies 23 RNases from the vertebrate 
family into four sub-families. Members of each sub-family incidentally also shared similar 
biological functions. The millisecond time-scale motions of representative members from each 
sub-family were characterized using 15N-CPMG relaxation dispersion experiments. The 
dynamical profile of all 23 RNases, on the µs time-scale, were probed using computer simulations. 
Results indicate, members within a sub-family not only perform similar biological functions but 
also exhibit remarkably similar dynamics. Hence, in this enzyme superfamily, dynamics is 
conserved in association to biological function. Characterization of dynamical properties of 
diverse RNases showed higher fluctuations in the loop regions as compared to other secondary 
structural elements in all RNases. However, distinct variations in the dynamical pattern of each 
sub-family arise from higher fluctuations of different loops in each sub-family. Loop L1 exhibits 
motions with highest amplitude in the members of the RNase A-like sub-family. On the other hand, 
L1 is truncated in members of EAR-like sub-family and residues of loop L4 have fluctuations 
higher than other regions. Further it is noted that the difference in dynamics between different 
sub-families arise from non-conserved residues, which may influence the functional identity of 
these sequences. 
 
Large protein families found in humans and other organisms are an outcome of gene duplication 
events. It is unlikely that two genes with same function are stably maintained in the genome unless 
that extra amount of gene product is advantageous.351 Therefore, the paralogous genes either 
adopts a new/related functions (neofunctionalization) or specializes in performing one of the 
function of the parent genes (sub-functionalization).352 For instance in the RNase A superfamily, 
a novel antibacterial activity emerged in hRNase3 of the EAR like sub-family while hRNase1 of 
the RNaseA like sub-family represents the progenitor gene before duplication. Mutations arising 
from functional divergence appears to confer optimization of protein structure and thereby protein 





conformational dynamics affecting binding affinity and specificity in structurally related proteins.285, 
353, 354 A recent experimental study has shown that mutations in the active site and distant region 
generating an ensemble of different conformations can evolve new enzyme function within the 
same fold.355 Results from these examples and chapter 2 highlight that conformational dynamics 
can provides a link between structural and functional diversity in protein/enzyme super-families. 
 
The catalytic efficiency and nucleotide binding preference for RNase family members have been 
determined by diverse research group under various experimental conditions (pH, temperature, 
buffer) and sometimes with substrate of unknown sequence making it difficult to understand their 
chemical and biological functions at the molecular level. Chapter 3 focuses on systematically 
characterizing the nucleotide binding properties of 7 hRNases and bRNaseA with two model 
substrates ACAC and AUAU using all atom MD simulations at microsecond time-scale and 
theoretical analysis. The results reveal that the interaction of all 7 hRNases with the model 
substrates is very different, ranging from stable enzyme-substrate complex (at µs time-scale) to 
weakly interacting. Detailed characterization reveals that different non-catalytic residues play a 
significant role in enzyme-substrate stabilization and therefore, could have important 
consequences for differences in the biological function in these enzymes. The interactions with 
the catalytic triad may need to be flexible for mechanistic aspects in all RNases. Further, insights 
into the role of enzyme dynamics in interaction with substrates unveil dynamical pattern similar to 
apo enzyme with variations in the amplitude of fluctuations in some loops for only a few RNases. 
 
Computer simulations performed at two temperatures, first is the room temperature (300 K) as 
most RNases experiments are performed at room temperature, and second is the human body 
temperature (310 K) as most RNases characterized in this study are human variants. It was noted 
that subtle change in temperature can have profound effects on structural and dynamical 
propertied of RNases. Variation in temperature also resulted in a change in substrate affinity and 
specificity for few RNases. However, the effect of temperature on substrate binding to RNases 
needs to be determined experimentally.  Often discrepancy is found in in-vitro and in-vivo 
experiments.  In several cases successful drug candidates from in-vitro experiments have failed 
to show any results in-vivo. This is in part due to difference in temperature of the two systems.356 
Therefore to attain conclusive insights all studies, in-vivo in-vitro and in-silico, should be 






Conformational motions critical to enzyme function have been identified in a number of enzymes. 
99, 202, 297, 357, 358  For enzymes like DHFR and CypA, it is now established that conformational 
motions regulate enzyme turnover.204, 359 In both these enzymes, networks that connect distal 
loops to active site residues are identified.103, 360 Further the population of conformations that 
assist in the progress of catalytic cycle in known.127, 129 However, these intricate details that 
connect dynamics to catalysis remain unknow for hRNases. Chapter 4 successfully used a 
computational approach to identify conformational sub-states and fluctuations associated with the 
RNase function. Previous evidence has indicated that conformational motions in the product 
release step is the rate-limiting for bRNaseA.136, 138, 216 A combination of umbrella sampling 
simulation and QAA identifies sub-states associated with product(s) release in hRNase3, 
hRNase5 and bRNaseA, one member from each sub-family for which the biological function is 
known (chapter 1). Interestingly QAA reveals the presence of separate conformational sub-states 
for the three RNases studied. Even motions associated with the sub-states were different in each 
enzyme. In addition, the structural interactions that allow product release were different for three 
RNases. These observations suggest that RNases have evolved to achieve their respective 
function by effectively utilizing the motions unique to each enzyme. 
 
The combination of umbrella sampling with QAA could further be used to characterize 
conformational motion unique to each enzyme in other protein families, enabling a better 
understanding of the role of dynamics in the evolution of diverse functions in structurally related 
super-families. Further, identifying conformational sub-states that pre-exist in the conformational 
landscape of related enzymes will allow selection of appropriate starting conformation required 
for successful enzyme design for a target reaction. In addition, the combination of umbrella 
sampling with QAA along the reaction pathway could be applied to identify conformational sub-
states and dynamical features critical to the catalytic mechanism other therapeutic enzymes. 
Identifying the motions that enable the formation of transition state or are critical to overcoming 
the rate limiting step, will open new avenues for developing next generation therapeutics. Small 
molecules can be designed to either enhance or inhibit enzyme function by modulate enzyme 
flexibility. In other words, use of this methodology can enable better understanding of the 
biophysical nature of enzymes and can generate applications in medicine, industry and enzyme 
design. 
 
In enzymes, inherently dynamic process is involved in substrate binding product release, and the 





catalytic steps is achieved as a result of coupling between slower long-range motions and faster 
active site dynamics.361 Long range motions in enzymes expand from the enzymes surface to the 
active site through a network of amino acids connected via non-bonding interactions. 
Conformational fluctuations that enable transitions between different catalytic cycle events limit 
the rate of catalysis in enzyme DHFR.127 To identify rate limiting motions in RNases function, it is 
therefore required to characterize intrinsic dynamics and sub-states in each step of the catalytic 
cycle of various members of the RNases family. Interesting insights have been obtained in the 
dynamic associated with the apo enzyme, ground state, and product release steps of RNases in 
Chapters 2 - 4. The work in chapter 5, focuses on characterizing dynamics in the ligand binding 
and the chemical step in select RNases. NMR chemical shift titrations and CHESPA reveal the 
existence of distinct long-range networks in hRNases and bRNaseA, suggesting that enzymes 
with diverse biological functions also have diverse dynamics. Further considerable reduced 
dynamics was observed in bRNaseA during the chemical step. Identified conformational sub-
states of the chemical step do not high amplitude fluctuations in the distant loops of bRNaseA as 
seen in the conformational sub-states of the product release step. This observation indicates that 
the chemical step in bRNaseA occurs in a relatively static environment. 
 
Overall the findings of this thesis reveal the occurrence of distinct long-range conformational 
fluctuations in the apo and ground-state enzymes, ligand binding and product release steps of 
hRNases with different biological functions and bRNaseA. Conformational sub-states with 
reduced fluctuations were identified in the chemical step of  bRNaseA (Figure 6.1). In addition, 
pre-existence of product release conformations in the ensemble of apo enzyme is established. 
Taken together, observations for this thesis suggest that in RNases, conformational fluctuations 
facilitate substrate binding, formation of transition state species and product release, while the 
actual chemical step is a result of reaction-ready active site configuration. However, the 









Figure 6.1: Conformational dynamics in the catalytic cycle of bRNaseA. (A) Root mean 
square fluctuations of Cα atoms in the top 10 QHA modes (RMSF10) in each step of bRNaseA 
catalytic cycle reveal existence of high amplitude fluctuations in apo (red), substrate bound 
(orange) and product release steps (green), while reduced dynamics is observed for the chemical 
step of RNA cleavage (turquoise). (B) All atom RMSF10 plotted on the structure of bRNaseA (PDB 
ID: 7RSA) using tube representation for each step of catalytic cycle. The dynamical range 
represented using the color spectrum is consistent across all steps with the blue and red ends of 
the spectrum corresponding to low and high dynamic regions, respectively. The thickness of the 
tube corresponds to the flexibility of residues in each step with thicker tubes corresponding to 








6.2 Future directions 
RNase structural homologs in humans are involved in a distinct biological function with promising 
therapeutic applications in several diseases including cancer, ALS and Parkinson’s disease. As 
these closely related enzymes share similar binding pockets and/or active sites, developing drugs 
targeting individual members is difficult. To target these enzymes individually, it is required to 
develop highly specific small-molecule binders and modulators that can alter enzymatic activity 
through long-range dynamical motions away from the active site. In this study, using a 
combinations NMR experiments and computer simulation functionally relevant motions unique to 
select RNases have been identified for events such as ligand binding and product release. 
Modulating the dynamical motions that can efficiently funnel the enzyme through its catalytic 
cycle, particularly in the rate limiting step will allow regulating these enzymes individually. 
However, it remains unknow if the kinetics and motions in rate limiting step of these closely related 
homologs is same. Outlined below is a summary of how knowledge obtained in this thesis could 
be combined with further computational and experimental studies to better understand distinct 
dynamics hRNases.  
 
1. In chapters 2 and 3 all atom simulation trajectories for hRNases in the apo state and substrate 
bound forms were computed. The conformations obtained from these MD runs can be further 
analyzed with QAA to identify the conformational sub-states and populations in apo and 
substrate bound forms respectively. These studies will also provide insights into conformational 
fluctuations and motions critical for molecular recognition of substrates or other binding 
partners. Populations of identified conformational sub-states could further be validated using 
conformational probabilities obtained from NMR relaxation dispersion experiments of hRNases 
in apo state and in presence of substrate analogs. 
 
2. In chapter 4 it was determined that members in individual sub-families of the RNase 
superfamily sample separate conformational sub-states in the product release step of the 
catalytic cycle. Whether the members within a sub-family access same conformational sub-
states during product release remains unknown. Therefore, exploring conformational sub-
states in product release step for more RNases from each sub-family would be an important 
step towards understanding the homogeneity in dynamics within each sub-family. It would 







3. Using hybrid QM/MM modeling with nudged elastic band (NEB) method, chapter 5 in this thesis 
identifies conformational sub-states and fluctuations that assist in phosphodiester cleavage 
step for bRNaseA of RNase A-like sub-family. This approach could be implemented to identify 
conformational sub-states in chemical turnover (RNA cleavage) step in members of other three 
sub-families as well. The results obtained will allow comparative analysis of conformational or 
dynamical changes associated with the enzyme mechanism in all identified sub-families.  
 
4. Enzymatic reactions proceed from substrate to product(s) via a transient high energy transition 
state (TS). The enzyme's ability to make the reaction faster depends on the fact that it stabilizes 
the TS. Hybrid QM/MM approach have proven useful to determine the dynamics of TS 
formation in enzymes. Identification and characterization of motions that facilitate attainment 
of TS would provide insights into the mechanistic details pertaining to the wide range of 
catalytic efficiencies observed in these closely related RNases. Modulating motions that 
promote TS formation could further be used to modulate enzyme activity in RNase family 
members. Obtaining information about TS in RNases will also provide a wealth of information 
necessary to design transition state analogs, which are also useful enzymatic inhibitors, unique 
to individual RNases. 
 
5. Studies in other enzymatic systems have indicated that rate of enzyme conformational changes 
coincides with the rate limiting step in the enzymatic catalytic cycle. The rate limiting step for 
bRNaseA is debated. While, the rate limiting state for hRNases remains unknown. In the light 
of wide range of catalytic efficiency in these enzymes, it is very much possible that rate limiting 
step in all human RNases might not be same. Therefore, to understand the role of dynamics 
in the function of hRNases it is first required to identify the rate limiting step in all hRNases. 
Thermodynamic and kinetic characterization of substrate binding, chemical step, and product 
release, using hybrid QM/MM simulations, will provide a detailed picture of the complete 
catalytic process in RNases. The heights of energetic barrier for each step would allow the 
determination of the rate-limiting step. Stopped-flow is one experimental technique that could 
also be used for this purpose. 
 
6. Detailed analysis of the conformational sub-states will provide information about location and 
amplitude of the functionally relevant dynamical motions associated with the RNA cleavage by 





the function of divergent RNases. The effect of these mutations on the enzymatic activity could 
be evaluated using steady-state Michaelis-Menten kinetics experiments. Further, 
characterizing the dynamics and conformational sub-states in mutant enzymes could further 
emphasize on the interrelation between primary sequence and enzyme dynamics. 
 
7. As observed in this study, unique dynamical properties and changes in sequence are localized 
to the distal loop regions emphasizing on their role in diversification of RNases superfamily. 
Engineering the distal loops by either inserting or deleting amino acids can induce changes in 
dynamics of these enzymes, modulating their respective function. Increase the length of loops 
would allow harnessing more energy from the bulk solvent to increasing the dynamics in 
enzyme thereby increasing catalytic turnover, as seen in 358. On the other hand, reducing the 
length of the loop might work in a vice versa fashion. Allosteric modulation of enzyme function 
could also be achieved by identification/design of small molecules that can bind to specific loop 
in individual RNases. Whether it is required to increase/decrease catalytic turnover and 
dynamics in induvial RNases depends on the goal of study. For example, antibacterial activity 
of hRNase3 does not depend on its ribonucleolytic activity, there improving catalytic turnover 
of hRNase3 is not useful for enhancing its biological function. 
 
8. It is suggested that human members of the EAR-like sub-family possess the ability to disrupt 
bacterial membrane integrity. However, it still remains unclear how these RNases specifically 
target the microbial cell wall and how it permeabilizes the membrane. Computational modelling 
of how hRNases interact with liposaccharide membrane could provide preliminary information 
on the mechanism of antibacterial activity in the enzymes. Understanding the bactericidal 
mechanisms is crucial for its development of hRNases as a novel antimicrobial agent. 
 
9. The 15N-CPMG investigation does not report conformational changes in hRNase5 on the 
millisecond time-scale. In combination with computer simulations, use of other experimental 
methods like hydrogen/deuterium exchange mass spectrometry could provide additional clues 






6.3 Assessing the quality of computer simulations  
Computer simulations are valuable tools that have immensely contributed towards understanding 
biological systems. Like experimental techniques, computer simulations have their own 
limitations. Simulations approaches include many different types of theorical foundation each with 
their own approximations, creating an uncertainty associated with the prediction.362 Unlike 
experiments, it is proven hard to assess how much of the simulation is representative of the actual 
biophysical properties. Quantification of the uncertainties in a simulation can increase the 
confidence and significance of the observables obtained from simulations 
 
The most important issues that arise while using computer simulations to describe the properties 
of an enzymatic system include: First, accurate description of the starting point for the simulations 
to ensure that the structure is at a reasonable minima; Second, the time-scale of computer 
simulations are still not fully comparable to the time-scale of enzymatic function creating an 
uncertainty in the amount of conformational sampling achieved during simulations; Third, 
reproducibility of the observation/quantity of interest, i.e. statistically significant conclusion(s). 
Some suggestions to assess the quality of computed simulation trajectories are outlined below: 
 
1. It is required to dedicate ample amount of time in carefully modeling the system(s) of interest 
and setting up the simulations. Among many other things choice of starting structure, desired 
ensemble, temperature, pressure  and the force field to accurately describe your system are 
important factors that can change the desired predictions considerably.363 If the time-scale of 
biological process cannot be reached by simplistic simulations, including enhanced sampling 
techniques to access the conformational landscape is a logical approach. Therefore, a 
simulation protocol and subsequent analysis of its results should take into account the intent 
of the study. 
 
2. Multiple trajectories should be computed starting from different starting structures.364 A variety 
in starting structures can be created by either minimizing the system or heating it at higher 
temperatures. Another way to generate new starting structures is to run a relatively small MD 
simulation and extract conformations at different time points each serving as an independent 
starting structure. The trajectories computed from all the different starting structures should 





measured with biophysical technique. To avoid bias, include all simulation data in analysis 
except the trajectories that were either not equilibrated or incorrectly setup.362  
 
3. The initial part of the simulation where the system is equilibrated to reach a local energy 
minimum relaxed state can introduce a bias in the analysis.365 Therefore, this equilibration 
portion of the simulation should not be included while computing the observables from 
simulation trajectory.    
 
4. Single simulation trajectories can be analyzed using time correlation analysis.366 Correlation 
time separates statistically independent values of the observable, having many statistically 
independent measurements of the observable suggests good sampling for that particular 
observable. 
 
5. Block averaging 362, 366, 367 is another good method to calculate the statistical uncertainty of the 
ensemble averages calculated from single simulation trajectory. In this method the simulation 
trajectory is divided into subsets. Mean of an observable is computed for each segment and 
then a standard error is calculated for all means providing a direct estimation of statistical 
uncertainty.  
 
6. Inadequate sampling in simulation trajectories can be checked by identifying if the simulation 
has converged. This can be done by either monitoring RMSD or certain dihedral angles in the 
simulation trajectory with respect to reference structure.366 A simulation is expected to be 
converged when the fluctuations in these quantities reduce along time.  
 
7. To analyze if each trajectory adequately samples the conformational landscape a combined 
clustering analysis can be useful.368 In this approach the conformations sub-states are 
grouped into clusters based on RMSD or dihedral space. If the simulations are converged all 
clusters should contain equal population of conformation from individual trajectory.  
 
8. Observables from simulations should be reported with level of confidence instead of error 
bars.362 Confidence level quantifies the frequency of interval in a sample data that the true 
value of unknown parameter lies in within the interval. This interval is defined as the point 





with 95 % level of confidence passes the qualitative test.  For non-gaussian observables use 
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